{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"name":"1. COVID-QA Preprocessing.ipynb","provenance":[],"collapsed_sections":[],"authorship_tag":"ABX9TyPDa+ndqTQP9oowsrtbRSMh"},"kernelspec":{"name":"python3","display_name":"Python 3"}},"cells":[{"cell_type":"code","metadata":{"id":"bsm8-XMMVC7r","executionInfo":{"status":"ok","timestamp":1601558102086,"user_tz":-330,"elapsed":1485,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"86786ffc-6e25-4e8e-acc3-0a1c80c19725","colab":{"base_uri":"https://localhost:8080/","height":34}},"source":["# mount the drive to access files which are on drive\n","from google.colab import drive\n","drive.mount('/content/drive')"],"execution_count":1,"outputs":[{"output_type":"stream","text":["Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"DJKasK0mVhei","executionInfo":{"status":"ok","timestamp":1601558160157,"user_tz":-330,"elapsed":1323,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# import json and load the file in json format\n","import json\n","path = \"/content/drive/My Drive/2020_Intern_03_VIIT_03_Chatbot/Coding Part (Implementation)/Database and JSON/All Data/Main Data/1. COVID-QA.json\"\n","file = open(path)"],"execution_count":4,"outputs":[]},{"cell_type":"code","metadata":{"id":"8setYmk2Xc-z","executionInfo":{"status":"ok","timestamp":1601558160160,"user_tz":-330,"elapsed":1142,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# load the data in json format\n","data = json.load(file)"],"execution_count":5,"outputs":[]},{"cell_type":"code","metadata":{"id":"evBqPfcRYh4L","executionInfo":{"status":"ok","timestamp":1601558160622,"user_tz":-330,"elapsed":1015,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"44750efa-2e34-4e75-b859-e6b5f8e7d5c4","colab":{"base_uri":"https://localhost:8080/","height":34}},"source":["# test the data is load or not\n","print(len(data['data']))"],"execution_count":6,"outputs":[{"output_type":"stream","text":["147\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"JknUEWo3Xk-h","executionInfo":{"status":"ok","timestamp":1601558161310,"user_tz":-330,"elapsed":1343,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# create a list of questioN and answer\n","question_list = []\n","answer_list = []\n","\n","# loop over the data\n","for article_id in (range(len(data['data']))):\n","    list_paragraphs = data['data'][article_id]['paragraphs']\n","                \n","    # loop over the paragraphs\n","    for paragraph in list_paragraphs:\n","        context = paragraph['context']\n","    \n","        # clean the text\n","        qas = paragraph['qas']\n","                    \n","        # loop over Q/A\n","        for qa in qas:\n","            question = qa['question']\n","            question_list.append(question)\n","            \n","            answer_ids = 1 if qa['answers'] else 0\n","\n","            for answer_id in range(answer_ids):\n","                answer = qa['answers'][answer_id]['text']\n","                answer_list.append(answer)"],"execution_count":7,"outputs":[]},{"cell_type":"code","metadata":{"id":"m7X4imp6aTjS","executionInfo":{"status":"ok","timestamp":1601558161858,"user_tz":-330,"elapsed":882,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"e3a65b1f-698d-4711-f158-ce9f2068661e","colab":{"base_uri":"https://localhost:8080/","height":34}},"source":["# check for the lenght of question list\n","print(len(question_list))"],"execution_count":8,"outputs":[{"output_type":"stream","text":["2019\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"3dCAzD3KbjYh","executionInfo":{"status":"ok","timestamp":1601558163528,"user_tz":-330,"elapsed":854,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"09f9ba71-6e09-4961-8d66-8cd3bc3e1b80","colab":{"base_uri":"https://localhost:8080/","height":34}},"source":["# check for the length of answer list\n","print(len(answer_list))"],"execution_count":9,"outputs":[{"output_type":"stream","text":["2019\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"K-n0xnpRhrHS","executionInfo":{"status":"ok","timestamp":1601558165323,"user_tz":-330,"elapsed":1230,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"e9d9d5ff-d4eb-4a42-bd2b-6f2ead6a0100","colab":{"base_uri":"https://localhost:8080/","height":54}},"source":["# test whether the questions are in the list or not\n","print(question_list) "],"execution_count":10,"outputs":[{"output_type":"stream","text":["['What is the main cause of HIV-1 infection in children?', 'What plays the crucial role in the Mother to Child Transmission of HIV-1 and what increases the risk', 'How many children were infected by HIV-1 in 2008-2009, worldwide?', 'What is the role of C-C Motif Chemokine Ligand 3 Like 1 (CCL3L1) in mother to child transmission of HIV-1?', 'What is DC-GENR and where is  it expressed?', 'How does the presence of DC-SIGNR affect the MTCT of HIV-1?', 'Why do low levels of DC-SIGNR enhance Mother to Child Transmission of HIV-1?', 'What is the percentage of Mother to Child Transmission of HIV-1, when there is no intervention?', 'Does C-C chemokine receptor type 5 (CCR5) affect the transmission of HIV-1?', 'How does Mannanose Binding Lectin (MBL) affect elimination of HIV-1 pathogen?', \"How can CCR5's effect in HIV-1 transmission be reduced?\", 'What is IFITM?', 'How many cysteine residues are contained in the first transmembrane domain of IFITM3?', 'What inhibits S-palmitoylation?', 'What interaction is inhibited by the presence of 2-bromopalmitic acid (2BP)?', 'What is a function associated with IFITM5?', 'What regulates the antiviral activity of IFITM3?', 'What is another name for IFITM5?', 'Why is the expression of IFITM5 not promoted by interferons?', 'What is the amino acid similarity between IFITM5 and the other IFITM proteins?', 'What is the amino acid similarity between IFITM 1, IFITM 2, and IFITM 3?', 'What amino acid might be involved in calcium binding in the C-terminal region of a protein?', 'What is the size of bovine coronavirus?', 'What is the molecular structure of bovine coronavirus?', 'How many nucleotides does bovine coronavirus contain?', 'What is the size of the orf1ab gene in bovine coronavirus?', \"Is the orf1ab gene at the 3' or 5' end of the bovine coronavirus genome?\", 'What is a significant cause of Influenze like illness among healthy adolescents and adults presenting for medical evaluation?', 'What is the most common species of Human Coronavirus among adults?\\n', 'Which Human Coronavirus showed species specific clinical characteristics of its infection?', 'What causes the outbreak of SARS and MERS.', 'What is the case fatality rate of SARS and MERS?', 'What were the common HCOV strains in the 5 year USA study?', 'Which species are more prevalent but less severe?', 'What is required for a Hepatitis B infection in cells?', 'What regulates the broad, but less specific, virus-cell interaction in a hepatitis B infection?', 'Which protein domain of the Hepatitis B envelope is necessary for infection?', 'Where is NTCP located in the body?', 'What does the NTCP protein mediate?', 'Is NTCP sufficient to allow HBV infection?', 'Why is NTCP thought to not be sufficient for HBV infection?', 'What kinds of viruses are Japanese encephalitis virus(JEV), tick-borne encephalitis virus(TBEV), eastern equine encephalitis virus (EEEV), sindbis virus(SV), and dengue virus(DV)?', 'What are the current clinically-available methods to detect encephalitis viral antigens?', 'What methods exist for detecting multiple antigens simultaneously in a one-sample, laboratory test?', \"How many antigens could be detected by Liew's multiplex ELISA test?\", 'What kind of antibodies were used in the ELISA-array assay?', 'How was the ELISA assay validated?', 'What capture antibodies were used in the study?', 'What was the spotting concentration range for the capture antibodies?', 'How was the proper spotting concentration determined?', 'How was cross reaction detection determined?', 'How was the ELISA-array assay validated?', 'In 2010, how many cases of tuberculosis were estimated in China?', 'What is the population of Shandong province?', 'What was the purpose of this study?', 'What was the age range for the people surveyed?', 'How was the survey designed?', 'Was was the sample size?', 'How were the clusters selected?', 'How many people were in a community cluster?', 'Who was excluded from the study?', 'When was the study conducted?', 'Who conducted the study?', 'What medium was used to collect the sputum samples?', 'What was the response rate for the study?', 'What was the average age of a study participant?', 'What was the prevalence rate in Shandong in 2010 for sputum positive cases of tuberculosis?', 'What was the most striking finding of the study regarding tuberculosis patients?', 'How many cases of sputum positive tuberculosis patients had no persistent cough?', 'How many tuberculosis patients in Shandong were over 65 years old?', 'What enzymes have been reported to be linked with severity of infection and various pathological conditions caused by microorganisms?', 'At what temperatures was the assay completed?', 'What criteria sets the guideline for drug-like properties?', 'What could be novel candidates as potent inhibitors of papain like cysteine proteases in resistant microorganisms?', 'What method is useful in administering small molecules for systemic delivery to the body?', 'Why is the nasal mucosa useful in the delivery of small molecules into the body?', 'What are the most common methods of inhaled delivery of medications?', 'What medications have shown good promise to in vivo delivery via dry powder inhalers?', 'How are siRNAs typically delivered for systemic effect?', 'What structures form the human airway?', 'What size of particle has been shown to be most effective in the delivery to the lower airway?', 'What are the essential conditions in siRNA delivery to effectively produce gene silencing in the lungs?', 'How long is the SAIBK gene?', 'How many open reading frames are in the SAIBK gene?', 'What virus has the closest genetic identity with the SAIBK gene?', 'How many surgical masks or respirators have past studies projected will be required for a pandemic in the United States?', 'What is the acronym MERS-CoV?', 'What are the critical factors that determine the effect of an epidemic?', 'When did the World Health Organization (WHO) officially declare the 2019-nCoV epidemic as a Public Health Emergency of International Concern?', 'What influenza virus was identified in China in 2013?', 'What past research has been done on severe, single-wave pandemics?', 'What is a clinical attack rate?', 'What was the clinical attack rate in the 2009 H1N1 pandemic?', 'What is the estimated R0 of COVID-19?', 'How many ventilators have past studies projected will be required for a pandemic in the United States?\\n', 'How is exhaled breath condensate used in viral research?', 'How many patients were i this study?', 'What was the conclusion of this study?', 'How long did the patient breath into the RTube?', 'What followed the reverse transcription step in the analysis?', 'What was the last step in the analysis?', 'What percentage of the patients were between 20 and 30 years old in this study?', 'Why is EBC an attractive method for screening?', 'What is the leading cause of death among children after the age of 1 month?', 'How has the number  of  childhood pneumonia been reduced?', 'What percentage of childhood deaths are due to  pneumonia?', 'How has the childhood population grown in the last two  decades?', 'What is the reduction in the number of childhood pneumonia cases?', 'How much  is the reduction in the childhood pneumonia deaths?', 'Childhood pneumonia rate for  high income countries vs low and middle income countries.', 'What  percentage of childhood pneumonia deaths occur outside hospital in low and middle  income countries?', 'Case Fatality Rates for Childhood Pneumonia in high income vs low and middle income countries.', 'How can childhood pneumonia affect the subsequent health of a person?', 'What is the increase in the risk of respiratory disease after having childhood pneumonia.', 'Which is the best method to identify pneumonia in a person?', 'What is responsible for the reduction of radiologic pneumonia?', 'What is the percentage reduction in pneumonia cases due to  vaccination?', 'What is the revised WHO definition of Bacterial Pneumonia?', 'What is the reduction in bacterial pneumonia under the revised WHO  definition of bacterial pneumonia?', 'What caused the increase in the  incidence of empyema in children in the recent past?', 'How have the incidence Empyema been reduced?', 'What pneumonia related or chest conditions indicate the need for child radiography?', 'What chest diseases and pneumonia were identified as leading causes prior to  the availability of vaccines?', 'Why has pertussis immunity in infants has decreased in infants?', 'What is the effect of childhood tuberculosis in childhood pneumonia?', 'What are the risk factors in childhood pneumonia?', 'How does air pollution affect the incidence of childhood pneumonia?', 'What is the strongest risk factor for childhood pneumonia?', 'What is the global coverage of influenza and pneumonia vaccines?', 'Is influenza vaccination during pregnancy safe? How long does it protect the child?', 'What is emphyema?', 'How is the term end point consolidation described  with regard to pneumonia diagnosis?', 'What factors make H5N1 a worldwide threat to public health?', 'What are the symptoms of H5N1 infection in humans?', 'Name some medications used to treat influenza.', 'Why have antiretrovirals medications had limited benefit in treating influenza?', 'What is the focus of the current study?', 'What is the result of the current study?', 'How do the polysaccharides in plants effect the immune response?', 'What does this study demonstrate?', 'In this study, how did treatment of EAP after infection affect survival?', 'What viruses have been responsible for most common childhood acute respiratory track infections (ARTI)?', 'Are there any vaccines against to protect against respiratory viral infections?', 'Which type of bacteria are implicated in carrying genes of drug resistance?', 'What may be a likely cause of sink-to-sink spreading of pathogens in the hospital setting?', 'What types of acute respiratory infections can be screened and diagnosed with multiplex PCR?', 'What is the role of antibodies during infection?', 'How can antibodies also create health problems?', 'Which technology  invention produced antibodies that are clones of a unique parent cell?', 'What mechanism is responsible for the creation of diversified repertoire for antibodies?', 'What  developments have been made possible by the study of B-cell repertoire?', 'What motivates the study of the rare B-cells that produce Broadly Neutralizing Antibodies (bnAb)?', 'How has the study of B-cells helped the treatment for Respiratory syncytial virus (RSV)?', 'How are the studies on B-cells helping the development of a universal influenza vaccine?', 'What role B-cell  play in malaria infection and prevention?', 'How can the study of B-cells help in the prevention and treatment of autoimmune diseases?', 'When was the  Middle East Respiratory Syndrome Coronavirus isolated first?', 'What is the Case fatality rate for MERS Coronavirus?', 'How does gender influence MERS-COV infection?', 'Which is the source animal for the MERS-COV?', 'What is the median time until death in MERS-COV?', 'What is the incubation period for MERS-COV?', 'What is the treatment for MERS-COV?', 'What age group had the most MERS-COV infections?', 'Why are nucleosides analogs used for chemotheraphy?', 'What nucleoside analog is the focus of the current study?', 'Gemcitabine has been shown to have antiviral activity against which viruses?', 'How does gemcitabine disrupt viral activity?', 'Why are cotton rats considered a strong animal model for biomedical research?', 'What is the structure of the CD40 Ligand?', 'What is the effect of CD40L on Dendritic Cells?', 'What is the effect of CD40L on B Cells?', 'What factor may influence viral replication and gene expression?', 'What accounts for the variation of codon usage among open reading frameworks?', 'What conditions are considered upper respiratory tracts infections?', 'What conditions are considered lower respiratory tract infections?', 'What immune cells are primarily involved in eliminating virus-infected cells?', 'What molecules have been shown to hinder T cell responses to viral infections?', 'The accumulation of what molecule hinders phagocytic activity in T cells?', 'When did the last Director General of the WHO resign?', 'Why might an organization like the WHO be necessary?', 'Where should the next Director General for the WHO come from?', 'What traits should the new Director General of the WHO have?', 'What is the Hepatitis C virus?', 'How many people have persistent hepatitis C virus?', 'What is the long-term risk of chronic hepatitis C infection?', 'What antiviral treatments are used for hepatitis C infection?', 'What is the main cause of death in the neonatal period of calves?', 'Where was hepcidin first discovered?', 'What is hepcidin?', 'What organ produces hepcidin?', 'What stimulates the release of hepcidin?', 'What element does hepcidin play a roles in regulating during metabolism?', 'Is hepcidin toxic?', 'Why is iron critical to bacteria?', 'How does hepcidin work in the duodenum?', 'How does hepcidin affect macrophages?', 'What leads to oxidative stress in the body?', 'What parameter is used to measure antioxidant levels?', 'What is Acute hemorrhagic encephalomyelitis?', 'What are the salient findings in Acute hemorrhagic encephalomyelitis?', 'What is RANBP2?', 'What is the suggested role of RANBP2 in the cell?', 'What is the hallmark finding of acute necrotizing encephalopathy?', 'What could trigger acute necrotizing encephalopathy?', 'When did she present with rapidly progressive right-hand weakness?', 'Compounds from what framework have shown promising anticancer and antiviral properties?', 'The replication of what virus is strongly inhibited by 2-(4-hydroxybenzyl)quinazolin-4(3H)-one (1)?', 'How many samples were obtained?', 'What percentage of patients were positive for at least one respiratory pathogen?', 'What percentage of patients tested positive for HBoV1?', 'When was HBoV1 first identified?', 'What are the symptoms of HBoV1 infection?', 'What are the ages of the patients in this study?', 'What was the male to female ratio for this study?', 'What causes acute respiratory illness in young children?', 'What is the molecular structure of the Human metapneumovirus (HMPV)?', 'What virus is closely related to the human respiratory syncytial virus (RSV)?', 'What diseases are caused by HMPV?', 'How large is the HMPV genome?', 'How many open reading frames are in the HMPV genome?', 'What are the two major genotypes of HMPV?', 'What is the most common subgroup of HMPV?', 'Who accounted for 44% of HMPV positive cases in Kenya between 2007 and 2011?', 'What does this study describe?', 'What was the difference in the group A and B genomes?', 'What was the purpose of this study?', 'How many control samples were used in this study?', 'What was the prevalence of coinfection?', 'What risks factors were associated with lower RTIs?', 'What tests can simultaneously identify and subtype multiple respiratory viruses?', 'What was the definition for an immunocompromised state in this study?', 'What was the length of the study?', 'How many patients had acute RTIs?', 'What was the most frequent coinfection?', 'What health regulations were changes due to the outbreak of C. burnetti?', 'What was the median seropresence of C. burnetti in sheep flocks not linked to human outbreaks?', 'What important risk factors to infection were found during the second case-controlled study?', 'What was the interquartile range of the incubation period?', 'How many controls were used in the second case study?', 'What public event was linked with the outbreak?', 'What causes Q fever?', 'What is Coxiella burnetii?', 'What is the primary reservoir for Coxiella burnetii?', 'How are humans typically infected with Coxiella burnetii?', 'What are critical to regulate cellular biological processes?', 'How is the HeteSim measured used?', 'What kind of data is included in the STRING database?', 'What is the function of MALAT1?', 'What test can detect reduced anticoccidial efficacy in the field?', 'What is toltrazuril used to treat?', 'What is multiple evanescent white dot syndrome?', 'What precedes about half of the reported cases of MEWDS?', 'What types of viruses can be diagnosed through serological testing?', 'What type of clinical test can differentiate multiple evanescent white dot syndrome (MEWDS) from optic neuritis?', 'What were the most common viruses sampled from nasal swabs in Ilorin, Nigeria', 'What was the most common virus detected in community members in this sample?', 'How bad is the burden of disease in developing countries?', 'Where do the majority of all infectious disease outbreaks happen?', 'What are some risk factors for countries to experience a high prevalence of Acute Respiratory Infections?', 'What symptoms are associated with acute respiratory infections?', 'What was the most common virus detected in community samples in Ilorin, Nigeria?', 'What was the prevalence of Coronavirus OC43 in community samples in Ilorin, Nigeria?', 'What was the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria?', 'What was the difference between community and clinic cases of acute respiratory infections?', 'How can countries enhance public health surveillance?', 'Why do respiratory tract infections pose major public health problems?', 'How much of a greater risk are children than adults to viral infections?', 'What is the most common infection in childhood?', 'What can respiratory viruses cause?', 'When do respiratory infections usually happen?', 'What are the most common viruses?', 'What is the most common viral infection for infants up to 3 months old?', 'What is the incidence of RSV in children older than 3 years of age?', 'What is the distance between the p4.7 and p12.7 genes in the Irish versus Japanese equine coronavirus variants?', 'What is the difference between the Tokachi09 and Irish coronavirus genomic sequences?', 'What suggests that Irish equine coronaviruses may have a low genetic diversity?', 'Where have most outbreaks of equine coronavirus occurred in the United States?', 'What kind of pertussis vaccine is used in middle and high income countries?', 'Where is the highest rate of childhood pertussis globally?', 'What type of pertussis vaccine has been recently recommended by the WHO?', 'What are the clinical symptoms of pertussis?', 'What type of swabs are used to sample patients with pertussis?', 'How frequently do pertussis outbreaks peak?', 'What is the WHO criteria for a pertussis infection?', 'What is used by the Canadian Public Health System to identify periods of influenza activity?', 'Why is laboratory confirmation of influenza infection not commonly performed?', \"What types of viral infections are monitored through Canada's Respiratory Virus Detection Surveillance System (RVDSS)?\", 'What is discussed in this publication?', 'What is discussed in this publication?', 'What is reported in this publication?', 'What is the conclusion regarding IRE1 and RNaseL proteins?', 'What is the structure of an Echovirus?', 'What diseases are associated with echoviruses?', 'In California, to where are meningitis cases reported according to the California Code of Regulations?', 'According to the California Code of Regulations, when should a meningitis case be reported?', 'Where is the Viral and Rickettsial Disease Laboratory located?', 'What type of reference genome was used in the study?', 'What was the read coverage for the E-30 genome in this study?', 'What are the structural regions of the enterovirus polyprotein in this study?', 'What can nuclear receptors regulate?', 'What are associated with cancer, diabetes, inflammatory disease, and osteoporosis?', 'What are nuclear receptors (NRs)?', 'What biological factors for nuclear receptors regulate?', 'How many families are in the NR superfamily?', 'What is a prerequisite to make a molecular docking study feasible?', 'What tool can be used to determine the 3D structure of proteins?', 'What are the shortcomings of X-ray crystallography?', 'What types of proteins are difficult to crystallize?', 'Where were the data collected for this study?', 'Who performed the sampling procedures?', 'When were the fecal samples collected?', 'What reference genome was used in the study?', 'What is the length of the replicase gene ORF1ab?', 'What type of coronavirus was detected in R. affinis and R. sinicus species?', 'What is a natural reservoir of coronavirus?', 'What is the genome size of the coronavirus?', 'What is the structure of the coronavirus?', 'What animals do gamma and delta coronavirus mainly infect?', 'How many types of coronaviruses are known to cause human disease?', 'What plays a role in regulating the immune response to a viral infection?', 'What is the conclusion of the coronavirus long-term surveillance studies?', 'What is the cause of Feline Infectious Peritonitis (FIP)?', 'What is the molecular structure of Feline Infectious Peritonitis Virus?', 'How is FECV detected in cats?', 'What type of vaccine is used to protect against FIPV infection?', 'Why is their controversy surrounding the FIPV vaccine?', 'For how long was the denatured polyacrylamide gel polymerized?', 'How was the binding strength measured?', 'What was the focus of this study?', 'What do neuroaminidase inhibitors target?', 'What is the function of neuroaminidase in the influenza virus?', 'What is Tamiflu?', 'What was the test for the level of cytotoxicity used in this study?', 'What method was used to measure the inhibition of viral replication?', 'What was the conclusion of this study?', 'Why have nucleic acid amplification tests been restricted to laboratory settings?', 'What screening method was evaluated in this study?', 'What was used to measure the performance of the NINA heaters?', 'What percentage of HIV-infected people go undetected in the United States?', 'What percentage of patients do not return for followup after HIV testing?', 'What statistical tests were used to compare categorical variables?', 'What was a severe limitation of this study?', 'What followup is needed to confirm the results of the current study?', 'What is the conclusion of this study?', 'What suggests that IP-10 plays a significant role on the pathogenesis of pneumonia?', 'What cell types help prevent pneumococcal and influenza infection in the lungs?', 'What is the most common, clinically-relevant multiresistant pathogen in both healthcare and community acquired infections?', 'What is the treatment of choice for MRSA infections?', 'What enzyme is essential for the metabolism of fatty acids?', 'What was the purpose of this research?', 'What is the conclusion of the study?', 'Why makes the marmoset an appropriate animal model for pathogen research?', 'How can the efficacy of DAAs be diminished?', 'Was is the response rate of the Hepatitis C virus to direct-acting antiviral treatments?', 'How do nonnucleoside NS5B polymerase inhibitors work?', 'How many patients were studied?', 'Was written consent obtained?', 'How much of the RNA template was in the reverse transcription reaction mixture?', 'How many RASs to NS5A inhibitors were identified?', 'Why is the substitution E62D important in drug resistance?', 'What are the key factors preventing the elimination of HCV infection in some patients?', 'What is needed to direct genetic mutations in RNA viruses?', 'What is the structure of the pestivirus?', 'What sequences are critical for the autonomous replication of the pestivirus genome?', 'What are the 4 structural proteins of the pestivirus polyprotein?', 'The BAC differed from the parental cDNA sequence by what amino acid substitutions?', 'What is the purpose of this research study?', 'Why are SSIs important to the overall burden on the healthcare system?', 'What is the \"Never Event\" policy?', 'Patients from how many medical centers were studied?', 'Which patients were excluded from the study?', 'What are the limitations of a deterministic model?', 'How does PEDV spread?', 'How does PEDV cause illness?', 'What is the size of the PEDV genome?', 'Which viruses are part of the Old World complex of Arenaviridae?', 'How can Old World and New World Arenaviruses be differentiated?', 'What is the incubation period for arenavirus?', 'What is the structure of the Arenavirus?', 'What proteins does the Arenavirus produce?', 'What diagnostic test has been show to have excellent sensitivity in detecting viral infections?', 'What is the effect of oseltamivir and zanamivir?', 'What is Glycyrrhizin?', 'What is the effect of Glycyrrhizin in viral infections?', 'What is another word for hypercytokinaemia?', 'What has been correlated with the pathogenicity of the H5N1 infection?', 'What is the conclusion of the study?', 'What is the mean duration of time from single lobe consolidation to bilateral multilobar lung infiltrates in human adenovirus type 55 (HAdV-55)?', 'What is the mean duration of time from first positive chest x-ray to bilateral multilobar lung infiltrates in human adenovirus type 55 (HAdV-55)?', 'What are the most frequent clinical manifestations of human adenovirus type 55 (HAdV-55) induced ARDS?', 'What do we know about the genomics of human adenovirus type 55 (HAdV-55)?', 'What are the clinical symptoms of human adenovirus type 55 (HAdV-55)?', 'What is the mean time from onset of symptoms to dyspnea in human adenovirus type 55 (HAdV-55)?', 'What is the mean time of onset of symptoms to ICU admission in human adenovirus type 55 (HAdV-55)?', 'What is the mean rate of respiration upon admission to the ICU when admitted for human adenovirus type 55 (HAdV-55)?', 'What is the white blood cell count in severe cases of human adenovirus type 55 (HAdV-55)?', 'What does a chest x-ray look like for a patient with a severe case of human adenovirus type 55 (HAdV-55)?', 'What are the high resolution pulmonary CT scan findings for patients with severe cases of human adenovirus type 55 (HAdV-55)?', 'Where could a clinician acquire a positive viral sample in severe cases of human adenovirus type 55 (HAdV-55)?', 'How long did it take for patients with positive human adenovirus type 55 (HAdV-55) endotracheal aspirates to develop a measurable viremia?', 'Does blood type play a role in the severity of human adenovirus type 55 (HAdV-55) infection?', 'What are the most common clinical manifestations of severe human adenovirus type 55 (HAdV-55) induced ARDS?', 'What is the mortality rate of severe ARDS from human adenovirus type 55 (HAdV-55)?', 'What role does T-cell count play in severe human adenovirus type 55 (HAdV-55) infection?', 'How successful are the use of invasive mechanical ventilation (IMV) and non-invasive positive pressure ventilation (NPPV) in the treatment of severe ARDS from human adenovirus type 55 infection?', 'How many patients were analyzed in the study?', 'How many patients with community-acquired pneumonia are hospitalized each year?', 'What chest X-ray findings are typically indicative of community-acquired pneumonia?', 'When did WHO declare a pandemic of pH1N1/2009v influenza?', 'What is the classical cutoff value for antibody titers?', 'What is meant by a protective HIA titer?', 'What are the results of the study?', 'What was the interpretation for the crossreactive antibodies?', 'How long did the pH1N1/2009 viral outbreak last?', 'What were the aims of this study?', 'What network of physicians provides real-time clinical data on the spread of influenza in France?', 'What are the criteria used to define an influenza-like illness in France?', 'What virus was the most common among the H1N1v negative patients?', 'What was the aim of this study?', 'Where is the bearded vulture (Gypaetus barbatus) commonly found?', 'What was the focus of this study?', 'What is the third most prevalent cancer in females in the United States?', 'What is the 1-year survival rate for colorectal cancer patients?', 'What is the 5-year survival rate for colorectal cancer patients?', 'How were nuclear morphological changes in HT-29 cells measured?', 'What is directly related to nuclear condensation?', 'What morphological cell changes are most associated with apoptosis?', 'What types of cells are suitable for colon cancer studies?', 'What was the goal of this study?', 'What is the conclusion of this study?', 'What was the conclusion of this study?', 'What are the implications of the novel fermentation-based glycosylation strategy described in this study?', 'What characteristics does glycosylation have on flavonoids?', 'What is fibrinogen-like protein 2 (FgI2)?', 'What represses murine hepatitis virus strain 3 (MHV-3) infection?', 'What was the goal of this study?', 'What is fulminant hepatitis?', 'How does Prothrombinase Fgl2 affect the coagulation process?', 'How long after MHV-3 infection were liver samples taken?', 'What is the relationship between urbanization and risk of emergence of flu-like diseases?', 'What factors and characteristics of semi-urban landscapes promote viral transmission?', 'What is the relationship between HIN1 viral transmission and poultry production.', 'What is the principle behind infection Convergence Model ?', 'What is the Boosted Regression Tree method?', 'What is the advantage of Boosted Regression Tree method?', 'What is the relationship between land use and emergence of HPAI H5N1?', 'Where is the highest risk of  HPAI H5N1 like disease emergence?', 'How does land use fragmentation increase the risk of flu-like diseases?', 'What is the relationship between the outbreak of HPAI H5N1 like diseases and rice cultivation?', 'What is the relationship between aquaculture and spread of H5N1 like diseases?', 'What is the relationship between proximity ofwater bodies to agricultural lands and spread of H5N1 like diseases?', 'What is the effect of diversity of chicken flock on H5N1 disease?', 'What is Compound Topological Index and how is it related to the risk of disease transmission?', 'In vitro comparison of antiviral activity of Chloroquine(CQ) and Hydroxychloroquine(HCQ) against COVID-19?', 'What will be the drug of choice for treating COVID-19 between Chloroquine and Remdesivir?', 'Mechanism of action of Chloroquine(CQ) and Hydroxychloroquine(HCQ) against COVID-19?', 'What is the effect of Chloroquine(CQ) and Hydroxychloroquine(HCQ) on endosomal maturation and endocytosis in COVID-19 treatment?', 'Evidence of Hydroxychloroquine(HCQ) being anti inflammatory in SARS-CoV-2 critically ill patients with elevated plasma cytokines?', 'What proportion of healthcare workers reported symptoms  of depression?', 'What proportion of healthcare workers reported symptoms of anxiety?', 'What proportion of healthcare workers reported symptoms of insomnia?', 'What proportion reported distress?', 'What were the Generalized Anxiety Disorder scale scores?', 'What were the  Insomnia Severity Index scores ?', 'What were the  Impact of Event Scale–Revised scores?', 'What were the results of analysis?', 'What were the results of analysis?', 'What are the conclusions of this study?', 'What are microtubule severing enzymes?', 'What genetic mutation is associated with hereditary spastic paraplegia?', 'What genetic mutation is associated with cerebral malformations?', 'What genetic mutation is associated with autism?', 'What is KATNAL1?', 'What organ is most associated with the KATNAL1 gene?', 'What CNS functions can be measured by studying the movement of mice in a T-maze?', 'What CNS functions are changed by mutations in the KATNAL1 gene?', 'How is Japanese encephalitis transmitted?', 'What element is essential to promoting JEV infection?', 'Where is Q130 located in the NS4B protein?', 'What is the mechanism of action for manidipine?', 'How many different pathogens are members of the Flaviviridae family of virus?', 'What is the size of a flavivirus?', 'How many open reading frames are in the flavivirus genome?', 'What are the structural protein elements of a flavivirus?', 'What is the function of the nonstructural protein elements of the flavivirus?', 'What are RVPs?', 'What is HTS?', 'What is the selective index in high throughput screening?', 'What is the structure of a recombiant  viral particle?', 'What measure is used in high-throughput screening to identify potential antiviral compounds?', 'How many known species of Rotavirus exist?', 'Is Rotavirus single or double-stranded?', 'What structural proteins are coded by Rotavirus?', 'What non-structural proteins are coded by Rotavirus?', 'What is qRT-PCR?', 'What is required to establish a secondary immune response to a viral infection?', 'What do immunoglobulin isotype recombination and somatic hyper mutation depend on?', 'What was used to quantify the amount of IgM secreting cells?', 'Where was the coronavirus discovered?', 'What is the number of confirmed cases reached on 8 February 2020?', 'What is presented in this study?', 'What is the proposed model?', 'When is SSA generally employed?', 'What is the main idea behind the proposed model?', 'What is the proposed model called?', 'How is FPASSA-ANFIS model evaluated?', 'What did the comparison of  the FPASSA-ANFIS model with several existing models, show?', 'How was the proposed model tested?', 'What were the outcomes of the test?', 'What are the large family of viruses, called coronaviruses?', 'Among whom are the coronaviruses distributed?', 'In what the Adaptive Neuro-Fuzzy Inference System (ANFIS) [22] is widely applied?', 'What does ANFIS offer?', 'In which applications has it been applied?', 'What is SI?', 'What is PSO?', 'What is SCA?', 'What is MVO?', 'For what SCA algorithm was applied to improve the ANFIS model ?', 'What may be a problem with individual SI algorithm?', 'What is OWA?', 'What is proposed in the current study?', 'What  is the FPA optimization algorithm inspired by?', 'What is the SSA optimization algorithm inspired by?', 'What is the proposed FPASSA method?', 'How does the proposed FPASSA start?', 'What do the authors propose?', 'What is vacuolar-type H(+)-ATPase (v-ATPase)?', 'What is archazolid?', 'How many complexes are within v-ATPase?', 'What is the role of v-ATPase in the plasma membrane of osteoclasts and renal epithelial cells?', 'What does angiogenesis depend on?', 'How were untreated MDA-MB-231 cells labeled?', 'What was the goal of the study?', 'What was the reported infection rate for influenza?', 'How many times more likely was an infection found in patients over 85 years old?', 'What can be the main challenges in managing a hospital outbreak of COVID-19?', 'Why early identification of COVID-19 patients can be difficult?', 'What are the steps that a hospital should take after COVID-19 outbreak?', 'Why exposure risk of COVID-19 is very high for ICU staff and what precautions should be taken?', 'Use of SIR/SEIR model in Statistics-Based Predictions of Coronavirus Epidemic Spreading?', 'What virus are used by the most successful neuronal circuit tracing methods?', 'In what direction does the Vesicular stomatitis virus spread through the nervous system?', 'What determines the whether the spread of Vesicular stomatitis virus is monosynaptic or polysynaptic?', 'What types of viruses can be used to study the connectivity of neuronal circuitry?', 'What is Carrageenan?', 'What is a potential therapeutic benefit of carageenan?', 'What is the optimal window for initiating treatment with carageenan and Zanamivir?', 'What was the mortality rate of influenza a virus subtype h7n9 (avian or bird flu)?', 'How many human cases were there of influenza a virus subtype h7n9?', 'How did most patients contract influenza a virus subtype h7n9?', 'Can influenza a virus subtype h7n9 be transmit human to human?', 'What kind of disease is caused by influenza?', 'How many severe cases are there for annual influenza epidemics?', 'How many deaths occur annually as a result of annual influenza epidemics?', 'Is coinfection common in influenza infection?', 'What percentage of people infected with influenza have a viral coinfection?', 'What are common concamitant infections during the course of influenza infection?', 'What is the anti-viral mechanism of action for carrageenan?', 'What is the hypothetical mechanical benefit for carageenan in preventing and treating upper respiratory infections?', 'What is carageenan?', 'What is the recovery benefit of carageenan in patients with any respiratory virus?', 'What is the anti-influenza benefit of carageenan?', 'What is the association between influenza viral load and carageenan?', 'Is Oseltamivir effective when taken intranasally?', 'What is the effect of intranasal Zanamivir on laboratory confirmed infleunza infection?', 'Do carageenan and Zanamivir delivered intranasally have a benefit when taken for influenza subtype H7N7 infection?', 'Do carageenan and Zanamivir delivered intranasally have a benefit when taken for influenza subtype H1N1 infection?', 'Is there a dose-dependent response to carageenan and Zanamavir intranasal therapy?', 'Do carageenan and Zanamavir together have a greater benefit than either in monotherapy?', \"Did the use of carageenan play a role in pandemic's caused by novel viruses?\", 'How was ILI defined?', 'What is this assay based on?', 'How was random sampling performed?', 'What used to detect pathogens?', 'What does the retrospective study use?', 'How many swabs were randomly selected and analyzed?', 'How were the swabs analyzed?', 'What viruses were detected?', 'What co-infections were found?', 'What seasonal differences were found?', 'What does the study highlight?', 'What does the study show?', 'Which are identified  as major viruses mostly responsible for ILI and pneumonia in several studies?', 'What percentage of these infections are identified?', 'What is Reunion Island?', 'What is the number of inhabitants of Reunion Island?', 'Where is Reunion Island located?', \"What is the island's health care system similar  to?\", 'When does influenza activity increase?', 'When does the  influenza vaccination campaign in Reunion Island start?', 'What is the  clinical and biological influenza surveillance has been based on?', 'What is this network composed of?', 'How are the influenza tests carried out?', 'What do 40-50% of the samples test positive for?', 'What are the ILI samples wich test negative for influence?', 'What tool has been developed to identify several viruses simultaneously?', 'What are the objectives of the study?', 'On which system the reverse transcription and preamplification steps were performed?', 'Which two seasons were identified for trends in virus circulation??', 'Which were the most frequently identified respiratory pathogens?', 'What were detected  only in summer?', 'What viruses were identified only in winter?', 'Respiratory viral pathogens were present in what percentage of samples?', 'What did the study highlight?', 'How many swabs remained without etiology?', 'What hypotheses can explain this result?', 'What could not be tested  for?', 'What does this study highlight?', 'What does the  study show?', 'What would be interesting to do?', 'What  is it most similar to?', 'How many people were affected as of Feb. 10, 2020?', 'How is the SARS-CoV-2 referred to?', 'How much  similarity the SARS-COV-2 genome sequence has with SARS-COV?', 'what similarity human SARS-COV and palm civet SARSlike COV share?', 'How much is the difference between the human SARS-CoV-2 and the bat RaTG13-CoV?', 'Why is it highly unlikely that RaTG13 CoV is the immediate source of SARS-CoV-2. ', 'What are the most revealing signs that SARS-CoV-2 evolved by natural evolution. ', 'What did the Nature Medicine paper report?', 'Why does the claim lack any scientific  basis?', 'How was the mouse-adapted SARS virus (MA15) generated?', 'How did  the SARS-CoV gain elevated replication and lung pathogenesis in aged mice ?', 'Why is it likely that MA15 is highly attenuated to  replicate in human cells?', 'Why were civets proposed to be an intermediate host of the bat-CoVs, capable of spreading SARS CoV to humans?', 'What was the finding  in 2013?', ' Why is it proposed that some bat SL-CoVs may be able to directly infect human hosts?', 'What was done to test if  an intermediate host may not be necessary and that some bat SL-CoVs may be able to directly infect human hosts. T', 'What were the results of this test?', 'Why were experiments with SL-SHC014-MA15 chimeric virus were later restricted?', 'Why is there  no credible evidence to support the claim that the SARS-CoV-2 is derived from the chimeric SL-SHC014-MA15 virus?', 'What did the rumour that the virus was made by humans in the lab, claim?', 'What was reported in  a rebuttal paper led by an HIV-1 virologist Dr. Feng Gao?', 'What happened to the report with initial claims?', 'What is the difference between evolution and synthetic constructs?', 'What is the conclusion of this report?', 'What is the conclusion of this report?', 'what is the clinical manifestation similar to?', 'What was the purpose of the research?', 'What preventative measure has been taken to decrease the incidence of diarrhea in children?', 'What  led to a great increase in their study among virologists worldwide?', 'How many hantaviral genotypes have been described', 'How many of them are pathogenic for humans?', 'What do Hantaviruses cause in their reservoir hosts?', 'What does hantavirus human disease  manifest as?', 'What is the  case-fatality ratios, for the most common viral serotypes? ', ' What are among the factors that may have increased the human caseload of HCPS between 1993 and the present?', 'What do authors consider  in this study?', 'What do authors consider  in this study?', 'Which diseases are a major concern among scientists studying infectious diseases?', 'What may alter population disease dynamics and lead to the emergence of zoonotic infections? ', 'Which are among the conspicuous examples which challenge prevention and control measures of public health systems?', 'More recently,  what did outbreaks of several viral-related diseases that  have emerged or re-emerged, involve?', 'What did, In the last century,  outbreaks of viral-related diseases that have emerged or re-emerged, involve?', 'Among zoonotic diseases, what are hosts of several pathogenic RNA viruses?', 'Which pathogenic RNA viruses are hosted by small mammals?', 'When did Hantavirus infections became a concern in the Americas?', ' What was the  hantavirus cardiopulmonary syndrome, HCPS (or hantavirus pulmonary syndrome), linked to?', 'What was identified as the reservoir of SNV?', ' What did a review of ancient Chinese writings in 960 AD, reveal?', 'How was HFRS  first brought to the attention of western medicine ?', 'What is HTNV?', 'Where was HTNV isolated from?', 'Which new genus was the virus later found to represent?', 'Which was  the first hantavirus to be isolated?', 'What is the categorization of hantaviruses as belonging to the family Bunyaviridae due in part to?', 'What was the hairpin morphology first described for?', 'How is the the precursor form GPC processed, during virus maturation?', 'When does the cleavage appear to be signaled?', 'Why must the two proteins Gn and Gc be co-expressed?', 'Which two distinct cellular receptors the glycoproteins are the known or presumed ligands for?', 'What is the underlying premise for many of these studies?', 'What is the premise for apathogenic forms to  blunt any pathological response in the host?', 'Which proteins and mRNAs prominently induced by hantaviruses include?', ' What have hantaviruses been identified as adversely affect?', ' What have hantaviruses been identified in potentiating?', 'What is N-protein?', 'What does the N-protein, as an RNA-binding protein, do?', 'As an RNA-binding protein that engages the hairpin termini of the genomic segments, what does the N-protein of hantavirus do?', 'As an RNA-binding protein that engages the hairpin termini of the genomic segments, what does the N-protein of hantavirus do?', 'What does the N-protein act as?', ' What can  some of the other activities of N have, be linked to?', ' What can  some of the other activities of N have, be linked to?', 'What is  N  also reported to interact with?', 'How do the viral RNAs become concentrated in P bodies during hantavirus infection?', 'What have confocal microscopy and biochemical-inhibitor studies shown?', 'What have confocal microscopy and biochemical-inhibitor studies shown on what N tracks?', 'What is the ultimate destination for N, for its assembly into viral particles?', 'How does it traffic?', 'What is a dominant negative inhibitor?', 'What is dynamitin associated with?', 'What is dynamitin associated with?', 'What does recent data indicate?', 'Why have Hantavirus diseases of man been suspected of having an immunopathogenic basis?', 'What is a critical feature of both?', 'What is the character of he resulting leakage?', 'Which is an especially attractive candidate as an important in vivo receptor for hantaviruses?', 'What  is the likely way that hantaviruses arrive at their target tissues?', 'What does the virus seed?', 'What happens with the viral seeding at the  local endothelium?', 'How long does the process of giving rise to primary viremia for hantavirus infections?', 'What happens by the time that secondary viremia emerges?', 'How is the  the expression of proinflammatory cytokines induced?', ' For HCPS, what does that expression favor?', ' For HCPS, what does that expression spare?', 'What happens for HFRS?', 'What is considered to be  a requirement for the development of systemic disease symptoms?', 'What do those abnormalities sometimes culminate in?', 'What leads to death in most fatal cases of HCPS?', 'What leads to death in most fatal cases of HCPS?', 'What potential mechanism,  could be presumed to underlie the pathogenesis of HCPS?', 'What potential mechanism,  could be presumed to underlie the pathogenesis of HCPS?', 'What potential mechanism,  could be presumed to underlie the pathogenesis of HCPS?', 'What  explanation have some investigators favored   for much of the capillary leak?', ' What animal models exist for both the asymptomatic carriage of PUUV and SNV?', 'For what can the Syrian hamster model used?', 'What does the hamster model for HCPS caused by?', ' Typically how long do the hamsters die post-inoculation?', 'What does the microscopic examination of the lung reveal, as with human HCPS?', 'What do ANDV-infected hamsters fitted with physiologic monitoring devices exhibit?', 'What do diminished pulse pressures, tachycardia, and hypotension in ANDV infected hamsters appear to closely mimic?', 'Compared to  humans, what do ANDV infected hamsters exhibit?', 'With what have three studies correlated  plasma viral RNA?', 'What are examples of delivery vectors for commercial anti-Salmonella vaccines?', 'What can be a factor in using common vectors for the delivery of vaccines?', 'Is a pre-existing immune response to commonly used delivery vector an advantage or a disadvantage?', 'What bacterial delivery vectors have been tested in animal hosts?', 'Which bacteial delivery vectors have gained favor for vaccines?', 'Why are E Coli and lactic acid are safe choices as delivery vectors for vaccines?', 'What is Listeria?', 'What is the advantage of Listeria as a  delivery vector for vaccines?', 'What are examples of  viral vectors for delivering vaccines?', 'Which viral vaccine delivery vector was first licensed?', 'What are examples of attenuated poxvirus vaccine delivery vectors?', 'What is the connection between chicken and Salmonella?', 'Why are some poxvirus  ideally suited as vaccine delivery vectors?', 'What is the advantage of adenovirus as vaccine delivery vector?', 'What are important criteria for selecting vaccine delivery vectors?', 'What are important criteria for selecting vaccine delivery vectors?', 'What are important criteria for selecting vaccine delivery vectors?', 'What happens when a recipient of a vaccine has immune response to the delivery vector?', 'What is the effect of host immune response to the delivery vector on the efficacy of vaccination?', 'What is the effect of host immune response to the delivery vector on the efficacy of vaccination?', 'What is an example  of the effect of immunity to the  delivery vector on the efficacy of vaccination?', 'What is the effect of host immune response to viral delivery vectors in the efficacy of vaccination?', 'What is the effect of host immune response to  the viral delivery vector on the efficacy of vaccination?', 'What is the effect of host immune response to the delivery vector on  the efficacy of vaccination?', 'What are methods to avoid the effect vector immunity on the efficacy of vaccination?', 'What are methods to  avoid the effect of vector immune response on the efficacy of vaccination?', 'How does cell-mediated immunity to viral delivery vector, reduce the immune response to vaccine?', 'How can vectors for which host has immunity, be used differently to increase the efficacy of vaccination?', 'How does the PED virus transmit between animals?', 'How can Bacilius subtilis be used as an oral vaccine?', 'What cells are infected by the PED virus?', 'What kind of immune responses are most effective in preventing PED virus?', 'What intestinal factors may reduce the effectiveness of orally-administered immunizations?', 'What is Bacillus subtilis?', 'What is the role of dendritic cells in the immune response?', 'Where do dendritic cells exist in the body?', 'What are the components of the gut-associated lymphoid tissue?', 'What type of cells form the intestinal mucosal barrier?', 'What factors determine an effective mucosal immune response?', \"What is an effective indicator of a vaccine's ability to generate an immune response?\", 'What is interleukin-1Beta?', 'When was the first case of COVID-19 identified?', 'Where did SARS-CoV-2 originate?', 'In what year did the first SARS epidemic occur?', 'When was World Health Organization (WHO) first notified about the SARS-CoV-2 epidemic in Wuhan City, China?', 'When did we discover that SARS-CoV-2, which causes COVID-19, was a novel coronavirus?', 'How long did it take to identify the cause of COVID-19?', 'What type of test was initially developed to screen for SARS-CoV-2?', 'How big was the temporary hospital built in Wuhan City for treatment of COVID-19 patients?', 'How long did it take China to build the temporary hospital in Wuhan for COVID-19 patients?', 'What is a key factor in managing emerging infectious disease threats?', 'In what year did the MERS epidemic occur?', 'How long did it take to publish the full genomic sequence of SARS-CoV-2 after it was identified?', 'What was the fatality rate for SARS-CoV?', 'What was the fatality rate for MERS?', 'What are some challenges associated with using media and social media to capture information about an emerging epidemic?', 'What are the risks of health workers failing to wash hands?', 'Who is at risk when health workers fail to wash their hands?', 'What was the R0 of SARS in absence of control measures?', 'What is superspreading?', 'How many people may have left Wuhan before travel restrictions were imposed?', 'How many severe cases of influenza-related illnesses are reported per year?', 'How many influenza-related deaths are reported each year?', 'What is the mortality rate of the H5N1 strain of influenza?', 'What cells are the main target of the influenza A virus in the lungs?', 'How many extracellular domains are in the CEAMCAM1 protein?', 'Where is CEACAM1 expressed in the body?', 'What motifs are absent in the short form of CEACAM1 protein?', 'What are the most common isoforms of CEACAM1?', 'How do CEACAM1 and CEACAM5 interact?', 'What are the SRC-family of kinases? ', 'What triggers the release of pro-inflammatory cytokines/chemokines to assist in viral clearance?', 'What mediates the anti-apoptosis of neutrophils?', 'How do natural killer cells fight influenza viruses?', 'How do influenza viruses escape binding by the natural killer cell activating receptors?', 'What is Enfuvirtide?', 'What is labeled in red?', 'What is marked in blue?', 'What is marked in green?', 'What is labeled in pink?', 'How many times was the experiment repeated?', 'What was the main finding in the study?', 'What do the results suggest?', 'What enhanced anti-HIV1 activity?', 'What figure shows that AP3 exhibited higher inhibitory activities on infection by HIV-1 IIIB and HIV-1 Bal strains?', 'What is the serum half-life of T20?', 'What kind of model best describes the pharmacokinetic profiles of AP3 and AP2?', 'What is the in vivo elimination half-life of AP3?', 'Why did the T20/N36 complex not show a typical alpha helical conformation?', 'What mutations have been typically associated with T20-resistant HIV-1 variants?', 'What are main steps for mitigating the COVID -19 transmission during transport of suspected and confirmed patients?', 'How many deaths each year are caused by gastroenteritis?', 'What percentage of sporadic diarrhea are caused by norovirus?', 'What is the most common cause of viral gastroenteritis in children?', 'Which types of adenovirus are associated with diarrhea?', 'When was the first tissue culture system developed?', 'What are the most common DNA-based techniques for detecting viruses?', 'What is Universal primer-PCR used for in viral studies?', \"What is Koch's first postulate?\", \"What is Koch's second postulate?\", \"What is Koch's third postulate?\", \"If all 3 of Koch's postulates are met, what does this indicate?\", \"Is Koch's postulate applicable to enteric viruses?\", 'What changes do viruses make to be unrecognizable to previously neutralizing antibodies?', 'What is hepatitis C?', 'How large is the HCV genome?', 'What are the non-structural proteins encoded by the HCV genome?', 'Why has it been difficult to develop a therapy for the Hepatitis C virus?', 'An antibody response to which proteins correlates with reduced HCV levels?', 'How are type A, B, and C viruses determined?', 'Which type of influenza causes epidemics and pandemics?', 'When did lions first occupy Europe?', 'What was the purpose of this study?', 'What has been the application of phage display technology?', 'What makes phage display technology useful for other applications?', 'What are the advantages of phage as a vaccine carrier?', 'What is the potential of phage for infectious and chronic diseases?', 'What is the regularity of the virion major coat protein lattice useful for?\\n', 'Why is the phage ab excellent model system for directed protein evolution?', 'What are filamentous bacteriophages genera Inovirua and Plectrovirus?', 'What invention has made bacteriophage useful for research?', 'What has the bacteriphage technology and the library of folded protein variants enabled?', 'What are the potential novel applications of the filamentous phage?', 'What themes are common in  the applications of filamentous phage?', 'What do applications of filamentous phage depend on?', 'What characteristics are determined by the display  mode?', 'How may the display be achieved?', 'What does  the term \"phage display\" refer to?', 'What does the term \"phage displayed library\" refer to?', 'What characteristic of filamentous phage has been demonstrated?', 'What application is a natural extension of the  ability to display recombinant exogenous sequences on its surface?', 'What makes it an attractive vaccine carrier?', 'What does the display mode determine?', 'Why are antibody epitope based peptide vaccines are no longer an active research area?', 'What phage may be useful in allergy immunotherapy?', 'Which are some phage based contraceptive vaccines for animals?', 'Which are some phage based contraceptive vaccines for animals?', 'What is one reason for the lack of success of immunization phage displayed peptides with native protein?', 'Despite shortcomings, what has the filamentous phage has been useful for?', 'What is the result of all species tests of phage particles?', 'What are the results of filamentous phage immunizations in mice?', 'What is the primary antibody response against the phage?', 'Why is phage self-adjuvanting?', 'On what does the antibody  response to phage depend on?', 'What do biodistribution studies of the phage after intravenous injection show?', 'What are the merits of the filamentous phage carriers?', 'What is a future potential of filamentous phage?', 'What were more potent inhibitors of Staphylococcus aureus growth than high-concentration free chloramphenicol?', 'What killed prostate cancer cells in vitro?', 'What was the effect of phage displaying  peptides on tumor?', \"Why is the phage displaying  an scFv against β-amyloid fibrils  is a good diagnostic for Alzheimers and Parkinson's disease?\", 'What is the structure of a filamentous phage particle?', 'What makes filamentous phage ideal scaffold for bioconjugation?', 'What trials have been done to demonstrate the potential of phage in applications for nanomaterials?', 'What trials have been done to demonstrate the potential of phage in applications for nanomaterials?', 'What is the filamentous phage varion is made of?', 'What demonstrate the potential of phage in applications for nanomaterials?', 'What was investigated in this study?', 'What was the range of genomic sequencing depths?', 'Which q-score reads were eliminated from the analysis?', 'What was the mean length of the sequenced read?', 'Which strain was similar to other Belgian porcine kobuvirus isolates?', 'What is Clodstridium difficile?', 'What is sporulation?', 'What is the key regulator to sporulation?', 'What are the main virulence factors in C. difficle?', 'What laboratory test can be used to monitor protein expression?', 'How is Venezuelan equine encephalitis virus transmitted?', 'What are the symptoms of Venezuelan equine encephalitis virus?', 'What is the mortality rate of Venezuelan equine encephalitis virus in children?', 'What is the mortality rate of Venezuelan equine encephalitis virus in adults?', 'What vaccine can be used to prevent Venezuelan equine encephalitis virus?', 'What can RNA sequencing be used to monitor?', 'What activates the UPR pathway in the cell?', 'What indicators does the UPR pathway use to regulate protein folding and secretion in the cell?', 'Where does EGR1 accumulate in the cell?', 'What is EGR1?', 'What is disease resilience?', 'What family of virus does SARS reside in?', 'What family of virus does MERS reside in?', 'When was SARS-CoV first identified?', 'How many people did SARS-CoV infect?', 'What percentage of people infected with MERS-CoV died?', 'What percentage of people infected with SARS-CoV died?', 'What was the reservoir for SARS-CoV and MERS-CoV?', 'What was the primary threatening clinical finding in patients infected with SARS-CoV and MERS-CoV?', 'What is the relationship between SARS-CoV and acute lung injury (ALI)?', 'What is the relationship between SARS-CoV and acute respiratory distress syndrome (ARDS)?', 'What is required for a person to survive a serious SARS-CoV infection?', 'How does cell-entry differ between SARS-CoV and MERS-CoV?', 'What is a major difference in clinical progression between SARS-CoV and MERS-CoV?', 'How does transmission differ between SARS-CoV and MERS-CoV?', \"How do SARS-CoV and MERS-CoV evade the immune system sensing it's genome?\", 'What role does initial viral titer play in the prognosis of SARS-CoV and MERS-CoV?', 'What is the timeline of the type I interferon (IFN) response in SARS-CoV infection?', 'How do SARS-CoV viral proteins interact with the immune response?', 'What was the role of corticosteroid use in hospitalized patients with SARS-CoV?', \"What is the role of interferon's (IFNs) in the treatment of SARS-CoV?\", 'What are some negative effects of decreasing immunopathology by immunomodulation?', 'What is the role of topoisomerase I in improving host resilience in viral lung infections?', 'What is the role of complement 5a (C5a) in increasing host resilience to viral lung infection?', 'What is the role of statins in increasing host resilience to viral lung infections?', 'Which medical comorbidities most profoundly influenced MERS-CoV outcomes?', 'Which immune factors were associated with increased SARS-CoV morbidity and mortality?', 'What is the prognostic role of coinfection in SARS-CoV and MERS-CoV infections?', 'Can host resilience be predicted?', 'Can biomarkers be used to predict outcomes in acute respiratory distress (ARDS) patients?', 'What work has been carried out this study?', 'How many confirmed cases were identified in February 2020?', 'What was the case fatality rate?', 'Who are the majority of cases?', 'What are the symptoms at the onset?', 'What  type of virus is 2019-nCOV?', 'What clade does it belong to?', 'What other betacoronaviruses are zoonotic in origin?', 'How does the pathogenicity of 2019-nCOV compare with other viruses?', 'How does the transmissibility of 2019-nCOV compare with other viruses?', 'Which electronic databases were used for this study?', 'What was the purpose of the search?', 'What topics were searched for?', 'What studies  were excluded?', 'What did the searches yield?', ' What is the the primary means for diagnosing the new virus strain?', 'What are roles of  the period and type of specimens?', 'What  are some of the other diagnostic methods?', 'How does RT-LAMP compare with other methods?', 'How do RT-iiPCR and a one-step rRT-PCR compare with other methods?', ' Why is RT-PCR not the best method sometimes?', 'What did the comparison between the molecular test  and serological test show?', 'What enhancements to the molecular tests were looked at?', 'What is the threshold sensitivity of  Real time PCR?', 'How is the reproducibility of real time PCR?', 'What are potential vaccines based on?', 'Which  kit is currently used in China?', 'Why were only four studies included?', 'Which  four studies were included?', 'What is te safety of the vaccines?\\n', 'What was the performance of the vaccine candidates?', 'How many clinical trials are registered?', 'What is the status of the nine trials?', 'What are the results on seroconversion?', 'What were the results on antibodies?', 'What were  the T-cell responses?', 'What were the differences in immune responses?', 'What is the observed benefit of the molecules?', 'What is the ongoing randomized trial investigating?', 'What are the many prospective and restrospective studies  conducted on?', 'What was the result of the phase 1 trial of IgG immunoglobin?', 'What role rapid diagnostics plays?', 'What other measures rapid diagnostics facilitates?', 'What  are ways to perform laboratory diagnostics?', 'What are key limtations of genetic detection?', 'What is a key limitation of serological  testing?', 'What is the limitation in virus testing?', 'What was the result of the treatment?', 'What  superiority did the treatment with integrative chinese and western medicine treatment have compared with using control treatment alone?', ' What was a characteristic of  SARS-CoV and MERS-CoV, specimens collected from the lower respiratory tract such as sputum and tracheal aspirates?', 'How do severe cases compare with mild cases?', 'What is the disadvantage of upper respiratory tract specimens?', 'What  are the existing practices in detecting  genetic material of viruses?', 'Why are Nucleic amplification tests (NAAT) usually preferred as in the case of MERS-CoV diagnosis?', 'Where  was the first validated diagnostic test designed?', 'How were the assays selected ?', 'How  were the assays used?', 'What were the results?', 'What did the trial on SAB-301 demonstrate?', 'What conditions are caused by Staphylococcus aureus?', 'What percentage of healthy adults are asymptotically colonized by pneumococcus bacteria?', 'What types of cells follow epithelial cells in the immune response to infections in the lung?', 'What enhances the expression of type I interferon?', 'What reduces the antimicrobial activities of alveolar macrophages?', 'What is Pneumolysin?', 'What factors make bacterial and viral co-infections so lethal?', 'What are inovirus-associated vectors?', 'How can random peptide libraries be used in applications?', 'Which Lactobacililus casei strain does not have the cholera toxin subunit A1 (CTA1) on the surface?', 'What is the most effective treatment against influenza?', 'What is the percentage decrease in influenza antibodies after 8 months after inoculation with the inactivated vaccine?', 'Why is matrix protein 2 (M2) an attractive target for a universal influenza vaccine?', 'Why have M2-based vaccines been ineffective?', 'Why are lactic acid bacteria considered an attractive delivery system for a live influenza vaccine?', 'What primer pairs were used for PCR?', 'What is considered essential to boost the interaction of the influenza vaccine with the mucosal immune system?', 'Name some adjuvants that have been used with an influenza vaccine.', 'What was found in the lungs of the control mice in this study?', 'What did this study show?', 'What regulates the secretion of proinflammatory cytokines?', 'Where does the NLRP3 inflammasome activate after a SARS-CoV infection?', 'What ion channel is essential for 3a-mediated IL-1Beta secretion?', 'What are viroporins?', 'What is the genus of the SARS coronavirus?', 'What is the family of the SARS coronavirus?', 'Is the SARS coronavirus enveloped?', 'Is the SARS coronavirus single-stranded or double-stranded?', 'How many laboratory-confirmed cases of SARS coronavirus infections were reported between November 2002 and July 2003?', 'What was the fatality rate of the SARS coronavirus outbreak between November 2002 and July 2003?', 'What are examples of proinflammatory cytokines?', 'How does NLRP3 detect RNA viral infection?', 'How many amino acids are in the SARS-CoV E protein?', 'What type of ion channels are formed by the SARS-CoV E protein?', 'What does the SARS-CoV protein activate?', 'What is critical to the development of a protective granuloma in tuberculosis infections?', 'What is tumor necrosis factor-alpha?', 'What regulates the activity of MAPK activity?', 'What causes tuberculosis?', 'What percentage of the world has been infected by tuberculosis?', 'How many new tuberculosis cases are there each year worldwide?', 'What are some mitogen activated protein kinases?', 'How is MAPK activated?', 'What enzymes are involved with phosphorylation?', 'How many MAPK phosphatases exist?', 'What is lipopolysaccharide?', 'What is Staph aureus?', 'What protein is in the critical path of immunity and cytokine expression?', 'What diminishes the effectiveness of annual influenza vaccinations?', 'what new  type of influenza vaccines are needed?', 'What alternatives to classical vectored vaccines are needed?', 'What is the advantage of virus vectored vaccine?', 'What is the advantage of virus vectored vaccines?', 'What is one of the issues with present vaccines?', 'What general types of vaccines are available?', 'What inactivated vaccines are available?', 'How is the split virus inactivated?', 'How is the TIV administered?', 'What does the TIV contain?', 'How is the TIV efficacy measured?', 'Which is the major surface and attachment glycoprotein on influenza virus?', 'How is the serum antibody response measured?', 'What is a gold standard for correlation with immunity to influenza?', 'What is the indication for protection to influenza?', 'What gives protection against clinical disease?', 'What can give protection against clinical disease?', 'How is the LAIV administered?', 'What does the LAIV contain?', 'Do LAIV replicate at body temperature?', 'What is a characteristic of LAIV?', 'Where do the LAIV replicate?', 'What does LAIV immunization do?', 'What do the inactivated vaccines rely on?', 'What enables virus invasion from immunity?', 'When does the vaccine strain selection occur in the northern hemisphere?', 'What is the efficacy of LAIV?', 'What does LAIV rely on?', 'What is the LAIV replacement schedule?', 'Why LAIV may provide broader broader  protection than TIV?', 'What has raised the possibility of universal influenza vaccine?', 'What is the advantage of recombinant DNA systems?', 'What is the advantage of recombinant DNA system?', 'What is the advantage of recombinant DNA systems?', 'What is the issue with each of these vaccines?', 'What is a concern with these vaccines?', 'How many serotypes of adenovirus are there?', 'Why adenovirus may be the safest vaccine vector?', 'Which is the most studied serotype?', 'Why is Ad5 is the most studied serotype? ', 'Why are adenovirus vectors most attractive?', 'What is the advantage of  the adenovirus ?', 'What is the advantage of adenovirus vector?', 'What is the advantage of adenovirus?', 'What is the advantage of adenovirus vaccines?', 'What is the advantage of oral capsule and intranasal deliveries?', 'What  did the first report on adenovirus as a vector demonstrate?', 'Which rAd5 delivery has been tested?', 'What was the result of the rAd5-HA testing?', 'What is  the result of rAd5 trials?', 'What is an example of failure of rAd5?', 'What was the failure of rAd5 vaccine for inducing HIV-1 specific T cell response?', 'What does immunization with adenovirus induce?', 'What is the advantage of inclusion of non-HA antigens to HA based vaccines?', 'What is the disadvantage of inclusion of non-HA  antigens to HA based vaccines?', 'What  was the first reported baculovirus vector based vaccine for influenza?', 'What is a drawback of Ad5 vector?', 'What alternatives to Ad5 vector have been explored?', 'What animal adenoviruses have been shown to induce immunity comparable to rdA5-HA?', 'what can evade anti-Ad5 response and also provide effective antigen delivery and immunogenicity?', 'What additional strategies have been explored to avoid preexisting immunity?', 'What is the advantage of AAV vector?', 'What is the advantage of the AAV vector?', 'What is the advantage of AAV vector?', 'What is the advantage of AAV vector?', 'Has AAV been studied as  vectors for influenza?', 'What are alphaviruses?', 'What are some alphavirus vectors that have been developed?', 'How do the alphavirus vectors work?', 'How do the alphavirus vectors work?', 'What is an important feature of the replicon  system?', 'How did the VEE based replicon system incorporating HA from PR8perform?', 'Why is the VEE replicon system particularly appealing?', 'What is the advantage of the VEE replicon system?', 'What were the VRPs derived from VEE developed for?', 'What did the clinical  trial with CMV VRP show?', 'What did the clinical trial with VRP show?', 'Which  baculovirus vaccine has been approved for \\n human use?', 'What  is the advantage of baculoviruses?', 'What is the advantage of baculovirus vectors?', 'How can baculovirus vectors be improved?', 'what baculovirus vector based immunization provided protection from lethal challenge?', 'What was the benefit of the robust innate immune response to baculovirus vector?', 'What is the Newcastle disease virus?', 'What are the appealing qualities of the NDV vector?', 'What is the appealing quality of the NDV vector?', 'What is the appealing quality of the NDV vector?', 'What did the first report on the NDV vector test conclude?', 'What is the added protection of NDV vector?', 'What have the limited NDV human trails shown?', 'What  are the attractive features of the PIV5 vector?', 'What  was the result of the test of efficacy of PIV5 in murine challenge?', 'What opportunity has the termination of smallpox vaccination provided?', 'What vaccinia vectors were created to address safety concerns?', 'How safe is MVA?', 'What is the status of MVA influenza vaccine?', 'What  is NYVAC?', 'How is NYVAC grown?', 'How safe is NYVAC?', 'What would limit the use of poxvirus vectored vaccines?', 'what is the advantage of the NYVAC as an influenza virus?', 'Where is poxvirus vaccine being used?', 'What have the studies on NP shown for the protection against influenza challege?', 'What is the goal of vaccine?', 'What has enabled the development of one size fits all vaccine?', 'Why is a revision of current vaccines is needed?', 'What is an example of an improved vaccine regime?', 'What can provide an improved vaccine regime?', 'What features can be created for creating vectored vaccines?', 'How can sustained immunity be generated?', 'What is the advantage of vectored vaccines?', 'What  is the enhanced memory immune response linked to?', 'What cellular process is the Tat protein essential to?', 'Where does the Tat protein move to in cells?', 'What is a nucleolus?', 'Where are rRNA and ribosomes created?', 'How many proteins were shown to change the amount of Jurkat T-cell nucleolus significantly?', 'What cellular processes occur in the nucleolus?', 'Which viruses target the nucleolus as part of their replication strategy?', 'What nucleolar antigen is essential of localization of Tat and Rev proteins?', 'What was studied in this report?', 'What was studied in this report?', 'Which isotope labeled arginine?', 'Which isotope labeled lysine?', 'How many cells were harvested from each culture?', 'How long is the nuclear protein PARP-1?', 'How long is the protein Alpha-tubulin?', 'Where was alpha-tubulin found most abundantly in the cell?', 'Where was alpha-tubulin found least abundantly in the cell?', 'What is shown in Table S1?', 'What types of cells are used to study Tat-mediated pathogenesis?', 'How many proteins displayed a significant fold change?', 'What is the significance of this study?', 'How are Mammarenaviruses spread from rodents to humans?', 'What are the main groups for Mammarenaviruses?', 'What is the cause of Lassa fever?', 'What type of vaccine is JUNV, Candid#1?', 'Why was the human A549 cell line chosen for this study?', 'For how long were the cells infected before analysis?', 'What drug is used to treat congestive heart failure?', 'What does ouabain inhibit?', 'What method can significantly alleviate the emergence of drug-resistant variants in RNA viral infections?', 'What factors did this study attribute to the efficient multiplication of mammarenaviruses?', 'How do the authors suggest that ATP1A1 and PHB contribute to the efficient multiplication of mammarenaviruses?', 'Which are the most abundant biological entities on Earth?', 'What contributed to a large part of mammalian genomic sequence?', 'What were the earliest replicating entities that fulfill several criteria for life?', 'What are some examples of autonomous bacteria that lost their independence and became intracellular  parasites or endosymbionts?', 'What entities with no genes satisfy the criteria for life?', 'Which group of RNA quasispecies satisfy criteria for life?', 'How are the ribozymes able to replicate, join and create peptide bonds?', 'Does RNA replication need polymerase enzymes?', 'How can DNA arise chemically from RNA?', 'What do ribozymes consist of?', 'What do ribozymes lack?', 'What do ribozymes exhibit?', 'What is CHIKV marked by?', 'What does Chikungunya cause?', 'What is Chikungunya virus?', 'Is there a treatment?', 'What conclusion is drawn in this report?', 'What is Chikungunya virus?', 'What is CHIKV?', 'How is CHIKV propagated to  humans?', 'From what  language the disease gets its name?', 'What is the word Chikungunya mean?', 'What  does Chikungunya mean in Swahili?', 'How is CHIKV maintained in Africa?', 'What is it vectored by, in Asia?', 'How does the transmission in Asia occur?', 'What spurred  the discovery of the new vector Ae. albopictus?', 'In the epidemic  peak how many cases per week were there on the island?', 'What does this review detail?', 'What  dose this review describe?', 'How many genotypes of CHIKV have been isilated?', 'What are the  genotypes based on?', 'hen did Asian genotype emerge?', 'When didthe Asian genotype diverge from African genotype?', 'What is the status of Asian CHIKV since its emergence?', 'What are the recent activities of CHIKV?', 'How was the Italian isolation found to have evolved from?', 'How many days is the incubation period?', 'In how many days do the symptoms arise?', 'What are exhibited in the two phases?', 'What are consequences of infection?', 'What percentage of the patients still have the CHIKV IgM after eighteen months?', 'What is te chronic stage characterized by?', 'What is affected by CHIKV?', 'What explains the pain associated with CHIKV?', 'What percentage of people suffering from the CHIKF are over 65 years old?', 'What percentage die?', 'What other group is disproportionately affected?', 'What complications are associated with CHIKV?', 'What happens after  host infection?', 'What did the Ae.Aegypti which is responsible for epidemics in Kenya, Comoros and Seychelles carry?', 'what was the result of the decline in population of Ae. Aegyptus  when the virus struck the Reunion Islands, due to massive use dichlorodiphenyltrichloroethane usage?', 'What did this mutation allow?', 'What vectored the large epidemic in La Reunion Islands?', 'What percentage of population was affected?', 'Where were  the CHIKV strain found?', 'What is the finding on E1-A226V in Indian Ocean?', 'What has the E1-A226V enabled?', 'What has become the preferred and lethal vector?', 'What was the finding on the Green Fluorescent tagged E1-A226V?', 'What became the main vector in the Indian Ocean within 1-2 y after CHIKV was introduced?', 'how long Ae. aegypti been established in North America?', 'What is the presence of Ae.albopictus in North America?', 'What percentage of newborns were infected from their mother?', 'What has been some instances of mother to  fetus transmission?', 'What  did the studies reveal regarding transmission from mothers during perinatal period?', 'What is theorized regarding transmission?', 'What did the study report?', 'What is a conclusion of this report?', 'What is a conclusion of this report?', 'What is the NIAID designation of CHIKV?', 'What are the strengths and advantages of DNA based vaccine?', 'How many facilities were monitored in this study?', 'What percentage of facilities believed they were adequately equipped to handle Ebola virus disease?', 'How many facilities believed they were adequately equipped to handle Ebla virus disease?', 'How many healthcare workers would be willing to continue working during the Ebola virus outbreak?', 'What does the study suggest would make healthcare workers more willing to care for patients during an Ebola virus outbreak?', 'What causes avian infectious bronchitis?', 'What differentiated the two chicken lines used in this  study?', 'Which organ was used for the RNA sequencing samples?', 'What is needed to elucidate zoonotic emergence?', 'What is the conclusion of  this report?', 'Why  have bats received attention in recent years?', 'What difference bats demonstrate compared to most non-Chiropteran mammals?', 'What suite of species-specific mechanisms do bats have to limit viral load?', 'How are mammalian cells typically rendered antiviral?', 'In non-flying mammals, what what would be elicited by IFN expression upon viral infection?', 'What do the bats do instead?', 'Why may the bats have this unique adaptation?', 'Why  was the field of virus dynamics developed?', 'How are bats connected to fatal viral diseases?', 'What is  an example of anti-viral defense in bats?', 'What would be caused by  this hyper-vigilance in most other mammals?', 'How are bats different?', 'What bat species cells were compared?', 'What was the conclusion of the study ?', \"What would be the benefit of learning more about bat's defenses and how they  drive virus evolution?\", 'Which cells are IFN-defective and therefore limited in  antiviral capacity?', 'What cells demonstrate idiosyncratic interferon response?', 'Which cells express constitutive IFN-a?', 'How were  the spread of GFP-expressing virus-infected cells across tissue monolayers tracked via inverted fluorescence microscopy?', 'How were  the spread of GFP-expressing virus-infected cells tracked?', 'How was the modeling carried out?', 'What was the finding in this study?', 'What supports the results?', 'What was additionally demonstrated?', 'What do  the studies suggest?', 'What was the methodology for this study?', 'What was demonstrated in deriving the equation for R 0?', 'What is a conclusion of the modeling?', 'What is a conclusion of the study?', 'What do  fits to rVSV-MARV infections on PaKiT01 cells suggest?', 'What do the findings indicate?', 'What is presented in this study?', 'What is a conclusion of  this study?', 'What age group has the highest rate of severe outcomes?', 'How is COVID-19 spread?', 'How many states in the U.S. have reported cases of COVID-19?', 'When did the White House launch the \"15 Days to Slow the Spread\" program?', 'What should mildly-ill patients do?', 'What type of virus is SARS-CoV-2?', 'What viruses are similar to the COVID-19 coronavirus?', 'What are the phases of a pandemic?', 'At which phase does the peak of the pandemic occur?', 'People with which medical conditions have a higher rate of severe illness?', 'What kind of test can diagnose COVID-19?', 'In what species did the COVID-19 virus likely originate?', 'What risk factors should be considered in addition to clinical symptoms?', 'What is the acronym SARS-CoV-2?', 'When was SARS-CoV-2 first identified?', 'Where was SARS-CoV-2 first identified?', 'What factor positively correlates with imported-and-reported cases counts of SARS-CoV-2 infection?', 'What is the doubling time of the COVID-19 pandemic?', 'When did the first known cases of Middle East respiratory syndrome (MERS) occur?', 'Where did the first known cases of Middle East respiratory syndrome (MERS) occur?', 'Where was the the case first to be publicly reported was from ?', 'In what animals MERS-CoV sequences have been found ?', 'Where is MERS-CoV is enzootic in DC?', 'What does MERS-COV cause?', 'Precisely how does the virus transmit to humans?', 'What appears to be a requirement for transmission?', 'What is a focal point of MERS?', 'What is MERS mostly known as?', 'What does the MERS LRT disease involve?', 'Where else MERS-COV has also been detected?', 'Who suffers severe diseases from MERS?', ' Compared to severe acute respiratory syndrome (SARS)  and another sometimes- fatal zoonotic coronavirus disease, how does MERS affect the patients?', 'To what have most human cases of MERS  been linked?', 'Among whom 20% of the virus detection are reported?', 'What have sero-surveys of MERS virus found?', 'How was the first culture of the new Coronavirus announced?', 'Where was the Email published?', 'When was the Email  published?', 'Whose was the first reported case?', 'How many  viral RNA or virus-specific antibodies been detected?', 'What is the death rate from MERS-COV?', 'What did the discovery process over two to three years reveal?', 'What does subsequent transmission of MERS-CoV to other humans require?', 'What would restrict access to both the virus and to viral diagnostics ?', 'How was the virus then made freely available? ', \"What has epidemiology and research identified the MERS-CoV's cell receptor is?\", 'How does MERS-CoV compare with SARS-CoV?', 'How does MERS-CoV compare with SARS-CoV?', 'How does MERS-CoV spread among people?', 'Who gets more severe disease from MERS?', 'What is the spread of MERS-CoV among humans, associated with?', 'What do the DCs suffer with MERS-CoV infection?', 'What happens to humans infected by MERS-CoV virus?', 'What is the incubation period of MERS?', 'What is the duration between when illness begins in one person and subsequently spreads to another?', 'What is the median time to death in case of progressive illness?', 'What is the progression  of symptoms to disease?', 'What did the later WHO definition of MERS clearly state?', 'What percentage of cases KSA has been a source of?', 'What is severe MARS noted for?', 'What symptoms appear among the  confirmed cases of MERS?', 'What do patients often present to a hospital with, in cases of MERS?', 'What can  MERS disease progress to?', 'What percentage of all  reported cases has MERS  reportedly killed ?', 'What percentage of of all reported cases has MERS  reportedly killed in KSA?', 'What was mortality in  South Korea from MERS disease?', 'Which are the preferred method for MERS-CoV detection?', 'What  have become a key diagnostic and taxonomic target for CoV species identification?', 'Why  it can be concluded that MERS-COV is a novel and distinct virus?', 'What  indicates the likely presence of infectious virus?', 'What is the sensitivity with which immunochromatographic tool could detect recombinant MERS-CoV nucleocapsid protein?', 'What is the specificity with which immunochromatographic tool could detect recombinant MERS-CoV nucleocapsid protein?', 'What is a different approach for the detection?', 'What is usual in serology testing?', 'How have some sero-assays bypassed the risks of working with infectious virus?', 'How have some sero-assays bypassed the risks of working with infectious virus?', 'What is the  detection of MERS-CoV infection using ELISA or S1 subunit protein microarray [84] is usually followed by?', 'What does the confirmatory process aim to  ensure?', 'When does  generally MERS infection does not trigger a detectable immune response?', 'When does the WHO recommend samlinf from the LRT?', 'What do the recommended samples include?', 'What are recommended when URT sampling is to  be conducted?', 'What paired sera are preferable?', ' When is a single sample  suggested to be sufficient?', 'How long human urine and stool have been found to contain MERS-CoV RNA?', 'What do individual studies report on viral  shedding?', 'What fraction of MERS cases shed viral RNA in their LRT specimens (tracheal aspirates and sputum) ?', 'How long MERS cases shed viral RNA in their LRT specimens (tracheal aspirates and sputum)? ', 'What percentage of contacts were still shedding RNA in their URT specimens?', 'What  samples  returned the highest MERS viral load values?', 'What is NPA?', 'What is  NPA?', 'What is BAL?', 'What is the the proportion of deaths among those infected with MERS-CoV?', 'What is the the proportion of deaths among those infected with MERS-CoV?', 'What   has prevented worldwide spread of MERS-COV?', 'What must be reported to the world organization for animal health as an emerging disease ?', 'What are juvenile DCs more often positive for?', 'What are older DCs are more likely to be positive for?', 'When does the camel calving season?', 'Why is there an increased risk to humans of spill-over during calving season?', 'Which may be an occupational group with significantly higher incidence of seropositivity to MERS-CoV ?', 'How long after Infectious MERS-CoV added to DC, goat or cow milk and stored at 4°C could be recovered?', 'How long after Infectious MERS-CoV added to DC, goat or cow milk and stored at 22°C could be recovered?', 'What ablated MERS-COV infection completely?', 'How long MERS-CoV remained viable at high ambient temperature (30°C) and low RH (30 %) ?', 'How long can pathogenic bacteria remain viable and airborne in a coughed aerosol?', 'How far can pathogenic bacteria spread in a coughed aerosol?', 'What is considered the mechanism of human-to-human transmission of MERS-COV?', 'What is the transmission of MERS-CoV is defined as?', 'What is the transmission of MERS-CoV is defined as?', 'What is the transmission of MERS-CoV is defined as?', 'What is the transmission of MERS-CoV is defined as?', 'What is the transmission of MERS-CoV is defined as?', 'What is the  the rate of general transmission, even in outbreaks?', 'What do the majority of human cases of MERS-CoV  seem not to do?', 'What is the basic reproduction number (R 0)?', 'What is the basic reproduction number (R 0 )  for MERS-COV?', 'Why has MERS had a constant presence in the Arabian Peninsula?', 'What was the first known MERS human-to-human transmission event was one characterized by?', 'Where was the first known MERS human-to-human transmission event?', 'Approximately what percentage of MERS cases were fatal in  KSA?', 'Approximately what percentage of MERS cases were died outside KSA?', 'What percentage of HCWs comprised of MERS cases in the KSA and South Korea?', 'How has most of the analysis of MERS-CoV genetics  been performed?', 'What does Clade A contain?', 'What does clade B comprise?', 'How many clades have become apparent in genome of  MERS-COV from humans and DCs?', 'Which city has had has had more MERS cases than any other region of the KSA ?', 'Which city harbours a wide range of MERS-CoV variants ', 'How has the vast majority of MERS-CoV transmission occurred?', 'How were the transmission circumstances created?', 'What percentage of humans have died  among all humans reported to be infected?', 'What would  aid accurate calculation of a case fatality ratio?', 'How does MARS-COV differ from SARS-COV?', 'Is there any evidence that MERS-CoV is a virus of pandemic concern?', 'How did the first WHO case definition  define probable cases of MERS?', 'What is PHEIC?', 'How is PHEIC defined?', 'What platform was instrumental in rapid sharing of COVID-19 information?', \"What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?\", \"What's the recommended method to disinfect floors for COVID-19?\", 'What is the role of computed tomography (CT) in COVID-19?', 'What kind of masks are recommended to protect healthcare workers from COVID-19 exposure?', 'What thickness of layers is recommended for CT image reconstruction in COVID-19 assessment?', 'What must the data gathering include?', 'What must be done to assist in recognition of the disease on images and to allow accurate reporting\\nof these findings?\\n', 'What is the major role of chest CT?', 'What is the reason to adopt low-dose CT?', 'What did the EMICT responsibilities include?', 'How were the radiology department areas divided?', 'How was the contaminated area connected to the CT room and other facilities?', 'What does the clean area include?', 'What does the semicontaminated area include?', 'What does the buffer area include?', 'How was the wearing and removing of the equipment performed?', 'What can lower the physical and mental stress levels of staff members?', 'Who must be assigned to the clean area?', 'What responses must EMICT consider once a disease has been identified?', 'What is the conclusion of the report?', 'What were the number of cases in mainland china as of March 11th?', 'How many COVID deaths occurred in Chinese mainland as of March 11th?', 'How many people have come in contact and how many of these are in observation?', 'When was the novel Coronavirus first reported?', 'When did China detect the first human case of H7N9 infection?', 'How many deaths were associated with MERS-CoV as of July 2014?', 'What illness is caused by the 2019-nCOV Coronavirus?', 'In addition to oral swabs, which tests detected the presence of 2019-nCOV virus?', 'What  is the relationship between the presence of virus in blood and anal swabs and disease severity?', 'Which patients were classified as severe in Chinese guidelines?', 'What is the relationship between the presence of virus in blood sample and disease severity?', 'What test could give an indication for special care for 2019-nCOV patients?', 'What is the relationship between the presence of virus in anal swabs and disease severity in 2019-nCOV?', 'What could be the implication of 2019-nCOV virus in anal swabs?', 'What  could account for the high transmission rate of the 2019-nCOV virus?', 'What could account for the dissemination of the 2019-nCOV virus across the whole body?', 'When did the World Health Organization declare the Ebola epidemic in West Africa as a Public Health Emergency of International Concern?', 'What is PPE?', 'Where did the 2014 Ebola epidemic in West Africa spread to?', 'What are the prerequisites for successful emergency preparedness for an epidemic?', 'What is the structure of a coronavirus?', 'What method is developed in this study?', 'What is the model simplified to?', 'What is the estimate of R 0?', 'What is the conclusion of this study?', 'What was the focus of the study?', 'What were the model assumptions?', 'What  compartments were the bats divided into?', 'What compartments were the host animals divided into?', 'What was the SARS-COV-2 reservoir?', 'What were the people divided into?', 'What was the mean incubation period?', 'What was the mean delay from symptom onset to detection/hospitalization of a case?', 'How long after onset, the cases detected in Thailand and Japan were hospitalized?', 'What was the duration from illness onset to first medical visit ?', 'What was the assumption of transmissibility of asymptomatic infection?', 'As of January 17, how many people were tested for body temperature?', 'What is mobile  population in Wuhan?', 'What was  the R0 of SARS?', 'What was the value of R0 in other researches?', 'What is the reported value of R0 for MERS?', 'What was  R0 for  the high transmissibility in  South Korea?', 'What is important for containing the transmission?', 'What did this model show?', 'What was the objective of the study?', 'What are coronaviruses?', 'What animals can carry coronavirus?', 'How many  COVID-19 cases were confirmed on the Diamond Princess cruise ship?', 'What was the time period of peak infection of COVID-19 on  the Diamond Princess cruise ship?', 'With the intervention of movement restrictions starting on 5th February 2020, what were the confirmed cases for COVID-19, were limited  to?', 'Who was the first COVID-19 identified case patient on the Diamond Princess cruise ship?', 'When was  the first  passenger patient on the Diamond Princess cruise ship diagnosed with COVID-19?', 'How many COVID-19 cases were confirmed on the Diamond Princess cruise ship?', 'What is the estimated mean incubation period for COVID-19 infection on the Diamond Princess cruise ship?', 'What was the effect of movement restriction policy on the Diamond Princess cruise ship started on 5th February 2020.', 'What would  have the number of confirmed cases on the Diamond Princess cruise ship,  without a movement restriction starting on the 5th February 2020?', 'When was the a cluster of pneumonia cases were first reported ?', 'What is the number of inbound passengers from China?', 'What percent of inbound passengers from China were from Wuhan?', 'What is the mechanism of action for rupintrivir?', 'Has rupintrivir been shown to reduce the symptoms of a rhinoviral infection?', 'What is the primary etiology of acute respiratory infection?', 'What is RSV?', 'What virus is most commonly associated with acute respiratory infections?', 'What viruses are most frequently associated with acute respiratory infections?', 'What are the clinical characteristics of asthma?', 'What risk factor was associated with hospitalization and death during the 2009 H1N1 influence pandemic?', 'How many surface proteins are on the H1N1 influenza virus?', 'What are the 2 surface proteins on the H1N1 influenza virus?', 'What pharmaceutical targets the NA glycoprotein of the H1N1 influenza virus?', \"What genetic mutation decreases a person's susceptibility to the H1N1 influenza virus?\", 'Why is ribavirin treatment limited?', 'To what the lack of exposure report could be attributed?', 'Why is the determination of asymptomatic or pre-symptomatic transmission, an urgent priority?', 'When does the infectivity of SARS-COV peak?', 'How can the 2019-nCov spread?', 'What is the estimate of the basic reproduction number?', 'What is assumed for the mean serial interval?', 'What  would a shorter mean serial interval mean?', 'What should have reduced the basic reproduction number in January?', 'What  are the delays between infection to illness and illness to laboratory confirmatiion?', 'What is the estimate of number of infections in Wuhan on 25 January 2020?', 'when is viral shedding the highest?', 'How does the transmission of the respiratory virus happen?', 'How do some respiratory viruses spread?', 'What can also play  a role?', 'What can play a role  in the infection of gastrointestinal tract?', 'What was attributed to the spread of SARS-COV at Amoy Gardens?', 'How were the first human infections identified?', 'What do mild clinical presentations of 2019-nCOV indicate?', 'Why is important to  determine the spectrum of clinical manifestations of 2019-nCoV infections?', 'What, beyond the assessment of severity, is important?', 'For whom would the infections be more severe?', 'When is this especially true?', 'What is the current understanding on viral-induced exacerbations?', 'What have evoked new understandings as to the mechanisms of viral exacerbations?', 'What is one of  the major sources of exacerbation of chronic airway inflammatory diseases?', 'What is the focus of this review?', 'What have the authors reviewed?', 'What is summarized?', 'What is highlighted by the authors?', 'What is consolidated in this review?', 'What is this disease  characterized by ?', 'Where can this disease manifest?', 'Why do treatment and management vary in efficacy?', 'What complicates this  further?', 'What are such exacerbations due to?', 'What do the acute exacerbations cause?', 'What are acute exacerbations  usually due to ?', 'What does the immune response elicited by these agents lead to?', 'Among these agents which is a major driver?', 'What is the viral involvement in COPD exacerbation? ', 'What is the reason for the involvement of respiratory viruses in exacerbation?', 'What does the involvement of respiratory viruses contribute to?', 'Why is it  important to identify the exact mechanisms underpinning viral exacerbations in susceptible subjects?', 'What is the lower airway the site of?', 'Where is the the first point of contact with sources of exacerbation', 'What is the focus of this review?', 'What is complied by the authors?', 'Before linking respiratory viruses, what was linked to acute exacerbations?', 'What did the advent of PCR technology lead to?', 'What are the predominant viruses linked to airway inflammatory diseases?', 'What other viruses are implicated in acute exacerbations but to a much lesser extent?', 'What other viruses have been recently reported as contributing to acute exacerbations?', 'What are the common feature of these viruses share?', 'Where do the respiratory viruses primarily infect and replicate?', 'What happens  during the replication process?', 'What does the inflammation lead to in healthy airways?', 'How may the responses be different in a chronically inflamed airway?', 'What will the review focus on?', 'How will this review serve?', 'Why is this approach significant?', 'What happens upon infection?', 'How does the infected airway cell respond?', 'What  does the epithelial proteins cause?', 'What is the effect of these factors?', 'What additional effects are caused  in patients with asthma and patients with CRS with nasal polyp ?', 'What is the result of increased eosinophilia?', 'What are the effects for patients with COPD and patients with CRS without nasal polyp (CRSsNP) ?', ' Which are the type 2 inflammatory cytokines expressed by the epithelial cells upon injury to the epithelial barrier?', 'Which cells lacking both B and T cell receptors but play a crucial role in secreting type 2 cytokines to perpetuate type 2 inflammation when activated ?', 'What is the effect cell death and injury to the epithelial barrier due to infection?', 'What happens when the 3 cytokines are expressed?', 'What  happens in the case of COPD?', 'What happens during viral infection of healthy individuals?', 'What happens upon viral infection in the airway?', 'What is the effect of the inflammation of the airway?', 'What increases the severity of exacerbations in the airway?', 'Why viruses do not need to directly infect the lower airway to cause an acute exacerbation?', 'what is suggested by the fact that  not all viral infections of the airway lead to acute exacerbations?', 'What is the effect of chronic airway inflammatory disease  in patients?', 'What is the effect of chronic airway inflammatory disease?', 'Why should future studies  be performed using metagenomics in addition to PCR analysis ?', 'What is highlighted by the authors in this review?', 'Who has impaired or reduced ability of viral clearance ?', 'What does their impairment stems from?', 'Where is this  especially evident?', 'What are other  effects?', 'What is the  effect of viral components remaining in the airway?', 'What do these factors do?', 'What is also linked with the chronic inflammation that precedes the malignancies?', 'What should be investigated in the future?', 'What further can viral persistence lead to?', 'What  effect the use of steroids to  suppress inflammation can have?', 'What should be further focus of research?', 'Which viruses may not cause prolonged inflammation due to strong induction of antiviral clearance?', 'What do these infections cause?', 'What do the necroptotic factors such as RIP3 do?', 'What  may the destruction of the epithelial barrier  cause?', 'What may the epithelial destruction cause?', 'What is recommended that patients with chronic airway inflammatory disease?', 'What is another mechanism that viral infections use to drive acute exacerbations?', 'What does infection of respiratory viruses cause?', 'What is an example of this?', 'What are also associated with viral infections and pneumonia development, which may worsen inflammation in the lower airway?', 'What is another area of interest?', 'What is usually linked with the development of chronic airway inflammatory diseases?', 'What follows  in the event of a viral infection such as RV infection?', 'What does the viral infection alter?', 'What is  the destabilization is further compounded by?', 'What does all this gradually lead to?', 'Why do these changes may  result in more severe and frequent acute exacerbations ?', 'How effective are microbiome based  trial therapies?', 'What can viral infections cause?', 'Which is the primary contact/infection site of most respiratory viruses?', 'What does the destruction of epithelial barrier, mucociliary function and cell death of the epithelial cells do?', 'What are viral infections are usually accompanied with?', 'What is the dysregulation of inflammation can be further compounded by?', 'What does  the change in the local airway environment and inflammation promote?', 'What does the the inflammatory environment dispersal of upper airway commensals into the lower airway cause?', 'Which are the most commonly  studied viruses in chronic airway inflammatory diseases?', 'What do the infections such as RSV are shown to do?', 'What does mucus overproduction do?', 'What does the disruption of the ciliary movement during viral infection may cause?', 'What are MicroRNAs(miRNA)?', 'What are  miRNAs found to be induced by?', 'What  were linked to the exacerbation of the airway inflammation disease?', 'Where might such miRNA changes have originated from?', 'What are both IFV and RSV infections shown to do?', 'What are IFV infection shown to do?', 'What happens in in asthmatic epithelium in IFV infection?', 'What do non-coding RNAs present as?', 'What mechanisms, other than miRNA modulation play a role?', 'What have  recent epigenetic studies indicated?', ' What have these studies also shown?', 'What has Spalluto et.al. have shown?', ' What infections such as RV and RSV that weakly induce antiviral responses may result in?', 'What can viral infection result in?', 'What sustains the inflammation  in the airway?', 'What may viral infections of the respiratory epithelium by viruses such as IFV, RV, RSV and HSV do?', 'What can happen  in response to the infection such as neutrophils?', 'In addition to worsening disease symptoms, what do viral-induced exacerbations do?', 'What may studies in natural exacerbations and in viral-challenge models using RNA-sequencing (RNA-seq) or single cell RNA-seq on a range of time-points  provide?', 'What analysis functions may be useful?', 'For what  purpose animal based models aare developed for?', 'What can be used unravel the immune profile of a viral infection in healthy and diseased condition?', 'For what purpose controlled in vivo human infections can be performed for mild viruses?', 'Why may the  mechanisms of exacerbation vary considerably?', 'What clinical condition is caused by Hantaan virus?', 'What is the structure of Hantaan virus?', 'What the animal vector reservoir for Hantaan virus?', 'What diagnostic test is correlated with the severity of HFRS?', 'How is Interferon used in practice?', 'What genotypes are associated with the severity of HFRS?', 'Which IFITM proteins have been shown to possess antiviral activity?', 'What is the hypothesized mechanism by which IFITMs work?', 'What genotype causes truncation of the IFITM3 protein?', 'What can cause a slowing growth in daily reported deaths?', 'When did Italy go into Iockdown?', 'Approximately how many deaths have been averted in Western Europe with current non-pharmaceutical interventions remaining in place until the end of March?', 'What are some non-pharmaceutical interventions?', 'Type of model used to infer the impact non-pharmaceutical interventions?', 'How can a semi-mechanistic Bayesian hierarchical model estimate changes to the reproductive number?', 'What is a key assumption of a semi-mechanistic Bayesian hierarchical model used for coronavirus?', 'What is the time lag between when transmission changes occur and when their impact can be\\nobserved in trends in mortality?', 'What is the key aim of non-pharmaceutical interventions?', 'What happens if the reproduction number is greater then 1?', 'When did China introduce strict movement restrictions and other measures including case isolation and quarantine?', \"What was the result of China's interventions introduced in January?\", 'What are examples of social distancing?', \"What was the estimated effect on China's reproduction number in March based on the intervention introduced in January?\", 'Why is it challenging to estimate the reproduction number?', 'What is an alternative way to estimate the course of an epidemic?', 'What is the estimated attack rate in Italy?', \"As of the end of March what is the proportion of Spain's population to be infected?\", 'Which Western European country is estimated to have the lowest attack rate?', \"What is Austria's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Belgium's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Denmark's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is France's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Germany's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Italy's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Norway's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Spain's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Spain's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is Switzerland's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", \"What is United Kingdom's estimated mean percentage [95% credible interval] of total population infected as of 28th March?\", 'What is the estimated averaged initial reproduction number [95% credible interval] for Western Europe as of 28th March?', 'Why is there high uncertainty in estimating the impact of interventions against the coronavirus?', 'Why is it statistically impossible to determine which individual intervention had the greatest effect on reducing the coronavirus reproduction number?', 'What is estimated to drop immediately after an introduction of a non-pharmaceutical intervention?', 'One way to understand the impact of interventions?', 'What is a lockdown?', 'Why is it hard to know the true incidence of infections number?', 'What is an example of a case-based measure against coronavirus?', 'What is an example of containment phase intervention?', 'What does a public events ban intervention mean?', 'An example of social distancing', 'Example of social distancing', 'What is a lockdown?', 'What is an infection-to-onset-distribution?', 'What is an onset-to-death distribution?', 'What is the population-averaged infection fatality ratio?', 'What is the time-varying reproduction number a function of?', 'What is an incubation period?', 'What is an incubation period?', 'What are the descriptive statistics for the onset-to-death for coronavirus?', 'What are the descriptive statistics for the incubation period for coronavirus?', \"What is the estimated infection-to-death distribution's mean for coronavirus?\", 'What is a well known approach to model the true number of infected individuals?', 'What is a way to measure virus transmission?', 'What term describes when a majority of the population has built an immunity to a virus?', 'What is the estimated number of people in Italy infected with coronavirus by March 28th?', 'In 2009 what was the reported H1N1 vaccination rate in China?', 'What is the highest alert level given by the World Health Organization to a pandemic?', 'What does it mean for a pandemic to have a WHO alert level of 6?', 'What was the estimated economic impact in the U.S. from the 2009 SARS pandemic?', 'How is 2019-nCOV transmitted?', 'What are ways in  which 2019-nCOV is transmitted?', 'Is oral swab for detecting 2019-nCOV infection, sufficient?', 'Is oral swab for detecting 2019-nCOV infection, sufficient?', 'What other tests should be considered for 2019-nCOV epidemiology?', 'What tests should  be done before a 2019-nCOV infected patient is discharged?', 'What is a Hantavirus?', 'What plays a role in innate immunity to Hantavirus infection?', 'What evidence suggests that RIG-I and DDX60 collaborate to exert antiviral effects?', 'What was the major contribution of this study?', 'What symptoms were reported?', 'What did the collected data include?', 'When was COVID  surveillance implemented in European region?', 'As of 21 February, how many cases were reported?', 'Where were the cases that were studied?', 'What was the median case age?', 'How many were male?', 'How many cases were there on 5 March?', 'When did the Chinese authorities share the sequence of a novel coronavirus ?', 'What is the name of the disease caused buy SARS-COV-2?', 'What country does this study exclude?', 'What does the study include?', 'What did the ECDC and WHO regional office ask the countries?', 'What was the overall aim of the surveillance?', 'What were the surveillance objectives?', 'What is the adopted WHO case definition?', 'When was the first reported death in France?', 'What is the presumed incubation period?', 'What were the places of infection?', 'What places were linked to these?', 'How many cases were hospitalised?', 'Why were they hospitalised?', 'What was time from onset to hospitalisation?', 'What was the duration of hospitalisation?', 'Why was this?', 'How many cases reported symptoms at this point?\\n', 'How many cases were asymptomatic?', 'What were the asymptomatic cases tested as?', ' For how many cases Fever reported as the sole symptom?', 'In how many cases the symptoms at diagnosis were consistent with the case definition for acute respiratory infection?', 'How many cases had data on preexisting conditions?', 'How many cases had no pre-existing conditions?', 'What other data on pre-existing conditions were reported?', 'How many reported viral pneumonia?', 'What was the clinical evolution of the hospitalised cases?', 'What happened to three cases who were aged 65 years or over?', 'What happened to the case who died?', 'What was the duration of hospitalisation reported for 16 cases ?', 'How were the assays confirmed?', 'What were the specimen types for 21 cases?', 'As of 5 March 2020, what  are the cases in the WHO European region?', 'What were the two contexts for transmission?', 'What  does the analysis show on the difference between locally acquired cases vs imported cases?', 'What is required for locally acquired cases?', 'What was common to all imported cases?', 'What testing and detection are needed?', 'What did the finding prompt ECDC to do?', 'Why is understanding the infection-severity  critical ?', 'Why are serological tests vital?', 'How can hospital based surveillance help?', 'How can present systems of surveillance be used?', 'How will  this approach used?', 'Why is additional research needed?', 'What growing dysjunction has been witnessed?', 'What is aiming to incorporate pathways to translation at the earliest stages?', \"How much  have  the number of biomedical research publications targeting 'translational' concepts has increased ?\", 'What ways to  solve the issues are outlined?', 'How do these exact processes ultimately restrict viral infectivity?', 'What does the author coin this evolutionary dilemma as?', 'How do many viruses resolve this ?', 'How may this \"Achilles Heel\" be safely targeted?', 'Why  may MMHP-targeting therapies exhibit both robust and broadspectrum antiviral efficacy?', 'What will  achieving this through drug repurposing do?', 'What are also discussed by the author?', 'What does  the author anticipate international efforts will do?', 'What do pathogens do upon infection?', 'What is the flip side ?', 'What do RBPs do?', 'What is included in RBPs?', 'What  do  tristetraprolin and AUF1, do?', 'What do RBPs include?', 'What domembers of the Roquin and Regnase families do?', 'What do the RBPs include?', 'What is the increasingly apparent role of RNA methylation machinery ?', 'Where do these activities take place?', 'What happens to these activities during infection?', ' In this way, what do the mRNA-destabilising RBPs constitute ?', \"What can be  done with the  'brake' on the immune system?\", 'What does the author anticipate that continued efforts will lead to?', 'What is another mRNA under post-transcriptional regulation by Regnase-1 and Roquin?', 'What does Furin encode?', 'What are Furin, along with other PCSK family members implicated in?', 'What do Braun and Sauter review?', 'What dis their recent work reveal?', 'What has the increasing abundance of affordable, sensitive, high-throughput genome sequencing technologies  led to?', 'What was this system used for the first time for?', 'What have decades of basic immunology research  provided ?', 'What has this focus on mammalian defences and pathologies sidelined?', 'What has CRISPR/Cas antiviral immune system of prokaryotes been repurposed as?', 'What is another  case in point?', 'What are the ancient lineage of NCLDVs?\\n', 'What do the recent efforts indicate regarding hundreds of human and avian infectious viruses?', 'What is neo-virology?', 'What is predicted these efforts on neo-virology will unlock?', 'What are the two of the four pillars of the National Innovation and Science Agenda?', \"What do Australia's Medical Research and Innovation Priorities include?\", 'What is essential for these priority outcomes?', 'What is the Japan AMED tasked with?', 'What serious question was raised?', 'What is a recent discovery?', 'Which bat virus have been found to be linked with diseases?', 'What assay played an important role?', 'What was the death toll in the 1918-1919 Spanish Influenza epidemic?', 'How many people were infected during the 1918 Spanish Influenza epidemic?', 'What was the case fatality rate in the 1918 Spanish Influenza epidemic?', 'What was the death toll in the 1918-1919 Spanish Influenza epidemic?', 'Are the modern day Influenza viruses related to the 1918 Spanish Influenza virus?', 'Why is the Spanish Influenza virus the Mother of the modern influenza viruses?', 'When was it  determined that the 1918  pandemic was caused by the H1N1 Influenza virus?', 'Did the Spanish Influenza or Swine flu or the H1N1 virus disappear in humans for some time?', 'When did the Swine Flu (Spanish Influenza) virus reappear in humans?', 'What descendant  lineages of the swine flu (Spanish Influenza) virus were identified in 2006?', 'Are the modern descendant influenza viruses as dangerous as the 1918 parent swine flu (Spanish Influenza) H1N1 virus?', 'How dangerous are the modern H1N1 (swine flu) and the H3N2 (Influenza A) viruses compared  to the 1918 H1N1 (swine flu Spanish Influenza)  viruses?', 'Are the descendant H1N1 strains of the 1918 H1N1 swine flu (Spanish Influenza) virus, still prevalent?', 'Is the origin and epidemiology of the 1918 swine flu (Spanish Influenza) known?', 'What is the geographical origin of the H1N1 swine flu ?', 'Is the geographical origin of the 1918 H1N1 swine flu known?', 'What is an unique feature of the 1918 swine flu?', 'What season or  time of the year do the new strains of influenza emerge?', 'Once appeared, when do the influenza like diseases occur in subsequent years?', 'When did the first wave of the H1N1 swine flu (Spanish Influenza) occur?', 'What was the death rate in the first wave of the 1918 swine flu pandemic?', 'When were the second and the third wave of the 1918-1919 swine flu pandemic?', 'What was the primary difference between the first wave and the 2nd and 3rd wave of the 1918-1919 swine flu pandemic?', 'Why the human influenza viruses do not disappear after herd immunity is developed?', 'What are the circumstances that promote the spread of influenza virus?', 'Do seasonal temperatures and humidity explain  the appearance of the three waves of the 1918 swine flu?', 'Which virus samples  from the 1918 swine flu pandemic have been identified?', 'Are viruses in the first and third waves of the 1918 swine flu pandemic same or derived from the virus from the second wave of the swine flu?', 'Was the 1918 swine flu virus novel to humans are was it derived from older viruses?', 'Do avian flu viruses change over long periods?', 'What  is the typical age profile of mortality in Influenza diseases?', 'What was the age profile of mortality in the 1918 swine flu?', 'Which age group was most susceptible to die during the 1918 swine flu pandemic?', 'What was the death rate among children during the 1918 swine flu pandemic?', 'What theory provides partial explanation for the age-specific profile of the death rate in the 1918 swine flu pandemic?', 'Is there a difference in the pathologic feature and course of disease between modern influenza pandemics and the 1918 swine flu pandemic?', 'Could the 1918 swine flu virus been controlled  by modern day drugs or vaccines?', 'Why was there such a high death rate in the 19118 swine flu pandemic?', 'Is the molecular basis of human adaptation of a virus understood?', 'What  was the initial growth phase pattern?', 'What was the result of under-reporting?', 'What is R0?', 'What  is likely increase of the reporting rate after the 17th January 2020?', 'What is the estimated value of R0?', 'What is the likely period of under-reporting?', 'Where and when was 2019-nCOV first identified?', 'What  are some of the symptoms caused by the virus?', 'What was the cumulative number of reported cases by 1 January 2020?', 'As of 26 January 2020, what had the outbreak resulted in?', 'As of 26 January 2020, what countries had sporadic cases?', 'What was the result  of the Imperial College estimation?', 'Who release the time series data from 10th  to 20th January 2020?', 'Who released the time series data from after 21st January 2020?', 'How was the epidemic curve modelled?', 'How was the epidemic curve modeled?', 'What study  is reported in this report?', 'How does the genome of 2019-vCOV compare with   SARS like viruses and SARS-COV?', 'How different is it from SARS-related viruses?', 'What novel features does the genome have?', ' What is important for understanding the origin and evolution of this novel lineage B betacoronavirus.', 'What are Coronaviruses?', 'What are four generas?', 'What do  evolutionary analyses show?', 'What are the examples that have emerged as human pathogens?', 'Where did these viruses originate before crossing the barrier to infect humans?', 'What COVs were known to infect humans before December 2019?', 'What do HCoV-OC43 and HCoV-HKU1 cause?', 'What is the contrast with SARS-COV and MERS=COV?', \"What was the authors' recent report on?\", 'What is analyzed in this study?', 'What genome sequence was available for this study?', 'What strains were included in  this study?', 'How was the Phylogenetic construction done?', 'How were the evolutionary distances computed?', 'How was the structural analysis of orf8 done?', 'What was done for the prediction of protein secondary structures?', 'What is  the RNA of the 2019-nCOV?', 'What was the G+C content?', 'How are 2019-nCOV and SARS-COV similar?', 'Where is the major distinction?', 'What do the S1 and S2 subunits of spike glycoprotein contain?', 'What are the chacateristics of the S2 subunit?', 'What would be the benefit of the identity of the S2 unit?', 'How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?', 'Where are the amino acid differences?', 'What is responsible for the interaction with  host receptor?', 'what will the investigation of external subdomain reveal?', 'How do most bat SARSr-COV differ from 2019-nCOV and  human SARS-COV?', 'Which strains  do  not have such deletions?', 'What is the consequence of  lack of deletions in Yunnan strains?', 'Being closest to 2019-nCoV, which species do the two bat SARS-related coronavirus ZXC21 and ZC45 infect?', 'What would lessen the likelihood of jumping the barrier?', 'What do the results indicate?', 'What  is orf8?', 'What orf8 length do Human SARS-CoVs isolated from early-phase patients, all civet SARS-CoVs, and other bat SARS-related CoVs contain?', 'From where have the original SARS-CON orf8 been acquired?', 'What does the orf8 derived from 2019-nCOV belong to?', 'What is the  relation between the new2019-nCOV and the conserved orf8?', 'orf8 was shown to do  what?', 'What high possibility does the novel  orf8 have?', 'What is the summary of this report?', 'Where was COVID19 first discovered?', 'Where can published genomic sequences be found for the 2019-nCoV virus?', 'What genes have been targeted for the diagnostic RT-PCR tests in 2019-nCoV?', 'How does being a smoker impact COVID-19 patient outcomes?', 'Are smokers more likely to contract influenza?', 'Why might we underestimate the spread of COVID19?', 'Where was the first imported case of COVID19 in the United States?\\n', 'When was the first case of COVID19 confirmed in the USA?', 'When was the second COVID19 case reported in the US?', 'Where was the second reported case of COVID in the United States?', 'When was the first local transmission of COVID reported in the United States?', 'When did the WHO declare COVID to be a Public Health Emergency of International Concern?', 'When did the United States declare COVID19 a public health emergency?', 'What are the most common symptoms of COVID19?', 'What symptoms might people experience with COVID19?', 'Who is at greater risk of dying from COVID19?', 'How long is the incubation time for COVID19?', 'How does COVID19 get spread?', 'Is it possible to get infected with COVID and another virus?', 'How many people  are estimated to need humanitarian assistance in 2020?', 'For whom does the  SARS-COV-2 pose a great threat?', 'What can undermine interventions?', 'Who are expected to be particularly susceptible?', 'Why populations may be particularly susceptible?', 'What is the impact of disease outbreaks?', 'What represents a barrier to testing?', 'Where are difficulties are exacerbated during humanitarian crises?', 'What can prevent contact tracing?', 'What is an example of intractable structural challenge?', 'What should be the priority of the national and international bodies trying to prevent the pandemic?', 'What  resources need to be identified?', 'What is an effective public health hygiene?', 'What has been demonstrated to  be  effective for prevention?', 'What has increased hand washing?', \"What is hand washing to protect one's own health  consistent with?\", 'What is possible in many resource -limited  settings?', 'What is the foremost authority on minimum standards for humanitarian assistance?', 'For what  there is evidence for  the efficacy of hand washing?', 'What are humanitarian WASH standards  based on?', 'What confers a high risk of  gender  based violence?', 'What is the deterrent effect of gender based violence around latrines?', 'What  will maximize the effectiveness of interventions?', 'What will happen without the adaptation of existing standards?', 'What is essential when pandemics threaten vulnerable populations?', 'What is a necessary component of effective health  governance?', 'Approximately how many people died during the 1918-1919 influenza pandemic?', 'What social and economic factors  contributed to the large fatality rate in the 1918 influenza pandemic?', 'What problems were faced by medical staff during the 1918 epidemic?', 'What helpful drugs are available now to control the disease or to provide palliative care for influenza patients?', 'How has the mortality rate due to influenza declined in USA over past decades?', 'Is there an Influenza vaccine?', 'for the 2009 influenza pandemic, what were the case fatality rates?', 'What  factors would contribute now to the faster rates of influenza infections?', 'What factors would be responsible in future for the prevention of an Influenza pandemic?', 'What was the detected fatality rate of H7N9 Avian flu?', 'Why would real  case fatality rate for the H7N9 be lower than detected rate?', 'What is the structure of the Ebolavirus?', 'When was the West African Ebolavirus outbreak?', 'What animals are considered to be maintenance hosts to the Ebolavirus?', 'What do circles indicate in Figure 1?', 'What do arrows indicate in Figure 1?']\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"GxFliXlPhuPo","executionInfo":{"status":"ok","timestamp":1601558167743,"user_tz":-330,"elapsed":1735,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"e63e279b-0496-4fbc-f651-d9aa8b65e658","colab":{"base_uri":"https://localhost:8080/","height":54}},"source":["# test whether the answers are in the list or not\n","print(answer_list)"],"execution_count":11,"outputs":[{"output_type":"stream","text":["['Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. ', 'DC-SIGNR plays a crucial role in MTCT of HIV-1 and that impaired placental DC-SIGNR expression increases risk of transmission.', 'more than 400,000 children were infected worldwide, mostly through MTCT and 90% of them lived in sub-Saharan Africa. ', 'High copy numbers of CCL3L1, a potent HIV-1 suppressive ligand for CCR5, are associated with higher chemokine production and lower risk of MTCT of HIV-1 among South African infants', 'Dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)) can interact with a plethora of pathogens including HIV-1 and is expressed in placental capillary endothelial cells', 'the presence of DC-SIGNR at the placental endothelial cell surface may protect infants from HIV-1 infection by capturing virus and promoting its degradation/presentation. ', 'in placenta containing low levels of DC-SIGNR, HIV-1 would preferentially binds CCR5 on endothelial cells resulting in a loss of placental barrier integrity and enhanced passage of maternal HIV-1-infected cells in foetal circulation leading to MTCT of HIV-1', 'Without specific interventions, the rate of HIV-1 mother-tochild transmission (MTCT) is approximately 15-45%', 'Genetic variants in CCR5 have been shown to influence vertical transmission of HIV-1. CCR5 promoter variants resulting in higher expression of the receptor were associated with increased risk of MTCT of HIV-1 among sub-Saharan Africans', 'Mannose-binding lectin (MBL) is an innate immune receptor synthesised in the liver and secreted in the bloodstream in response to inflammation signal. MBL promotes pathogen elimination by opsonization and phagocytosis,', 'The 32-pb deletion polymorphism in CCR5 has be shown to protect from vertical transmission of HIV-1', 'interferon-induced transmembrane', 'three', '2-bromopalmitic acid (2BP)', 'IFITM5 with FKBP11', 'bone formation factor.', 'S-palmitoylation on the protein', 'bonerestricted IFITM-like (BRIL) protein', 'the region upstream of the ifitm5 gene lacks the interferon regulatory elements', '~ 65% similarity', '~ 85% similarity', 'aspartate', '31 kb', 'single-stranded, linear, and nonsegmented RNA', '30,847 nucleotides', '20kb', '5= side', 'HCoV', 'HCoV-OC43', 'HCoV‐HKU1', 'Highly virulent species of HCoV', 'ranged from 14% to 45%', ' HCoV-OC43 and HCoV-229E', 'HCoV-HKU1, HCoV-OC43, HCoV-NL63, and HCoV-229E', 'both intracellular and cell-surface factors', 'heparan sulfates in the membrane proteins', 'Nterminus of HBV preS1 (amino acids 1-47) ', 'lateral surface (canalicular) of hepatocytes', 'bile acid transport ', 'not sufficient', 'the majority of HepaRG cells were found to express NPCT but not to be infected', 'arboviruses', 'ELISA and IFA', 'two-dimensional gel electrophoresis , protein chip, mass spectrometry, and suspension array technology', '9', 'monoclonal', 'using cultured viruses and inoculated chicken eggs with patient sera', '4D5, 2B5, 1F1, 2B8, 4F9, and 4E11', 'from 0.2 to 0.0125 mg/ml', 'combination of minimized cross reaction and higher signal intensity', 'by applying JEV, YF, and DV cultures', 'using cultured viruses and inoculated chicken eggs with patient sera', '108 per 100,000', '94 million', 'estimate the TB prevalence in Shandong', '15 years old or above', 'in accordance with WHO recommendations', '52500', 'A stratified multi stage random sampling', '1250 to 1750', 'Military barracks and prisons', 'March to June 2010', 'clinicians, public health doctors, radiologists, laboratory technicians and nurses', 'Löwenstein-Jensen medium', '95% to 97%', '46 years', '22.1', 'a large proportion of TB patients did not present consistent cough', '45%', 'over half', 'cysteine proteases', '32uC, 37uC, 42uC', \"Lipinski's ''Rule of five''\", '1-substituted pyridylimidazo[1,5-a]pyridine derivatives', 'Intranasal', 'the surface area can result in rapid absorption of the medication into the blood', 'Metered dose inhalers (MDIs) and dry powder inhalers (DPIs)', 'insulin [39] and low-molecular-weight heparin [40]', 'intratracheal or intranasal delivery', 'respiratory bronchioles, alveolar ducts, and alveolar sacs', '1-5 μm', 'delivered to their site of action, be stable, enter the target cells, and be present in the cytoplasm at sufficient concentration', '27,534 nucleotides', '10', 'Chinese IBV strain SC021202', 'an estimated 7.3 billion', 'Middle East respiratory syndrome coronavirus', 'Transmissibility and severity', 'January 30, 2020', 'H7N9', 'After a new influenza virus (H7N9) was identified in China in 2013, a series of modeling articles described the effect of, and level of preparedness for, a severe, single-wave pandemic in the United States.', 'the proportion of individuals who become ill with or die from a disease in a population initially uninfected', '20%', '2.2', '35\\u202f000 to 60\\u202f000', 'the isolation of respiratory viruses', '102', 'EBC collection using the RTube™ is not reliable for diagnosis of respiratory infections', '10 minutes', 'denaturation step', 'amplification step', '52%', 'easy to perform and can be conducted in a home environment', 'Pneumonia remains the leading cause of death in children outside the neonatal period,', 'New conjugate vaccines against Haemophilus influenzae type b and Streptococcus pneumoniae have contributed to decreases in radiologic, clinical and complicated pneumonia cases', ' approximately 900,000 of the estimated 6.3 million child deaths in 2013 ', 'global childhood population from 605 million in 2000 to 664 million in 2015 ', 'Recent data suggest that there has been a 25% decrease in the incidence of pneumonia, from 0.29 episodes per child year in low-and middle-income countries in 2000, to 0.22 episodes per child year in 2010 [3] . This is substantiated by a 58% decrease in pneumonia-associated disability-adjusted life years between 1990 and 2013, from 186 million to 78 million ', 'Pneumonia deaths decreased from 1.8 million in 2000 to 900,000 in 2013', 'The incidence in high-income countries is estimated at 0.015 episodes per child year, compared to 0.22 episodes per child year in low-and middle-income countries [3] . On average, 1 in 66 children in high-income countries is affected by pneumonia per year, compared to 1 in 5 children in low-and middle-income countries.', 'up to 81% of severe pneumonia deaths occur outside a hospital ', 'the case fatality rate is estimated to be almost 10-fold higher in low-and middle-income countries as compared to high-income countries', 'Early life pneumonia can impair longterm lung health by decreasing lung function [6] . Severe or recurrent pneumonia can have a worse effect on lung function; increasing evidence suggests that chronic obstructive pulmonary disease might be related to early childhood pneumonia', 'The risk of developing at least one of the major sequelae was estimated as 6% after an ambulatory pneumonia event and 14% after an episode of hospitalized pneumonia.', 'Chest radiologic changes have been considered the gold standard for defining a pneumonia event', 'Widespread use of pneumococcal conjugate vaccination and Haemophilus influenzae type B conjugate vaccination has decreased the incidence of radiologic pneumonia.', 'Haemophilus influenzae type B conjugate vaccination in high-burden communities, the vaccination was associated with an 18% decrease in radiologic pneumonia [13] . Introduction of pneumococcal conjugate vaccination was associated with a 26% decrease in radiologic pneumonia in California between 1995 and 1998 [14] . In vaccine efficacy trials in low-and middle-income countries, pneumococcal conjugate vaccination reduced radiologic pneumonia by 37% in the Gambia [15] , 25% in South Africa [16] and 26% in the Philippines ', ' A revised case definition of \"presumed bacterial pneumonia\" has been introduced, and this definition includes pneumonia cases with WHO-defined alveolar consolidation, as well as those with other abnormal chest radiograph infiltrates and a serum C-reactive protein of at least 40 mg/L ', ' Using the revised definition, the 10-valent pneumococcal conjugate vaccine (pneumococcal conjugate vaccination-10), had a vaccine efficacy of 22% in preventing presumed bacterial pneumonia in young children in South America [22] , and pneumococcal conjugate vaccination-13 had a vaccine efficacy of 39% in preventing presumed bacterial pneumonia in children older than 16 weeks who were not infected with human immunodeficiency virus (HIV) in South Africa [21]', ' An increased incidence of empyema in children was noted in some high-income countries following pneumococcal conjugate vaccination-7 introduction, and this was attributed to pneumococcal serotypes not included in pneumococcal conjugate vaccination-7, especially 3 and 19A', 'These trends have been reversed since the introduction of pneumococcal conjugate vaccination-13. Data from the United States suggest that empyema decreased by 50% in children younger than 5 years ', 'chest radiography should not be routinely performed in children with ambulatory pneumonia [31] [32] [33] . Indications for chest radiography include hospitalization, severe hypoxemia or respiratory distress, failed initial antibiotic therapy, or suspicion for other diseases (tuberculosis, inhaled foreign body) or complications. ', 'prior to availability of new conjugate vaccines confirmed S. pneumoniae and H. influenzae type B as the most important bacterial causes of pneumonia, with Staphylococcus aureus and Klebsiella pneumoniae associated with some severe cases. Respiratory syncytial virus was the leading viral cause, identified in 15-40% of pneumonia cases, followed by influenza A and B, parainfluenza, human metapneumovirus and adenovirus', 'Because pertussis immunity after acellular pertussis vaccination is less long-lasting than immunity after wild-type infection or whole-cell vaccination, many women of child-bearing age have waning pertussis antibody levels. ', 'A recent systematic review of tuberculosis as a comorbidity of childhood pneumonia reported culture-confirmed disease in about 8% of cases [50] . Because intrathoracic tuberculosis disease is only culture-confirmed in a minority of cases, the true burden could be even higher; tuberculosis could therefore be an important contributor to childhood pneumonia incidence and mortality in high-prevalence areas', ' incomplete or inadequate vaccination must be considered as a major preventable risk factor for childhood pneumonia. Other risk factors include low birth weight, which is associated with 3.2 times increased odds of severe pneumonia in low-and middle-income countries, and 1.8 times increased odds in high-income countries [51] . Similarly, lack of exclusive breastfeeding for the first 4 months of life increases odds of severe pneumonia by 2.7 times in low-and middle-income countries and 1.3 times in highincome countries. ', ' Indoor air pollution from use of solid or biomass fuels increases odds of pneumonia by 1.6 times; lack of measles vaccination by the end of the first year of age increases odds of pneumonia by 1.8 times ', 'The single strongest risk factor for pneumonia is HIV infection, which is especially prevalent in children in sub-Saharan Africa. HIV-infected children have 6 times increased odds of developing severe pneumonia or of death compared to HIV-uninfected children', ' By the end of 2015, Haemophilus influenzae type B conjugate vaccination had been introduced in 73 countries, with global coverage estimated at 68%. However, inequities are still apparent among regions: in the Americas coverage is estimated at 90%, while in the Western Pacific it is only 25%. By 2015, pneumococcal conjugate vaccination had been introduced into 54 countries, with global coverage of 35% for three doses of pneumococcal conjugate vaccination for infant populations', 'Influenza vaccination during pregnancy is safe, provides reasonable maternal protection against influenza, and also protects infants for a limited period from confirmed influenza infection (vaccine efficacy 63% in Bangladesh [63] and 50.4% in South Africa [64] ). However as antibody levels drop sharply after birth, infant protection does not persist much beyond 8 weeks', 'a rare complication of pneumonia', 'as a dense or fluffy opacity that occupies a portion or whole of a lobe, or the entire lung.', 'rapid spread and high pathogenicity', 'fever, encephalitis, pneumonia, and severe acute respiratory syndrome (SARS)', 'zanamivir (Relenza) and oseltamivir (Tamiflu)', 'drug-resistance and frequent antigenic mutation', 'effect of EAP against H5N1 influenza infection', 'the anti-H5N1 effects of EAP offer an alternative strategy for developing antiinfluenza agents', 'enhance the secretion of cytokines and chemokines, such as TNF-, IL-6, IL-8, and IL-12', 'EAP leaf extract is a prophylactic and immune enhancement agent against H5N1 influenza virus infection', 'did not provide a survival advantage', 'The most frequently reported viruses include respiratory syncytial virus (RSV), influenza viruses A and B (IAV, IBV), parainfluenza viruses (PIVs), human rhinovirus (HRV) and adenovirus (ADV), ', 'Currently, there are no approved vaccines or medications available for most of the respiratory viruses', 'Gammaproteobacteria', 'via a common sanitary pipe', 'influenza and parainfluenza viruses, RSV, adenovirus, rhinovirus, human metapneumovirus, enterovirus, bocavirus and coronavirus', 'Antibodies against foreign antigens are a critical component of the overall immune response and can facilitate pathogen clearance during a primary infection and also protect against subsequent infections.', 'Dysregulation of the antibody response can lead to an autoimmune disease, malignancy, or enhanced infection. ', ' in the 1970s with the development of hybridoma technology to produce monoclonal antibodies ', 'somatic rearrangement during B cell differentiation was responsible for antibody diversification ', '(1) vaccine candidates that elicit protective antibodies; (2) antibodies that prevent disease when given prophylactically; and (3) antibodies that can be given as therapy after the onset of disease.', 'discovery of broadly neutralizing antibodies (bnAbs) that protect against infection across diverse viral isolates has intensified efforts to understand the developmental pathway of the rare B cells that produce these antibodies', \"For RSV, stabilized versions of the fusion (F) protein in the pre-fusion conformation have led to insights in the B cell's response to infection and has generated potentially safer and more efficacious vaccine candidates\", 'Influenza also performs fusion through the stem region of the hemagglutinin protein, and the identification of B cells that target this relatively conserved site has spurred research on the development of a universal influenza vaccine (', ' Rare memory B cells producing antibodies specific for the EBV fusion machinery have been isolated; these can neutralize both B cell and epithelial cell infection (20). A new paradigm in malaria vaccine development is also emerging with the discovery of IgM+ and IgD+ memory B cells targeting the Merozoite Surface Protein 1, that rapidly respond to malaria re-infection', 'The study of autoantigen-specific B cells and a detailed analysis of B cell subsets with pathogenic potential in humans could lead to a better understanding of how to prevent and treat autoimmune diseases.', '(MERS-CoV) was first isolated in 2012, in a 60-year-old man who died in Jeddah, KSA due to severe acute pneumonia and multiple organ failure', 'Recent fatality rate (CFR) of 21%', ' MERS-CoV infects males more than females', 'Dromedary camels are the major animal source of MERS-CoV transmission to humans.', 'median time until death is 11-13 days (range 5-27 days) among severely ill patients', ' incubation period of 16 days with a mean of 5-6 days [', 'ere is no specific treatment for MERS-CoV. Like most viral infections, the treatment options are supportive and symptomatic', 'majority of confirmed cases of MERS-CoV were reported among people aged 40 and above', 'they inhibit cellular DNA/RNA polymerases', 'gemcitabine', 'Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus (ZIKV), HCV, poliovirus (PV), influenza A virus (IAV), HIV, and enteroviruses (EV)', 'by targeting the salvage pathway of pyrimidine biosynthesis', 'its well defined immunological and genetic information, costeffectiveness, and abundant inbred strains and research reagents', 'a sandwiched extracellular structure composed of a β-sheet, α-helix loop, and a β-sheet', 'it promotes cytokine production, the induction of cell surface co-stimulatory molecules, and facilitates the cross-presentation of antigen by these cells', 'it promotes germinal center formation, immunoglobulin (Ig) isotype switching, somatic hypermutation to enhance antigen affinity, and lastly, the formation of long-lived plasma cells and memory B cells', 'the average codon usage frequencies in the host genome', 'mutational pressure and translational selection', 'common cold, pharyngitis, otitis, sinusitis, laryngotracheitis, epiglottitis', 'bronchitis, pneumonia and bronchiolitis', 'NK cells (CD3-/CD16+/CD56+)', 'Excessive reactive oxygen species (ROS)', 'reactive oxygen species (ROS)', 'June 30, 2017', 'to promote, set standards in, and evaluate progress toward better health for people in all countries', 'a lowincome or middle-income country', 'open-minded and creative', 'enveloped, positive-stranded RNA virus', '170 million people worldwide', 'cirrhosis and hepatocellular carcinoma', 'pegylated alpha-interferon and ribavirin', 'Calf septicemia', 'human urine', 'low molecular weight, antimicrobial peptide hormone', 'liver', 'inflammatory reactions and high Fe concentrations', 'Fe', 'potentially toxic', 'bacteria utilize Fe for survival, growth and proliferation', 'control of excessive Fe absorption', 'regulation of Fe release', 'production of ROS', 'superoxide dismutase', 'a rare form of acute disseminated encephalomyelitis', 'fulminant encephalopathy with hemorrhagic necrosis', 'nuclear pore protein', 'intracellular protein trafficking or energy maintenance and homeostasis of neuronal cells', 'multiple, symmetric brain lesions located in the thalami bilaterally, putamina, deep periventricular white matter, cerebellum, and brainstem', 'viral infection in previously healthy children', '1 month later', 'quinazolin-4-one', 'tobacco mosaic virus', '11,399', '49.2%', '2.2%', '2005', 'cough, rhinitis, fever', '≤14 years old', '1.82:1', 'Human metapneumovirus (HMPV)', 'single-stranded RNA virus', 'Human metapneumovirus (HMPV)', 'mild upper respiratory infection to bronchiolitis and pneumonia', '13 kb', 'eight', 'A and B', 'HMPV A2', 'children under 6 months of age', 'a whole genome sequencing (WGS) approach for HMPV', 'The length of the F-M2 intergenic region', ' to comprehensively investigate the viral epidemiology of adult RTIs', '27', '4.1% of cases', 'parainfluenza infection, old age, and immunosuppression', 'multilocus polymerase chain reaction coupled with electrospray ionization mass spectrometry', 'corticosteroid treatment, solid organ or hematopoietic stem cell recipient, or chemotherapy for an underlying malignancy during the past 6 months', '9-month', '263', 'rhinovirus', 'forbid the display of sheep in the latter third of their pregnancy and require regular testing of animals for C. burnetii in petting zoos', '1%', 'close proximity to the ewe and duration of exposure', '16 to 24 days', '36', \"farmers' market\", 'Coxiella burnetii (C. burnetii)', 'small, gram-negative obligate intracellular bacterium', 'sheep, goat and cattle', 'inhalation of contaminated aerosols from parturient fluids, placenta or wool', 'long non-coding RNAs', 'calculate the relatedness of objects with the same or different types', 'weighted protein interactions', 'regulates cell cycle and survival', 'faecal oocyst count reduction test (FOCRT)', 'anticoccidial', 'a rare, sudden onset of unilateral chorioretinopathy', 'flu-like illness', 'herpes simplex virus (HSV) I-II, varicella zoster virus (VZV), West Nile virus, coxsackievirus, echovirus (subgroup of enterovirus), and corona virus', 'multimodal imaging', 'Parainfluenza virus 4, respiratory syncytial virus B and enterovirus', 'Coronavirus OC43', '2-5 times higher than in developed countries', 'Africa', 'age, sex, overcrowding, nutritional status, socio-economic status, and where study of ARIs is currently limited', 'sore throat, fever, couch, running nose, vomiting, body ache, leg pain, nausea, chills, shortness of breath ', 'Coronavirus OC43', '13.3% (95% CI 6.9-23.6%)', '12.5%', 'increased severity of illness in the clinical sample', 'active community surveillance', 'world-wide occurrence, ease of transmission and considerable morbidity and mortality effecting people of all ages', 'two to three times more frequently', 'acute RTI', 'common colds, pharyngitis, croup, bronchiolitis, viral pneumonia and otitis media', 'during winter and early spring months', 'respiratory syncytial virus (RSV), influenza A and B (INF-A, INF-B) viruses, parainfluenza viruses (PIVs), and human adenoviruses (HAdVs)', 'RSV', '13%', '544 base pairs', '148-nucleotide insertion', 'high level of homology between viruses', 'adult riding, racing and show horses', 'acellular', 'Southeast Asia', 'whole cell pertussis vaccines', 'apnea, cyanosis, cough with vomit, or whoop/whooping cough', 'mid-nasal nylon flocked', 'every 2 to 4 years', 'a minimum of 2 weeks of cough, whoop, or posttussive vomiting', 'weekly proportion of laboratory tests that are positive for influenza', 'diagnosis will often not alter patient management, a paucity of real-time, accurate, inexpensive testing methods [4] and because influenza is not recognized as the etiology of the clinical presentation', 'nfluenza, respiratory syncytial virus (RSV), para-influenza virus (PIV), and adenovirus', 'the potential anti-virus activity of inositol-requiring enzyme 1 (IRE1), a well characterized effector of the cellular homeostatic response to an overloading of the endoplasmic reticulum (ER) protein-folding capacity. IRE1, an ER-membrane-resident ribonuclease (RNase), upon activation catalyses regulated cleavage of select protein-coding and non-coding host RNAs, using an RNase domain which is homologous to that of the known anti-viral effector RNaseL. ', 'The review first discusses the anti-viral mechanism of the OAS/RNaseL system and evasion tactics employed by different viruses. This is followed by a review of the RIDD pathway and its potential effect on the stability of viral RNAs. ', 'comparison of the enzymatic activity of the two RNases followed by deliberations on the physiological consequences of their activation.', 'In the context of a virus infection, the pathway leading from both these proteins have the potential to lead to cell death. Notwithstanding the fact that this might be an efficient way of virus clearance, it also portends pathological outcomes for the infected organism. Future research would probably lead to design of drugs targeting these proteins based on the structural homology of their effector domains, regulating the pathological denouement of their activation without compromising their anti-viral or potential anti-viral functions.', 'nonenveloped, single-stranded, positive-sense RNA', 'respiratory illness, hand-foot-and-mouth disease, and aseptic meningitis,', 'California Department of Public Health (CDPH)', 'within 1 day of identification', 'CDPH', 'E-30', '260-fold', 'one structural (P1-capsid) and two nonstructural (P2 and P3) regions', 'homeostasis, differentiation, embryonic development, and organ physiology', 'Nuclear receptors (NRs)', 'class of ligand-inducible transcription factors', 'homeostasis, differentiation, embryonic development, and organ physiology', 'seven', 'a reliable 3D (three dimensional) structure of the target protein', 'X-ray crystallography', 'time-consuming and expensive', 'membrane proteins', 'KEGG (Kyoto Encyclopedia of Genes and Genomes)', 'veterinarians', 'from November 2004 to November 2014', 'BatCoV HKU10', '20.4 kb', 'BtCoV/Rh/YN2012', 'Bats', '26-32 kb', 'enveloped, non-segmented, positive-strand RNA viruses', 'birds', 'Six', 'NF-κB', 'Rhinolophus bats seem to harbor a wide diversity of CoVs', 'FIP virus (FIPV)', 'enveloped virus with a nonsegmented, positive sense, single-stranded RNA genome', 'shedding in their faeces', 'an attenuated, temperature-sensitive strain of type II FIPV', 'the vaccine contains type 2 strain, whereas type 1 viruses are more prevalent in the field', '30 minutes', 'nano Isothermal Titration Calorimeter (ITC)', ' the anti-influenza A (H2N2) virus activity of patchouli alcohol', 'NA glycoproteins of influenza A and B virus', 'cleave the α-ketosidic linkage between terminal sialic acid and an adjacent sugar residue', 'NA inhibitor', 'CC 50', 'MTT method', ' patchouli alcohol possesses anti-influenza A (H2N2) virus activity', 'time, equipment, and technical expertise requirements', 'HIV-1 RT-LAMP assay', 'whole blood specimens', '20%', '35 to 50%', \"Chi-square test and Fisher's exact test\", 'unable to evaluate the levels of immunomodulators in the serum samples of a control group', 'a larger, longitudinal study on the etiology and severity of pneumonia', 'mixed respiratory infections and IP-10 may play major, interconnected roles in the pathogenesis of pneumonia', 'highest serum IP-10 levels', 'airway epithelial cells 19 , resident alveolar macrophages (AMs) and blood monocytes-derived macrophages', 'Methicillin-resistant Staphylococcus aureus (MRSA)', 'vancomycin', 'isocitrate lyase', 'to assess the overall in vitro bactericidal activity of nine newly synthesized diamides', 'the marmoset an appropriate animal model for biodefense-related pathogens', 'the small size of marmosets, their immune response to infection that is comparable to humans, and the ability to house more statistically relevant numbers within high containment', 'the presence of resistance-associated substitutions', 'up to 98%', 'inhibit polymerase activity by allosteric mechanisms', '31', 'was obtained', '5 μl', '2 strains out of 25 (8%)', 'confers a higher level of resistance than the one achieved by the RAS alone', 'baseline and emergent resistance variants', 'Infectious cDNA clones', 'single stranded positive sense RNA genomes', '5′ and 3′ untranslated regions (UTRs)', 'nucleocapsid protein C, envelope glycoproteins E rns , E1 and E2', 'aa', 'to examine whether a relationship exists between operation volumes and SSIs', 'The total length of stay and expenditure for patients with SSIs after CABG surgery is significantly longer and higher than those without SSIs', 'hospitals would no longer receive higher payments for the additional costs associated with treating patients for certain healthcare-acquired infections', '19', 'CABG patients under the age of 18 years or over 85 years', 'cannot reliably represent effects originating from stochasticity, from effects in small populations, or from heterogeneities', 'fecal-oral contact', \"destroys the lining of piglets' intestines\", '26 to 32 kb', 'Lassa and Lujo viruses', 'through the use of serological assays', '1-3 weeks', 'bisegmented, negative-sense, single stranded RNA genome', 'a glycoprotein, a nucleoprotein (NP), a matrix protein (Z), and a polymerase (L)', 'PCR assays', 'neuraminidase inhibitors', 'a triterpene saponine', 'interfere with replication and/or cytopathogenic effect (CPE) induction of many viruses', \"cytokine storm'\", 'caspase-dependent apoptosis in airway cells', 'glycyrrhizin might also serve as lead structure for the development of novel anti-influenza drugs', '2 days', '4.8 days', 'Persistent high fever, dyspnea and rapid progression to respiratory failure within 2 weeks, together with bilateral consolidations and infiltrates', 'This pathogen was fully characterized by whole-genome sequencing', 'Flulike symptoms, such as fever, cough and little sputum, were commonly observed at the onset of illness', '5 days', '9.6 days', '43 breaths per minute', ' low or in the normal range', 'CXRs revealed multiple bilateral lobar or segment consolidation in the lungs of all five patients, and radiographic lesions progressed rapidly after ICU admission', 'Consolidations within a single lobe or several lobes with a clear border and air bronchogram were the most common findings on HRCT scans. Nodules, patches, pleural effusion, abscess and a cavity were also seen visualized by HRCT', 'All patients had HAdV-55 viremia. In four of the five patients, it was first detected in endotracheal aspirate (ETA) samples', '1 to 10 days', ' HAdV-55 may cause severe ARDS in immunocompetent young men with blood type B', 'Persistent high fever, dyspnea and rapid progression to respiratory failure within 2 weeks, together with bilateral consolidations and infiltrates at the same time, are the most frequent clinical manifestations', 'HAdV-55-induced severe ARDS has a very high mortality rate (80%) despite appropriate respiratory support.', 'a lower T-cell count may be a risk factor for HAdV-55 infection in young adults', 'we found that severe HAdV-55 infection could cause a rapid progression of respiratory failure, with a very high failure rate for NPPV and IMV', 'Two hundred', '600,000', 'the presence of new parenchymal infiltrates', '11 June 2009', '1/40', 'conferring 50% protection against a viral challenge', \"a substantial proportion of Reunion Island's population had pre-existing immunity to 2009 pandemic influenza virus\", 'the remote exposure of these individuals to H1N1 viruses circulating before 1957', '9 weeks', 'to investigate the different pathogens involved in ILI and describe the associated symptoms', 'Réseau Sentinelles', 'a sudden fever above 39uC with myalgia and respiratory signs', 'rhinovirus', 'to elucidate the proximate causes of breeding failure behind the recent decline in productivity in the Spanish Pyrenees', 'the Pyrenees', 'the antiproliferative effect of a copper (II) complex on HT-29 colon cancer cells', 'colorectal cancer', '83.2%', '64.3%', 'detection of nuclear condensation', 'apoptotic chromatin changes', 'membrane permeability, cell shrinkage, disruption of the mitochondrial membrane, and chromatin condensation', 'HT-29 cells', 'to explore the feasibility of DNA vaccination of poultry', 'it is possible to develop a multivalent DNA vaccine for poultry that can protect against multiple HPAI H5N1 strains and that could keep pace with the continued evolution of avian influenza viruses', 'Two E. coli W mutants were engineered that could effectively produce the bio-active flavonol glycosides hyperoside and quercitrin', 'the economically viable production of various glycosides', 'solubility, stability and bio-activity', 'a pro-coagulant protein', 'Fgl2 depletion', 'to determine the role of CC10 in FH and the regulation of Fgl2 by CC10', 'a serious life-threatening disease characterized by massive hepatocyte necrosis', 'transforming prothrombin directly into thrombin,', '72 h', ' findings suggest that urbanization spatially combines risk factors to produce particular types of peri-urban landscapes with significantly higher HPAI H5N1 emergence risk.', ' higher levels of chicken densities, duck and geese flock size diversities, and fraction of land under rice or aquaculture than rural and urban areas. We also found that land-use diversity, a surrogate measure for potential mixing of host populations and other factors that likely influence viral transmission', ' landscapes where intensive and extensive forms of poultry production overlap were found at greater risk', 'The convergence model can be so adapted by incorporating the dynamics of urban, agricultural, and natural ecosystem transformations proposed with this framework. These associated multifaceted interactions including feedbacks that affect ecological communities, hosts and pathogen populations, are the proximate drivers of disease emergence.', 'BRT utilizes regression trees and boosting algorithms to fit several models and combines them for improving prediction by performing iterative loop throughout the model ', 'The advantage of BRT is that it applies stochastic processes that include probabilistic components to improve predictive performance.', ' high land-use diversity landscapes, a variable not previously considered in spatial studies of HPAI H5N1, are at significantly greater risk for HPAI H5N1 outbreaks', 'Emergence risk should be highest in the most rapidly transforming urban areas, peri-urban zones where mixes of urban-rural, modern-traditional land uses and poultry husbandry coincide most intensely.', 'Landscape fragmentation produces ecotones, defined as abrupt edges or transitions zones between different ecological systems, thought to facilitate disease emergence by increasing the intensity and frequency of contact between host species [31] Furthermore, fragmentation of natural habitat tends to interrupt and degrade natural processes, including interspecies interactions that regulate densities of otherwise opportunistic species that may serve as competent hosts', ' extent of rice cultivation is a risk factor, mainly due its association with free ranging ducks acting as scavengers', 'extent of aquaculture is a known risk factor [10] , possibly because water bodies offer routes for transmission and persistence of the virus', 'Proximity to water bodies increases the risk of outbreaks [47, [50] [51] [52] , possibly by increasing the chance of contact between wild water birds and domestic poultry.', 'diversity of chicken flock-size had a strong association with HPAI H5N1 ', 'Compound Topographical Index (CTI, also known as Topographical Wetness Index) is a measure of the tendency for water to pool. Studies in Thailand and elsewhere [54] have shown that the extent of surface water is a strong risk factor, possibly due to the role of water in long-range transmission and persistence of the virus. I', 'compare the antiviral activity of CQ versus HCQ, the dose-response curves', ' two potential drugs, CQ appears to be the drug of choice for large-scale use due to its availability, proven safety record, and a relatively low cost.', 'CQ and HCQ are weak bases that are known to elevate the pH of acidic intracellular organelles', 'Since acidification is crucial for endosome maturation and function, we surmise that endosome maturation might be blocked at intermediate stages of endocytosis,', ' HCQ is a safe and successful anti-inflammatory agent', '50.4%', '[44.6%', '34.0%', '[71.5%', 'among men vs women: 2.0 [0-6.0] vs 4.0 [1.0-7.0]; P < .001', 'among frontline vs second-line workers: 6.0 [2.0-11.0] vs 4.0 [1.0-8.0]; P < .001', ' 21.0 [8.5-34.5] vs 18.0 [6.0-28.0] in Hubei outside Wuhan and 15.0 [4.0-26.0] outside Hubei; P < .001).', 'participants from outside Hubei province were associated with lower risk of experiencing symptoms of distress compared with those in Wuhan (odds ratio [OR], 0.62; 95% CI, 0.43-0.88; P = .008)', 'Frontline health care workers engaged in direct diagnosis, treatment, and care of patients with COVID-19 were associated with a higher risk of symptoms of depression (OR, 1.52; 95% CI, 1.11-2.09; P = .01), anxiety (OR, 1.57; 95% CI, 1.22-2.02; P < .001), insomnia (OR, 2.97; 95% CI, 1.92-4.60; P < .001), and distress (OR, 1.60; 95% CI, 1.25-2.04; P < .001).', 'In this survey of heath care workers in hospitals equipped with fever clinics or wards for patients with COVID-19 in Wuhan and other regions in China, participants reported experiencing psychological burden, especially nurses, women, those in Wuhan, and frontline health care workers directly engaged in the diagnosis, treatment, and care for patients with COVID-19.', 'a family of AAA-ATPase proteins', 'SPG4', 'KATNB1', 'KATNAL2', 'microtubule severing enzyme', 'central nervous system', 'working memory and spatial memory', 'circadian rhythms, sleep and behaviour', 'arthropod', 'calcium', 'transmembrane domain 3', 'voltage-gated Ca(2+) channel (VGCC) inhibitor', '70', '11-kb', 'single', 'capsid (C), membrane (premembrane [prM] and membrane [M] ), and envelope (E)', 'viral replication, virion assembly, and virus escape from immune surveillance.', 'Recombinant viral particles', 'high-throughput screening', 'the 50% cytotoxic concentration', 'a natural virus-like envelope on the outside and a replicon on the inside', 'selective index of >10', 'nine species', 'double-stranded ribonucleic acid', 'VP1-VP4, VP6 and VP7', 'NSP1-NSP5/NSP6', 'qualitative real-time polymerase chain reaction', 'the generation of antigen-specific \"memory\" B and T lymphocytes', 'expression of AID', 'ELISpot technique', 'Wuhan, China', '34,598', 'new forecasting model to estimate and forecast the number of confirmed cases of COVID-19 in the upcoming ten days based on the previously confirmed cases recorded in China', 'an improved adaptive neuro-fuzzy inference system (ANFIS) using an enhanced flower pollination algorithm (FPA) by using the salp swarm algorithm (SSA)', 'to improve FPA to avoid its drawbacks (i.e., getting trapped at the local optima)', 'to improve the performance of ANFIS by determining the parameters of ANFIS using FPASSA.', ' FPASSA-ANFIS', 'using the World Health Organization (WHO) official data of the outbreak of the COVID-19 to forecast the confirmed cases of the upcoming ten days.', 'it showed better performance in terms of Mean Absolute Percentage Error (MAPE), Root Mean Squared Relative Error (RMSRE), Root Mean Squared Relative Error (RMSRE), coefficient of determination ( R 2 ), and computing time. ', ' using two different datasets of weekly influenza confirmed cases in two countries, namely the USA and China', 'showed good performances', ' pathogens for human beings, which infect respiratory, hepatic, gastrointestinal, and neurologic diseases.', ' among humans, birds, livestock, mice, bats, and other wild animals ', ' in time series prediction and forecasting problems', 'flexibility in determining nonlinearity in the time series data, as well as combining the properties of both artificial neural networks (ANN) and fuzzy logic systems.', 'in various forecasting applications, for example, in [23] , a stock price forecasting model was proposed using ANFIS and empirical mode decomposition', 'swarm intelligence', 'particle swarm optimization', 'sine-cosine algorithm', 'multi-verse optimizer', 'to forecast oil consumption in three countries, namely, Canada, Germany, and Japan.', 'may stock at local optima', ' ordered weighted averaging', 'an improved ANFIS model based on a modified flower pollination algorithm (FPA) using the salp swarm algorithm (SSA).', 'inspired by the flow pollination process of the flowering plants.', 'inspired by the behavior of salp chains', ' is a hybrid of FPA and SSA, in which the SSA is applied as a local search method for FPA', ' by receiving the historical COVID-19 dataset.', 'an efficient forecasting model to forecast the confirmed cases of the COVID-19 in China for the upcoming ten days based on previously confirmed cases.', 'the major proton pump that acidifies intracellular compartments of eukaryotic cells', 'v-ATPase inhibitor', 'two', 'they pump protons into the extracellular space', 'the proliferation, migration and differentiation of endothelial cells', 'CellTracker Green CMFDA Dye', 'describe GE and RTI outbreaks with infection and all-cause lethality rates according to the individual characteristics of nursing home residents', '30.0%', '1.5 to 1.6 times', ' (1) early identification of outbreak, (2) rapid expansion of patients, (3) high risk of nosocomial transmission, (4) unpredictability of size impacted, and (5) lack of backup resource.', 'Early identification of 2019-nCoV infection presents a major challenge', '2019-nCoV patients should be admitted', ' substantial exposure risk for ICU staff because of the following reasons', 'susceptible persons is S, infected (persons who are sick and spread the infection) -I, removed (persons who do not spread the infection anymore, this number is the sum of isolated, recovered and dead people) -R; the infection and immunization rates ', 'Pseudorabies (PRV) and Rabies viruses (RABV)', 'anterograde', 'method of delivery of the G gene', 'rVSV vectors', 'a clinically proven and marketed compound for the treatment of viral upper respiratory tract infections', 'carrageenan and Zanamivir act synergistically against several influenza A virus strains (H1N1(09)pdm, H3N2, H5N1, H7N7)', '72 hours post infection', 'more than 35%', 'more than 400 human cases', 'Most patients with A(H7N9) infections had contact with poultry or visited live animal markets', 'some sporadic cases seemed to be a result of human to human transmissions', ' influenza is an acute respiratory disease', ' Worldwide, annual epidemics result in about three to five million cases of severe illness', '250,000 to 500,000', 'influenza virus infections are often accompanied by other viral pathogens', 'Analysis by qRT-PCR revealed that 54.5-83.3% of influenza A or B positive patients were found to have at least one concomitant respiratory viral infection [9] [10] [11] [12] . The detection frequency with immunofluorescence was found to be even higher (90-100%) [13, 14] . ', 'human rhinovirus (hRV), respiratory syncytial virus, adenovirus, human coronavirus, human metapneumovirus and parainfluenza virus', 'The antiviral mechanism of carrageenan is based on the interference with viral attachment; as a consequence, viral entry is inhibited ', 'a protective physical barrier in the nasal cavity', 'a high molecular weight sulfated polymer derived from red seaweed (Rhodophyceae) that has been extensively used in food, cosmetic and pharmaceutical industry and is generally recognized as safe by the FDA ', '1.9 day faster recovery from common cold symptoms than placebo treated patients in the intention-to-treat population', 'anti-influenza activity was shown by subgroup analysis of 49 influenza infected patients who benefited from a 3.3 days faster recovery from symptoms', 'a significant reduction of the influenza viral load in nasal fluids and a significant increase in the number of virus free patients within the treatment period of 7 days', 'In contrast to Oseltamivir, which needs to be activated by metabolic conversion, Zanamivir is directly applied as active drug and can also be administered intranasally', 'challenge trials showed that treatment starting before and up to 36 hours post virus inoculation was associated with prevention of laboratory confirmed influenza and febrile illness as well as a reduction in viral titers, duration of shedding and symptoms', 'the combination of two effective, established mono-therapies resulted in a significantly enhanced survival in lethally H7N7 infected mice', 'carrageenan and Zanamivir starting 72 hpi significantly protects lethally influenza H1N1(09)pdm infected mice', 'While H1N1(09)pdm was highly sensitive to inhibition by both substances alone, H7N7 required much higher concentrations of carrageenan and Zanamivir, respectively, to achieve similar inhibition efficiencies', 'the H1N1(09)pdm model the combination of carrageenan with 1 mg/kg BW/day Zanamivir showed statistically significant enhanced survival in comparison to placebo treatment even after a treatment start 72 hpi', 'A second scope of this combination is the protection against newly emerging pandemic viruses during the time until identification of the virus followed by manufacturing and distribution of vaccines', 'as a sudden onset of fever more than 38 degrees Celsius and cough, associated or not with other symptoms such as breathing difficulty, headache, etc. ', 'on the multiplex ligation-dependent probe amplification (MLPA) technology.', ' with Excel 1 using the anonymized surveillance database of the Cire OI. The sampling frame contained identification number of swab assigned by Cire OI, laboratory identification number, sex, age, date of onset of symptoms, date of swab collection and result of influenza RT-PCR.', ' Respifinder 1 Smart 22 kits a multiplex RT-PCR (PathoFinder, Maastricht, The Netherlands) which can detect 22 respiratory pathogens. ', 'nasal swabs collected by sentinel GPs from ILI patients in 2011 and 2012.', '250 ', ' by multiplex reverse transcriptase polymerase chain reaction (RT-PCR) including research of 18 viruses and 4 bacteria.', 'respiratory viruses in 169/222 (76.1%) samples, mostly rhinovirus (23.4%), influenza A virus (21.2%), influenza B virus (12.6%), coronavirus (4.9%) and Human metapneumovirus (3.6%). ', 'Nine swabs (5.3% of positive swabs) revealed co-infections with two viruses identified, among which six concerned co-infections with influenza viruses.', 'seasonal differences, with circulation of Human Metapneumoviruses, RSV A and B and coronavirus only during summer; whereas parainfluenza viruses were identified only during winter.', ' a substantial circulation of multiple respiratory pathogens in Réunion Island throughout the year. I', 'that ILI are not only attributable to influenza and underlines the need for biological surveillance. As the use of multiplex RT-PCR showed its efficacy, it is now used routinely in the surveillance of ILI.', 'Influenza viruses, Respiratory Syncytial viruses (RSV) and Parainfluenza viruses', 'less than 50%', ' a French overseas territory', ' 850,000', 'n the southern hemisphere between Madagascar and Mauritius in the Indian Ocean (Latitude: 21°05.2920 S Longitude: 55°36.4380 E.)', ' to mainland France and epidemiological surveillance has been developed by the regional office of the French Institute for Public Health Surveillance (Cire OI), based on the surveillance system of mainland France', ' during austral winter, corresponding to summer in Europe', 'April ', \"a sentinel practitioner's network\", '58 general practitioners (GPs) spread over the island and represented around 7% of all Réunion Island GPs.', ' Nasal swabs are randomly collected all along the year and are tested by RT-PCR for influenza viruses', ' for influenza A virus, A(H1N1)pdm09 or B virus', 'are of unknown etiology', ', multiplex reverse transcriptase polymerase chain reaction (RT-PCR) ', 'to characterize respiratory pathogens responsible for ILI consultations in sentinel GPs in 2011 and 2012. Secondary objectives were to highlight seasonal trends on respiratory pathogens circulation and to describe occurrence of co-infections, especially during the flu season.', 'on the epgradient Mastercycler 1 (Eppendorf) and the hybridization, ligation and detection steps on the LightCycler 1 480 system (Roche Applied Science).', 'winter season during weeks 23 to 39 between June and September and summer season during the rest of the year.', ' rhinovirus (23.4%), influenza A not H1N1 (21.2%) and influenza B (12.6%) ', 'Human Metapneumovirus, RSV A and B, and influenza A(H1N1)pdm09', 'Parainfluenza 1,2 and 4 viruses', '76.1', 'several co-infections, showing that concomitant the multiple etiology of ILI', ' 53 swabs, representing 24% of the sample', ' a poor quality of swabs, preventing from identifying a pathogen, noninfectious causes or other pathogens not included in the multiplex PCR.', 'RNAse P, a marker of human cells,', ' circulation of multiple pathogens in Réunion Island throughout the year.', 'that ILI is not specific to influenza and so it is essential to have biological results in order to establish the differential diagnosis and thus explain the etiology of symptoms.', 'to repeat this study every 3 or 5 years adding clinical data to monitor the evolution of respiratory pathogens in Réunion Island over time.', 'bat beta-coronaviruses, with the highest being >96% identity ', 'greater than 40,000', ' as coronavirus disease discovered in 2019 (COVID-19)', '∼80% identity with SARS-CoV', ' 99.8% homology, with a total of 202 single-nucleotide (nt) variations (SNVs) identified across the genome ', 'greater than 1,100 nt ', 'are distributed throughout the genome in a naturally occurring pattern following the evolutionary characteristics typical of CoVs', 'The absence of a logical targeted pattern in the new viral sequences and a close relative in a wildlife species (bat', 'the construction of a chimeric CoV with a bat CoV S gene (SHC014) in the backbone of a SARS CoV that has adapted to infect mice (MA15) and is capable of infecting human cells', ' because of significant divergence in the genetic sequence of this construct with the new SARS-CoV-2 (>5,000 nucleotides).', 'by serial passage of an infectious wildtype SARS CoV clone in the respiratory tract of BALB/c mice.', 'due to six coding genetic mutations associated with mouse adaptation. ', 'due to the mouse adaptation.', 't was proposed that the S gene from bat-derived CoV, unlike that from human patients-or civetsderived viruses, was unable to use human ACE2 as a receptor for entry into human cells ', 'several novel bat coronaviruses were isolated from Chinese horseshoe bats and the bat SARS-like or SL-CoV-WIV1 was able to use ACE2 from humans, civets and Chinese horseshoe bats for entry ', 'Combined with evolutionary evidence that the bat ACE2 gene has been positively selected at the same contact sites as the human ACE2 gene for interacting with SARS CoV [', ' the exact S gene from bat coronavirus SL-SHC014 was synthesized and used to generate a chimeric virus in the mouse adapted MA15 SARS-CoV backbone. ', 'The resultant SL-SHC014-MA15 virus could indeed efficiently use human ACE2 and replicate in primary human airway cells to similar titres as epidemic strains of SARS-CoV. While SL-SHC014-MA15 can replicate efficiently in young and aged mouse lungs, infection was attenuated, and less virus antigen was present in the airway epithelium as compared to SARS MA15, which causes lethal outcomes in aged mice', 'as gain of function (GOF) studies under the US government-mandated pause policy ', 'upon careful phylogenetic analyses by multiple international groups [5, 14] , the SARS-CoV-2 is undoubtedly distinct from SL-SHC014-MA15, with >6,000 nucleotide differences across the whole genome.', 'that SARS-CoV-2 has HIV sequence in it and was thus likely generated in the laboratory. I', ' they used careful bioinformatics analyses to demonstrate that the original claim of multiple HIV insertions into the SARS-CoV-2 is not HIV-1 specific but random ', ' Because of the many concerns raised by the international community, the authors who made the initial claim have already withdrawn this report.', 'Evolution is stepwise and accrues mutations gradually over time, whereas synthetic constructs would typically use a known backbone and introduce logical or targeted changes instead of the randomly occurring mutations that are present in naturally isolated viruses such as bat CoV RaTG13.', ' there is currently no credible evidence to support the claim that SARS-CoV-2 originated from a laboratory-engineered CoV. It is more likely that SARS-CoV-2 is a recombinant CoV generated in nature between a bat CoV and another coronavirus in an intermediate animal host. ', 'More studies are needed to explore this possibility and resolve the natural origin of SARS-CoV-2. We should emphasize that, although SARS-CoV-2 shows no evidence of laboratory origin, viruses with such great public health threats must be handled properly in the laboratory and also properly regulated by the scientific community and governments.', 'to that of the severe acute respiratory syndrome (SARS) caused by SARS-CoV. ', 'to evaluate the effectiveness of zinc supplementation on diarrhea and average daily weight gain (ADG) in pre-weaned dairy calves', 'Zinc supplementation', 'an outbreak in 1993–94 in the southwestern United States', 'Well over 40', 'nearly half of them', 'persistent infections', ' a cardiopulmonary compromise, hantavirus cardiopulmonary syndrome (HCPS)', 'between 30% and 40%', ' Habitat disturbance and larger-scale ecological disturbances, perhaps including climate change,', ' the features that influence the structure of host population dynamics that may lead to viral outbreaks', 'the macromolecular determinants of hantaviruses that have been regarded as having potential contribution to pathogenicity.', ' emerging zoonotic diseases', 'Changes in biotic and abiotic conditions', ' influenza A, Ebola virus, hepatitis C virus, severe adult respiratory distress (SARS), coronavirus, and human immunodeficiency virus', 'hantaviruses, and the expansion of the geographic range of West Nile virus.', 'arenaviruses and dengue viruses', 'small mammals', ' Arenaviridae and Bunyaviridae: Hantavirus ', ' disease, hantavirus cardiopulmonary syndrome, HCPS (or hantavirus pulmonary syndrome), was linked to ', 'infection by the newly-discovered Sin Nombre virus (SNV)', ' the rodent Peromyscus maniculatus (deer mouse)', 'descriptions closely resembling hemorrhagic fever with renal syndrome (HFRS), the syndrome caused by Old World hantaviruses', 'with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954', ' etiologic agent, Hantaan virus', ' from the striped field mouse Apodemus agrarius,', 'Hantavirus of the family Bunyaviridae', 'The categorization of hantaviruses as belonging to the family Bunyaviridae is due in part to', ' the consistent presence of three RNA genomes that are circularized in vivo as a result of the presence of terminal complementary nucleotides that help fold the genome into a -hairpin‖ morphology,', 'Uukuniemi phlebovirus ', 'a membrane -bound protease into Gn and Gc, a cleavage that occurs', 'after the conserved peptide signal WAASA at the C-terminal of Gn ', 'to allow them stability so that the two can be assembled correctly in the Golg', ' the \\uf0623 integrin chain and decay accelerating factor, or DAF', ' blunt any pathological response in the host [', 'would tend to induce an earlier innate response that would render it more likely that the virus would be quickly cleared or rendered less competent in its replication', 'hantaviruses have been identified as adversely affecting', 'endothelial migration over substrata ', ' VEG-F-induced endothelial permeability', 'a structural component of the viral nucleocapsid', 'engages the hairpin termini of the genomic segments with high affinity', ' it limits the access of the RNA to host nucleases ', ' helps to render viral replication a closed process within the cytoplasm', 'a peripheral membrane protein', ' to the interference with an array of the intracellular processes of the normal cell', ' to fundamental requirements of replication', 'with actin microfilaments, and the SUMO-1 protein', ' through their interaction with N and DCP1', ' that N tracks along microtubules', 'not with actin filaments ', 'the Golgi', ' via the endoplasmic reticulum-Golgi intermediate complex (ERGIC), also known as vesicular-tubular cluster ', ' dynamitin', 'dynein-mediated transport', \" reduced N's accumulation in the Golgi\", ' that microtubular transport is indeed utilized for the New World hantavirus SNV', 'plasma viral RNA with', ' a transient (~ 1-5 days) capillary leak involving the kidney and retroperitoneal space in HFRS and the lungs in HCPS', 'is exudative in character, with chemical composition high in protein and resembling plasma.', ' β3 integrin', 'through uptake by regional lymph nodes, perhaps with or within an escorting lung histiocyte', 'local endothelium', ' the first few infected cells give rise, ultimately, to a primary viremia', 'appears to take a long time ', ' the agents of the more severe forms of HFRS and HCPS have begun to achieve sufficient mass', ' through PAMP-PRR interactions and other means', 'the pulmonary bed and lymphoid organs', 'the retroperitoneum and, in general, the kidney', ' For HCPS, that expression favors the pulmonary bed and lymphoid organs, yet, for unknown reasons, spares the retroperitoneum and, in general, the kidney. In HFRS the situation is reversed,', 'Local elaboration of inflammatory and chemotactic mediators ', 'shock and death', ' not hypoxemia, due to the prominent pulmonary edema', 'intoxication of the heart by as-yet-undefined mediators that leads to the low cardiac output state and the associated shock syndrome ', ' Innate immune mechanisms.', 'Direct viral effects', 'Pathogenic effects caused by the activities of specific viral macromolecules.', 'direct viral toxicity, acting through the inhibition of endothelial cell barrier function', 'their native carrier rodents, the bank vole Myodes glareolus and the deer mouse P. maniculatus', 'ANDV or the related Maporal virus from Venezuela, for which an HCPS-mimetic disease is observed', 'by capillary leak that results in pulmonary edema and the production of a pleural effusion with exudative characteristics', '11 and 14-d', 'abundant fibrin deposition, thickened alveolar septa, and viral antigen expressed abundantly in the microvascular endothelium.', 'diminished pulse pressures, tachycardia, and hypotension', 'the shock that is believed to be the proximate cause of demise in patients who succumb to HCPS ', 'exceptionally high titers of live ANDV in their tissues, with much of the viral replication occurring in hepatocytes', 'with disease severity for HCPS and HFRS,', 'Ty21a for typhoid fever in humans, several Salmonella serovars against salmonellosis in chickens and other animals', 'commonly employed vectors, for example Salmonella and adenovirus, often have pre-existing immune responses in the host and this has the potential to modify the subsequent immune response to a vectored antigen. ', 'for bacterial vectors there can in fact, in some cases, be an enhancement in immunogenicity, typically humoral, while for viral vectors pre-existing immunity is a hindrance for subsequent induction of cell-mediated responses.', ' attenuated bacteria, including Escherichia coli, Vibrio cholerae, lactic acid bacteria (LAB), specifically Lactococcus lactis, Mycobacterium, Listeria, Shigella and Salmonella, have been tested for the targeted delivery of heterologous antigens of bacterial, viral and parasitic origin into a variety of animal hosts', 'Bacteria such as E. coli and lactic acid bacteria ', 'E. coli is a commensal and lactic acid bacteria are present in most fermented food items and are therefore naturally present in the host. They are also a much safer option than traditional attenuated vaccines in children and immunecompromised people.', ' Listeria species are Gram-positive intracellular food-borne pathogens', 'The advantages of Listeria are that it can invade a variety of cells, including antigen presenting cells (APCs). After invading the host cell, Listeria resides inside the phagosome; however, it can escape the phagosome with the help of listeriolysin O (LLO; Hly) and reside in the cytoplasm of the cells, thereby efficiently presenting antigen to both CD8 and CD4 T cells ', 'recombinant vaccines are based on both DNA viruses (such as fowlpox virus-based vaccines which target avian influenza virus and fowlpox virus, or vaccinia virusbased vectors against the rabies virus in wildlife) and RNA viruses [such as Newcastle disease virus-based vaccines to be used in poultry or yellow fever virus (YFV)-based vaccines to be used in horses against West Nile virus] ', 'YFV (YF-17D strain) was the first to be licensed for use in humans, where the cDNAs encoding the envelope proteins of YFV were replaced with the corresponding genes of an attenuated Japanese encephalitis virus strain, SA14-14-2', 'modified vaccinia virus Ankara (MVA) and New York attenuated vaccinia virus NYVAC strains', 'Chickens (Gallus gallus) are a natural animal reservoir for Salmonella, which makes them an important source of Salmonella-associated gastroenteritis in humans. ', 'They are ideal candidate vectors due to their large DNA-packing capacity and their thermal and genetic stability ', 'adenovirus (Ad) vector is another of the most widely evaluated vectors to date to express heterologous antigens, due to ease of production, safety profile, genetic stability, the ease of DNA genome manipulation, and the ability to stimulate both innate and adaptive immune responses and induce both T and B cell responses ', 'a vaccine should be inexpensive, so that it can be administered to a large population at minimal cost', 'Safety is a major concern, as even a low level of toxicity is unacceptable ', 'long-lasting cellular and (where appropriate) humoral immune responses to the vectored antigen must be induced following administration of these vaccines, preferably with a single dose', 'considering a vector such as Salmonella, if a host has previously been infected there will exist robust B and T memory responses, and as such, when a vaccination is delivered, an anamnestic response to the Salmonella antigens will be induced (while the response to the vectored antigen will be a primary response)', 'for virally vectored antigens, the existence of pre-existing immunity to the vector (particularly neutralizing antibody) will restrict delivery of the virus into cells, thereby effectively reducing the dose of the vectored antigen. Again, this might be expected to result in a reduction in the antigenicity of the vectored antigen.', 'theoretically reduce the exposure of the heterologous antigen to the immune system, as the vector is rapidly cleared.', 'mice that had been primed with Salmonella alone, and then boosted with Salmonella expressing tetC, induced much lower anti-tetC responses than mice that had not been primed. This argues strongly that prior immunological immunity to the vector can seriously dampen subsequent antigen-specific humoral responses.', 'pre-existing immunity is a major obstacle of many viralvectored vaccines, such as Ad serotype 5 or herpes simplex virus type 1 (HSV-1), where the rate of seroprevalence to these viruses is very high [40-45 % and 70 % (or more) of the US population, respectively] ', 'Vector-specific antibodies may impede the induction of immune responses to the vaccine-encoded antigens, as they may reduce the dose and time of exposure of the target cells to the vaccinated antigens', ' In a large-scale clinical trial (STEP) of an Ad serotype 5 (AdHu5)-based HIV-1 vaccine, the vaccines showed a lack of efficacy and tended to increase the risk of HIV-1 infection in vaccine recipients who had pre-existing neutralizing antibodies to AdHu5 (', ' the use of vectors derived from nonhuman sources, using human viruses of rare serotypes (Kahl et al., 2010; Lasaro & Ertl, 2009) , heterologous prime-boost approaches (Liu et al., 2008) , homologous reimmunization (Steffensen et al., 2012) and removing key neutralizing epitopes on the surface of viral capsid proteins (Gabitzsch & Jones, 2011; Roberts et al., 2006) ', 'The inhibitory effect of pre-existing immunity can also be avoided by masking the Ad vector inside dendritic cells (DCs) (Steffensen et al., 2012) . In addition, mucosal vaccination or administration of higher vaccine doses can overcome pre-existing immunity problems (Alexander et al., 2012; Belyakov et al., 1999; Priddy et al., 2008; Xiang et al., 2003) .\\n', ' this is because viruses will induce neutralizing antibody on the first dose, and in subsequent doses this antibody will limit the number of transduced cells, therefore limiting the responses. This is particularly a problem with a common viral vector such as Ad, where a large proportion of the population will have immunological memory against common serotypes', ' it will be possible to utilize such vectors only by developing vaccines from alternative serotypes. It may be that a vector such as Pre-existing immunity against vaccine vectors attenuated influenza virus, with the ability to easily develop reassortants, will be useful in this context.\\n\\nIn addition, immunological memory in the form of opsonizing antibody certainly plays an important role in the early uptake of Salmonella by macrophages and DC. This may be beneficial, as the live bacterial vector used for delivery purposes harbours mutations in genes encoding proteins responsible for their survival in the animal host. This not only encumbers their ability to cause disease, making them safe live vectors, but also limits the number of replications. The presence of opsonizing antibodies should mean a higher level of bacterial uptake, leading to higher presentation to the immune system and therefore a better immune response.', 'fecal–oral contact', 'recombinant vaccine carrier', 'intestine epithelial cells', 'mucosal', 'gastric acids, pepsin, and trypsin', 'Gram-positive bacterium', 'antigen-presenting cells', 'gut-associated lymphoid tissue (GALT)', \"Peyer's patches (PPs), isolated lymphoid follicles (ILFs), mesenteric lymph nodes (MLNs), and scatter throughout the subepithelial lamina propria (LP) of the small intestine and colon\", 'lymphoid cells', 'serum IgG and mucosal SIgA', 'cytokines', 'pro-inflammatory cytokines', 'Wuhan City, China', 'Wuhan City, China', ' rapid and transparent sharing of information between countries and agencies', '31 December', '26 January 2020', '4 weeks', ' reverse transcription polymerase chain reaction', '1000 bed hospital', '10 days', 'transparent sharing of information between countries and agencies', '2012', '2 weeks', '10%', '34%', 'the volume and diversity of the information available and the relative lack of verification mechanisms', 'autoinfection, but also in infection of patients hospitalised for other causes when they provide care', ' the health worker, but also for their families and the communities in which they live', '3', 'where a case infected significantly more contacts than the average', '5 m people', 'Between 3-5 million', 'over 250 000', '53%', 'primary human alveolar epithelial type II (ATII) cells', 'four', 'epithelial and endothelial cells 11 , as well as B cells, T cells, neutrophils, NK cells, macrophages and dendritic cells (DCs)', 'immunoreceptor tyrosine-based inhibitory motifs (ITIMs)', 'CEACAM1-4L and CEACAM1-3L', 'heterophilically', 'signaling molecules', 'pattern recognition receptors (PRRs)', 'Phosphorylation of CEACAM1 ITIM motifs and activation of caspase-3', 'by recognizing and killing infected cells', 'modification of influenza hemagglutinin (HA) glycosylation', 'HIV fusion inhibitor', 'residues corresponding to the NHR pocket region', 'residues for the PBD', 'MT-hook residues adjacent to the N terminus of PBD', 'mutant residues in PBD of AP2 and AP3', 'twice', 'AP3, exhibited improved antiviral activity, drug resistance profile and pharmacological properties over T20', 'AP3 has potential for development as a new anti-HIV drug', 'adding two amino acids of Met and Thr to the N-terminus of a CHR-peptide ', 'Fig. 1b', 'about 2 h', 'non-compartment model', '6.02 h', 'Because T20 lacks the pocket-binding domain (PBD)', 'GIV motif (residues 36-45: GIVQQQNNLL) in the gp41 NHR domain 10', 'firstly, early recognition of the deteriorating patient; secondly, HCW safety; thirdly, bystander safety; fourthly, contingency plans for medical emergencies during transport; fifthly, post-transport decontamination', 'two to three million', '60%', 'Rotavirus', 'type 40 and 41', '1907', '1. Universal primer-PCR [41] ; 2. Random priming-based PCR [42] ; 3. Virus Discovery cDNA, Amplified Fragment Length Polymorphism (VIDISCA) [43] ; and 4. Sequence-Independent Single Primer Amplification (SISPA)', 'detect novel variants', 'The microbe occurs in every case of the disease in question and under circumstances which can account for the pathological changes and clinical course of the disease', 'the microbe occurs in no other disease as a fortuitous and nonpathogenic parasite', 'after being fully isolated from the body and repeatedly grown in pure culture, the microbe can induce the disease anew', 'microbe is the cause of the disease', 'not applicable', 'point mutations on immunodominant regions of surface proteins', 'positive-sense single stranded RNA enveloped virus', '3,000 aminoacids', 'p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B', 'high mutation rate', 'glycoproteins E1 and E2', 'antigenic differences of their nucleoprotein and matrix protein', 'influenza A', 'By Mid Pleistocene (,500,000 years ago)', 'to assess the evolutionary history of lion', 'protein–protein interactions.', ' inherent biological, biochemical, and biophysical properties of filamentous bacteriophage, as well as the ease of its genetic manipulation', 'high immunogenicity, relative antigenic simplicity and ability to activate a range of immune responses', 'prophylactic and therapeutic agent', ' enables a variety of bioconjugation and surface chemistry applications, particularly in nanomaterials', 'the phage’s large population sizes and fast generation times', 'non-enveloped, rod-shaped viruses of Escherichia coli whose long helical capsids encapsulate a single-stranded circular DNA genome.', 'principle of modifying the filamentous phage genome to display polypeptides as fusions to coat proteins on the virion surface ', 'the ability to seamlessly connect genetic information with protein function for a large number of protein variants simultaneously, and has been widely and productively exploited in studies of proteinprotein interactions', '(i) filamentous phage as a vaccine carrier; (ii) engineered filamentous phage as a therapeutic biologic agent in infectious and chronic diseases; (iii) filamentous phage as a scaffold for bioconjugation and surface chemistry; and (iv) filamentous phage as an engine for evolving variants of displayed proteins with novel functions. ', ' unique biological, immunological, and physicochemical properties of the phage, its ability to display a variety of biomolecules in modular fashion, and its relative simplicity and ease of manipulation', \"its ability to display polypeptides on the virion's surface as fusions to phage coat proteins \", ' maximum tolerated size of the fused polypeptide, its copy number on the phage, and potentially, the structure of the displayed polypeptide', ' by fusing DNA encoding a polypeptide of interest directly to the gene encoding a coat protein within the phage genome (type 8 display on pVIII, type 3 display on pIII, etc.)', ' a recombinant filamentous phage displaying a single polypeptide sequence on its surface (or more rarely, bispecific display achieved via fusion of polypeptides to two different capsid proteins)', 'a diverse pool of recombinant filamentous phage displaying an array of polypeptide variants (e.g., antibody fragments; peptides)', 'is highly immunogenic in the absence of adjuvants (Meynell and Lawn, 1968 ) and that only the major coat protein, pVIII, and the minor coat protein, pIII, are targeted by antibodies', 'as carrier to elicit antibodies against poorly immunogenic haptens or polypeptide', \"The phage particle's low cost of production, high stability and potential for high valency display of foreign antigen\", ' the maximum tolerated size of the fused polypeptide, its copy number on the phage, and potentially, the structure of the displayed polypeptide. ', '(i) in many cases, peptides incompletely or inadequately mimic epitopes on folded proteins (Irving et al., 2010 ; see below); (ii) antibodies against a single epitope may be of limited utility, especially for highly variable pathogens (Van Regenmortel, 2012); and (iii) for pathogens for which protective immune responses are generated efficiently during natural infection, peptide vaccines offer few advantages over recombinant subunit and live vector vaccines, which have become easier to produce over time.', 'Phage displaying peptide ligands of an anti-IgE antibody elicited antibodies that bound purified IgE molecules', ' immunization with phage displaying follicle-stimulating hormone peptides on pVIII elicited antibodies that impaired the fertility of mice and ewes ', 'Phage displaying or chemically Rubinchik and Chow (2000) conjugated to sperm antigen peptides or peptide mimics (Samoylova et al., 2012a,b) and gonadotropin-releasing hormone (Samoylov et al., 2012) are also in development.', \" it seems that peptide antigens elicit a set of topologically restricted antibodies that are largely unable to recognize discontinuous or complex epitopes on larger biomolecules. While the peptide may mimic the chemistry of a given epitope on a folded protein (allowing it to crossreact with a targeted antibody), being a smaller molecule, it cannot mimic the topology of that antibody's full epitope.\", 'as a carrier for peptides with relatively simple secondary structures, which may be stablilized via anchoring to the coat proteins (Henry et al., 2011) . This may be especially true of peptides with poor inherent immunogenicity, which may be increased by high-valency display and phage-associated adjuvanticity', ' is immunogenic without adjuvant in all species tested to date, including mice (Willis et al., 1993) , rats (Dente et al., 1994) , rabbits (de la Cruz et al., 1988) , guinea pigs (Frenkel et al., 2000; Kim et al., 2004) , fish (Coull et al., 1996; Xia et al., 2005) , non-human primates (Chen et al., 2001) , and humans (Roehnisch et al., 2014) ', 'serum antibody titers against the phage typically reach 1:10 5 -1:10 6 after 2-3 immunizations, and are maintained for at least 1 year postimmunization (Frenkel et al., 2000) . ', 'composed of a mixture of IgM and IgG2b isotypes in C57BL/6 mice, while secondary antibody responses are composed primarily of IgG1 and IgG2b isotypes, with a lesser contribution of IgG2c and IgG3 isotypes (Hashiguchi et al., 2010) .', \"Host cell wall-derived LPS enhances the virion's immunogenicity, and its removal by polymyxin B chromatography reduces antibody titers against phage coat proteins (Grabowska et al., 2000) . The phage's singlestranded DNA genome contains CpG motifs and may also have an adjuvant effect. \", 'MyD88 signaling and is modulated by stimulation of several Toll-like receptors (Hashiguchi et al., 2010) , indicating that innate immunity plays an important ', ' it is cleared from the blood within hours through the reticuloendothelial system (Molenaar et al., 2002) , particularly of the liver and spleen, where it is retained for days (Zou et al., 2004) , potentially activating marginal-zone B-cell responses. ', ' the filamentous phage is not only a highly immunogenic carrier, but by virtue of activating a range of innate and adaptive immune responses, serves as an excellent model virus-like particle antigen.', ' as elements of combination therapeutics against certain drug-resistant infections.', 'M13 or fd phage displaying either a targeting peptide or antibody fragment and tethered to chloramphenicol by a labile crosslinker ', 'M13 phage loaded with doxorubicin and displaying a targeting peptide on pIII', 'Using the B16-OVA tumor model, Eriksson et al. (2007) showed that phage displaying peptides and/or Fabs specific for tumor antigens delayed tumor growth and improved survival, owing in large part to activation of tumor-associated macrophages and recruitment of neutrophils to the tumor site (Eriksson et al., 2009) ', ' ability of the phage to penetrate into brain tissue (Ksendzovsky et al., 2012) ', 'is enclosed by a rod-like protein capsid, ∼1000 nm long and 5 nm wide, made up almost entirely of overlapping pVIII monomers, each of which lies ∼27 angstroms from its nearest neighbor and exposes two amine groups as well as at least three carboxyl groups (Henry et al., 2011)', 'The regularity of the phage pVIII lattice and its diversity of chemically addressable groups', 'Lee et al. (2002) engineered M13 phage to display a ZnS-binding peptide on pIII and showed that, in the presence of ZnS nanoparticles, they selfassemble into highly ordered film biomaterials that can be aligned using magnetic fields.', 'Taking advantage of the ability to display substrate-specific peptides at known locations on the phage filament Hess et al., 2012) , this pioneering FIGURE 3 | Chemically addressable groups of the filamentous bacteriophage major coat protein lattice. ', 'made up of ∼2,500-4,000 overlapping copies of the 50-residue major coat protein, pVIII, arranged in a shingle-type lattice. Each monomer has an array of chemically addressable groups available for bioorthogonal conjugation, including two primary amine groups (shown in red), three carboxyl groups (show in blue) and two hydroxyl groups (show in green). The 12 N-terminal residues generally exposed to the immune system for antibody binding ', 'construction of two-and threedimensional nanomaterials with more advanced architectures, including semiconducting nanowires (Mao et al., 2003 (Mao et al., , 2004 , nanoparticles , and nanocomposites (Oh et al., 2012; Chen et al., 2014)', 'The capacities of nanopore sequencing for viral diagnostics', '19.2 to 103.5X', 'lower than 7', '816 nt', '17V079', 'Gram positive, anaerobic bacterium', 'adaptive strategy that enables bacteria to survive harsh environmental conditions for prolonged periods of time', 'Spo0A', 'toxins A and B', 'Western blot', 'by mosquitoes', 'fever, malaise, and vomiting', '35%', '10%', 'TC83', 'changes in gene expression', 'protein misfolding', 'inositolrequiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6)', 'nucleus', 'a transcription factor', ' the ability of a given host to tolerate an infection, and to return to a state of health', 'coronavirus', 'coronavirus', '2003', '8000', '35-50%', '10%', 'animal reservoirs', 'severe lung pathology', 'Many infected patients have acute lung injury (ALI)', ' In some patients there is a progression to the more severe form of ALI, acute respiratory distress syndrome (ARDS)', \" a successful host must not only be able to clear the pathogen, but tolerate damage caused by the pathogen itself and also by the host's immune response\", 'SARS-CoV uses the ACE2 receptor to gain entry to cells, while MERS-CoV uses the ectopeptidase DPP4', 'Unlike SARS-CoV infection, which causes primarily a severe respiratory syndrome, MERS-CoV infection can also lead to kidney failure', ' SARS-CoV also spreads more rapidly between hosts, while MERS-CoV has been more easily contained, but it is unclear if this is due to the affected patient populations and regions', 'SARS-CoV and MERS-CoV are contained in double membrane vesicles', 'In patients with high initial viral titers there is a poor prognosis', 'In a mouse model of SARS-CoV infection, the type I IFN response is delayed', 'several viral proteins suppress the type I IFN response, and other aspects of innate antiviral immunity', 'Retrospective analysis revealed that, when given at the correct time and to the appropriate patients, corticosteroid use could decrease mortality and also length of hospital stays', ' there is some evidence that simultaneous treatment with IFNs could increase the potential benefits', 'decreasing immunopathology by immunomodulation is problematic because it can lead to increased pathogen burden, and thus increase virus-induced pathology', 'A recent paper demonstrates that topoisomerase I can protect against inflammation-induced death from a variety of viral infections including IAV', 'Blockade of C5a complement signaling has also been suggested as a possible option in decreasing inflammation during IAV infection', 'They act to stabilize the activation of aspects of the innate immune response and prevent excessive inflammation', 'if they were obese, immunocompromised, diabetic or had cardiac disease', 'a higher neutrophil count and low T-cell counts', 'One factor that increased disease for patients infected with SARS-CoV and MERS-CoV was infection with other viruses or bacteria', 'A recent study looking at malaria infections in animal models and human patients demonstrated that resilient hosts can be predicted', 'Clinical studies have started to correlate specific biomarkers with disease outcomes in ARDS patients', 'A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. ', ' 25,000', ' 2%', 'males with a median age of 55 years and linked to the Huanan Seafood Wholesale Market ', 'fever, cough, and myalgia or fatigue.', 'betacoronavirus', ' forms a clade within the subgenus sarbecovirus of the Orthocoronavirinae subfamily ', 'The severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)', 'Based on current evidence, pathogenicity for 2019-nCoV is about 3%, which is significantly lower than SARS-CoV (10%) and MERS-CoV (40%)', '2019-nCoV has potentially higher transmissibility (R0: 1.4-5.5) than both SARS-CoV (R0: [2] [3] [4] [5] and MERS-CoV (R0: <1)', 'PubMed, Embase and Cochrane Library', ' to identify published studies examining the diagnosis, therapeutic drugs and vaccines for Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019-nCoV), in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.', 'randomized controlled trials (RCTs) and validation trials (for diagnostics test) published in English, that measured (a) the sensitivity and/or specificity of a rapid diagnostic test or a point-of-care testing kit, (b) the impact of drug therapy or (c) vaccine efficacy against either of these diseases with no date restriction applied. For the 2019-nCoV, we searched for all in vitro, animal, or human studies published in English between 1 December 2019 and 6 February 2020, on the same outcomes of interest. ', ' Studies that examined the mechanisms of diagnostic tests, drug therapy or vaccine efficacy against SARS, MERS and 2019-nCoV', \"A Google search for 2019-nCoV diagnostics (as of 6 February 2020; Table S2 ) yielded five webpage links from government and international bodies with official information and guidelines (WHO, Europe CDC, US CDC, US FDA), three webpage links on diagnostic protocols and scientific commentaries, and five webpage links on market news and press releases. Six protocols for diagnostics using reverse transcriptase polymerase chain reaction (RT-PCR) from six countries were published on WHO's website [9] . Google search for 2019-nCoV vaccines yielded 19 relevant articles.\", 'real time RT-PCR', 'It was found that the respiratory specimens were positive for the virus while serum was negative in the early period. It has also suggested that in the early days of illness, patients have high levels of virus despite the mild symptoms.', 'reverse transcription loop-mediated isothermal amplification (RT-LAMP), RT-insulated isothermal PCR (RT-iiPCR) and a one-step rRT-PCR assay based on specific TaqMan probes.', ' RT-LAMP has similar sensitivity as real time RT-PCR. It is also highly specific and is used to detect MERS-CoV. It is comparable to the usual diagnostic tests and is rapid, simple and convenient.', ' have also shown similar sensitivity and high specificity for MER-CoV.', 'high levels of PCR inhibition may hinder PCR sensitivity ', ' that the molecular test has better sensitivity and specificity. ', 'Studies looked at using nested PCR to include a pre-amplification step or incorporating N gene as an additional sensitive molecular marker to improve on the sensitivity ', '10 genome equivalents per reaction', 'has a good reproducibility with the inter-assay coefficients of variation of 1.73 to 2.72%.', 'messenger RNA, DNA-based, nanoparticle, synthetic and modified virus-like particle)', ' kit developed by the BGI have passed emergency approval procedure of the National Medical Products Administration, and are currently used in clinical and surveillance centers of China', 'Most studies on SARS and MERS vaccines were excluded as they were performed in cell or animal models ', ' Phase I clinical trials on SARS or MERS vaccines', ' All vaccine candidates for SARS and MERS were reported to be safe, ', 'well-tolerated and able to trigger the relevant and appropriate immune responses in the participants', 'nine', ' five studies on hydroxychloroquine, lopinavir plus ritonavir and arbidol, mesenchymal stem cells, traditional Chinese medicine and glucocorticoid therapy usage have commenced recruitment. The remaining four studies encompass investigation of antivirals, interferon atomization, darunavir and cobicistat, arbidol, and remdesivir usage for 2019-nCoV patients', ' Seroconversion measured by S1-ELISA occurred in 86% and 94% participants after 2 and 3 doses, respectively, and was maintained in 79% participants up to study end at week 60.', 'Neutralising antibodies were detected in 50% participants at one or more time points during the study, but only 3% maintained neutralisation activity to end of study.', ' detected in 71% and 76% participants after 2 and 3 doses, respectively.', 'no differences in immune responses between dose groups after 6 weeks and vaccine-induced humoral and cellular responses were respectively detected in 77% and 64% participants at week 60', 'Molecules developed by the university scientists inhibit two coronavirus enzymes and prevent its replication. The discovered drug targets are said to be more than 95% similar to enzyme targets found on the SARS virus. ', 'It investigates the usage of Lopinavir/Ritonavir and Interferon Beta 1B.', ' usage of ribavirin with lopinavir/ritonavir/ribavirin, interferon, and convalescent plasma usage.', 'The trial conducted in the United States in 2017 demonstrated SAB-301 to be safe and well-tolerated at single doses. ', 'enables prompt and accurate public health surveillance, prevention and control measures. Local transmission and clusters can be prevented or delayed by isolation of laboratory-confirmed cases and their close contacts quarantined and monitored at home', 'specific public health interventions such as closure of high-risk facilities and areas associated with the confirmed cases for prompt infection control and environmental decontamination ', ' (a) detecting the genetic material of the virus, (b) detecting the antibodies that neutralize the viral particles of interest, (c) detecting the viral epitopes of interest with antibodies (serological testing), or (d) culture and isolation of viable virus particles.', 'lack of knowledge of the presence of viable virus, the potential cross-reactivity with non-specific genetic regions and the short timeframe for accurate detection during the acute infection phase.', 'the need to collect paired serum samples (in the acute and convalescent phases) from cases under investigation for confirmation to eliminate potential cross-reactivity from non-specific antibodies from past exposure and/or infection by other coronaviruses.', ' the long duration and the highly specialized skills required of the technicians to process the samples. ', 'Significantly shorted time from the disease onset to the symptom improvement in treatment (5.10 ± 2.83 days) compared to control group (7.62 ± 2.27 days) (p < 0.05) No significant difference in blood routine improvement, pulmonary chest shadow in chest film improvement and corticosteroid usgae between the 2 groups. ', 'in the respect of improving clinical symptoms, elevating quality of life, promoting immune function recovery, promoting absorption of pulmonary inflammation, reducing the dosage of cortisteroid and shortening the therapeutic course', 'have higher and more prolonged levels of viral RNA because of the tropism of the virus. ', 'viral loads are also higher for severe cases and have longer viral shedding compared to mild cases', 'hey have potentially lower viral loads and may have higher risk of false-negatives among the mild MERS and SARS cases [102, 103] , and likely among the 2019-nCoV cases.\\n', '(a) reverse transcription-polymerase chain reaction (RT-PCR), (b) real-time RT-PCR (rRT-PCR), (c) reverse transcription loop-mediated isothermal amplification (RT-LAMP) and (d) real-time RT-LAMP [104] . ', 'it has the highest sensitivity at the earliest time point in the acute phase of infection ', ' in Germany', 'based on the match against 2019-nCoV upon inspection of the sequence alignment. ', 'Two assays were used for the RNA dependent RNA polymerase (RdRP) gene and E gene where E gene assay acts as the first-line screening tool and RdRp gene assay as the confirmatory testing. ', 'All assays were highly sensitive and specific in that they did not cross-react with other coronavirus and also human clinical samples that contained respiratory viruses ', ' to be safe and well-tolerated at single doses.', 'mild skin infections to fatal necrotizing pneumonia', '8-30%', 'alveolar macrophages', 'The subsequent infection with Gram-positive bacteria', 'Reduced TNFα production by NK cells', 'a pneumococcal pore-forming toxin', 'epithelial barrier damage, exaggerated innate immune response, and cytokine storm', 'engineered, non-lytic, filamentous bacteriophages', 'the identification of peptide ligands by receptors, the mapping of substrate sites for enzymes, and the creation of antibody peptide libraries', 'pgsA-sM2/L. casei', 'Vaccination', '75%', 'highly conserved among influenza A virus strains', 'low immunogenicity', 'considered safe and exhibits an adjuvant-like effect on mucosal and systemic immunity', '59-GGGGTACCTCATTATTAACA-39, and 59-ACGTCGACT-CATTATTCAAGTTCAATAATG AC-39', 'the incorporation of an adjuvant', 'liposomes, nanoparticles, and immunostimulating complexes (ISCOMs)', 'severe pneumonitis', 'recombinant L. casei expressing CTA1-sM2 induced long-lasting immunity and conferred protection against lethal infections by influenza', 'Nod-like receptor family, pyrin domain-containing 3', 'in lipopolysaccharide-primed macrophages', 'ion channel activity of the 3a protein', 'transmembrane pore-forming viral proteins', 'Betacoronavirus', 'Coronaviridae', 'enveloped', 'single-stranded', 'At least 8,098', '9.6%', 'tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6', 'by sensing the cellular damage or distress induced by viroporins', '76 amino acids', 'Ca 2+ -permeable', 'NLRP3 inflammasome', 'tumor necrosis factor-α', 'cytokines', 'MAPK phosphatase-1', 'Mycobacterium tuberculosis', \"one third of the world's population\", '9.2 million', 'extracellular signal-regulated kinase 1 and 2 (ERK1/2), p38 MAPK, and c-Jun N-terminal kinase (JNK)', 'phosphorylation', 'tyrosine phosphatases, serine/threonine phosphatases, and dual-specificity phosphatases (DUSPs)', 'at least 10', 'a cell wall component of Gram-negative bacteria', 'Gram positive bacteria', 'MAPK', 'Constant evolution of circulating influenza virus strains and the emergence of new strains', 'efficacious vaccines conferring cross-clade protection to avoid the need for biannual reformulation of seasonal influenza vaccines.', 'Recombinant virus-vectored vaccines', 'a vectored vaccine often enables delivery of the vaccine to sites of inductive immunity such as the respiratory tract ', ' virus vectors enable native expression of influenza antigens, even from virulent influenza viruses, while expressed in the context of the vector that can improve immunogenicity. ', ' low efficacy in the populations at greatest risk of complications from influenza virus infection, i.e., the young and elderly', 'trivalent inactivated influenza vaccine (TIV), quadrivalent influenza vaccine (QIV), and live attenuated influenza vaccine (LAIV; in trivalent and quadrivalent forms)', 'whole virus inactivated, split virus inactivated, and subunit vaccines.', 'the virus is disrupted by a detergent', 'intramuscularly ', ' three or four inactivated viruses, i.e., two type A strains (H1 and H3) and one or two type B strains. ', 'humoral responses to the hemagglutinin (HA) protein,', 'hemagglutinin (HA) protein,', ' by the hemagglutination-inhibition (HI) assay,', 'strain-specific HI titer ', ' a four-fold increase in titer post-vaccination, or a HI titer of ≥1:40 is considered protective ', 'serum antibodies', 'mucosal IgA antibodies also may contribute to resistance against infection', 'nasal spray', 'the same three or four influenza virus strains as inactivated vaccines but on an attenuated vaccine backbone ', 'they do not replicate effectively at core body temperature', 'LAIV are temperature-sensitive and cold-adapted ', 'replicate in the mucosa of the nasopharynx', 'LAIV immunization induces serum antibody responses, mucosal antibody responses (IgA), and T cell responses.', 'specific antibody responses to the HA, and to a lesser extent NA proteins for protection.', 'The immunodominant portions of the HA and NA molecules undergo a constant process of antigenic drift, a natural accumulation of mutations', 'in February', 'it is generally considered to be as effective as inactivated vaccines and may be more efficacious in children ', 'antigenic match', ' the HA and NA antigens are replaced on the same schedule as the TIV', 'due to the diversity of the immune response consistent with inducing virus-neutralizing serum and mucosal antibodies, as well as broadly reactive T cell responses', 'improved understanding of immunity to conserved influenza virus antigens', 'allow ready manipulation and modification of the vector genome', 'enables modification of the vectors to attenuate the virus or enhance immunogenicity', 'adding and manipulating the influenza virus antigens', 'is either replication-defective or causes a self-limiting infection', ' like LAIV, safety in immunocompromised individuals', '53 ', ' A live adenovirus vaccine containing serotypes 4 and 7 has been in use by the military for decades', 'Adenovirus 5 (Ad5) ', 'having been tested for gene delivery and anti-cancer agents, as well as for infectious disease vaccines', 'their genome is very stable and there are a variety of recombinant systems available which can accommodate up to 10 kb of recombinant genetic material ', 'is a non-enveloped virus which is relatively stable and can be formulated for long-term storage at 4 °C, or even storage up to six months at room temperature ', 'Adenovirus vaccines can be grown to high titers, exceeding 10 1° plaque forming units (PFU) per mL when cultured on 293 or PER.C6 cells ', 'the virus can be purified by simple methods ', ' Adenovirus vaccines can also be delivered via multiple routes, including intramuscular injection, subcutaneous injection, intradermal injection, oral delivery using a protective capsule, and by intranasal delivery.', 'induce robust mucosal immune responses and may bypass preexisting vector immunity ', 'immunogenicity of recombinant adenovirus 5 (rAd5) expressing the HA of a swine influenza virus, A/Swine/Iowa/1999 (H3N2)', 'A rAd5-HA expressing the HA from A/Puerto Rico/8/1934 (H1N1; PR8) was delivered to humans epicutaneously or intranasally ', 'The vaccine was well tolerated and induced seroconversion with the intranasal administration had a higher conversion rate and higher geometric meant HI titers ', 'clinical trials with rAd vectors have overall been successful, demonstrating safety and some level of efficacy,', ' a gene therapy examination where high-dose intravenous delivery of an Ad vector resulted in the death of an 18-year-old male', 'the study was stopped after interim analysis suggested the vaccine did not achieve efficacy and individuals with high preexisting Ad5 antibody titers might have an increased risk of acquiring HIV-1 ', 'potent cellular and humoral immune responses that are initiated through toll-like receptor-dependent and independent pathways which induce robust pro-inflammatory cytokine responses', ' to improve immunogenicity and broaden breadth of both humoral and cellular immunity', 'as both CD8 + T cell and neutralizing antibody responses are generated by the vector and vaccine antigens, immunological memory to these components can reduce efficacy and limit repeated use ', ' using Autographa californica nuclear polyhedrosis virus (AcNPV) expressing the HA of PR8 under control of the CAG promoter (AcCAG-HA) ', 'preexisting immunity,', 'adenovirus serotypes have been explored as vectors, particularly non-human and uncommon human serotypes', 'Swine, NHP and bovine adenoviruses expressing H5 HA antigens ', ' Low prevalence serotypes such as adenovirus types 3, 7, 11, and 35', 'Prime-boost strategies, using DNA or protein immunization in conjunction with an adenovirus vaccine booster immunization', 'Like rAd vectors, rAAV have broad tropism infecting a variety of hosts, tissues, and proliferating and non-proliferating cell types ', ' The wild type viruses are non-pathogenic and replication incompetent in humans and the recombinant AAV vector systems are even further attenuated ', 'As members of the parvovirus family, AAVs are small non-enveloped viruses that are stable and amenable to long-term storage without a cold chain.', 'While there is limited preexisting immunity, availability of non-human strains as vaccine candidates eliminates these concerns.', 'There are limited studies ', 'positive-sense, single-stranded RNA viruses of the Togaviridae family', 'Semliki Forest virus (SFV), Sindbis (SIN) virus, Venezuelan equine encephalitis (VEE) virus, as well as chimeric viruses incorporating portions of SIN and VEE viruses', ' The replication defective vaccines or replicons do not encode viral structural proteins, having these portions of the genome replaces with transgenic material.', 'The structural proteins are provided in cell culture production systems.', 'the self-replicating nature of the RNA. Despite the partial viral genome, the RNAs are self-replicating and can express transgenes at very high levels', 'demonstrated to induce potent HA-specific immune response and protected from challenge in a murine model, despite repeated immunization with the vector expressing a control antigen, suggesting preexisting immunity may not be an issue for the replicon vaccine', 'the VEE targets antigen-presenting cells in the lymphatic tissues, priming rapid and robust immune responses', 'VEE replicon systems can induce robust mucosal immune responses through intranasal or subcutaneous immunization [72] [73] [74] , and subcutaneous immunization with virus-like replicon particles (VRP) expressing HA-induced antigen-specific systemic IgG and fecal IgA antibodies ', 'as candidate vaccines for cytomegalovirus (CMV)', 'vaccine was immunogenic, inducing CMV-neutralizing antibody responses and potent T cell responses. Moreover, the vaccine was well tolerated and considered safe ', 'vaccine was safe and despite high vector-specific immunity after initial immunization, continued to boost transgene-specific immune responses upon boost ', 'baculovirus-derived recombinant HA vaccine was approved for human use and was first available for use in the United States for the 2013-2014 influenza season', 'readily manipulated', 'The vectors can accommodate large gene insertions, show limited cytopathic effect in mammalian cells, and have been shown to infect and express genes of interest in a spectrum of mammalian cells', 'While the insect promoters are not effective for mammalian gene expression, appropriate promoters can be cloned into the baculovirus vaccine vectors.', 'only intranasal immunization', ' non-specific protection from subsequent influenza virus infection', 'a single-stranded, negative-sense RNA virus that causes disease in poultry. ', 'As an avian virus, there is little or no preexisting immunity to NDV in humans and NDV propagates to high titers in both chicken eggs and cell culture. ', \"As a paramyxovirus, there is no DNA phase in the virus lifecycle reducing concerns of integration events, and the levels of gene expression are driven by the proximity to the leader sequence at the 3' end of the viral genome. This gradient of gene expression enables attenuation through rearrangement of the genome, or by insertion of transgenes within the genome.\", 'pathogenicity of NDV is largely determined by features of the fusion protein enabling ready attenuation of the vaccine vector', 'it induced a robust serum antibody response and protected against homologous influenza virus challenge in a murine model of infection ', 'providing protection against both the influenza virus and NDV infection.', 'the NDV vector is well-tolerated, even at high doses delivered intravenously ', \" PIV5 has a stable RNA genome and no DNA phase in virus replication cycle reducing concerns of host genome integration or modification. PIV5 can be grown to very high titers in mammalian vaccine cell culture substrates and is not cytopathic allowing for extended culture and harvest of vaccine virus [98, 99] . Like NDV, PIV5 has a 3'-to 5' gradient of gene expression and insertion of transgenes at different locations in the genome can variably attenuate the virus and alter transgene expression [100] . PIV5 has broad tropism, infecting many cell types, tissues, and species without causing clinical disease, although PIV5 has been associated with -kennel cough‖ in dogs\", 'Mice intranasally vaccinated with a single dose of PIV5-H5 vaccine had robust serum and mucosal antibody responses, and were protected from lethal challenge. Notably, although cellular immune responses appeared to contribute to protection, serum antibody was sufficient for protection from challenge', 'has resulted in a large population of poxvirus-naï ve individuals that provides the opportunity for the use of poxviruses as vectors without preexisting immunity concerns ', 'The modified vaccinia virus Ankara (MVA) strain was attenuated by passage 530 times in chick embryo fibroblasts cultures. The second, New York vaccinia virus (NYVAC) was a plaque-purified clone of the Copenhagen vaccine strain rationally attenuated by deletion of 18 open reading frames', 'MVA has undergone extensive safety testing and shown to be attenuated in severely immunocompromised animals and safe for use in children, adults, elderly, and immunocompromised persons. With extensive pre-clinical data, recombinant MVA vaccines expressing influenza antigens have been tested in clinical trials and been shown to be safe and immunogenic in humans ', 'results combined with data from other (non-influenza) clinical and pre-clinical studies support MVA as a leading viral-vectored candidate vaccine.', 'The NYVAC vector is a highly attenuated vaccinia virus strain. NYVAC is replication-restricted', 'in chick embryo fibroblasts and Vero cells enabling vaccine-scale production. In non-permissive cells, critical late structural proteins are not produced stopping replication at the immature virion stage ', ' NYVAC is very attenuated and considered safe for use in humans of all ages', 'current influenza vaccination strategies rely upon regular immunization with vaccines matched to circulating strains', 'immunization with this vector induces weaker vaccine-specific immune responses compared to other poxvirus vaccines, a feature that may address the concerns surrounding preexisting immunity ', ' licensed poxvirus for veterinary use that include fowlpox-and canarypox-vectored vaccines for avian and equine influenza viruses, respectively ', ' immunization with NP expressed by AAV, rAd5, alphavirus vectors, MVA, or other vector systems induces potent CD8 + T cell responses ', 'protect against infection and disease, while inducing population-based immunity to reduce or eliminate virus transmission within the population', ' recent ability to probe the virus-host interface through RNA interference approaches that facilitate the identification of host genes affecting virus replication, immunity, and disease.', 'strategies for at-risk populations, particularly those at either end of the age spectrum', 'a vectored influenza virus vaccine that expresses the HA, NA and M and/or NP proteins for the two currently circulating influenza A subtypes and both influenza B strains so that vaccine take and vaccine antigen levels are not an issue in inducing protective immunity', 'Recombinant live-attenuated or replication-deficient influenza viruses', 'full-length influenza virus proteins, as well as generate conformationally restricted epitopes, features critical in generating appropriate humoral protection.', 'induce immunity at sites of inductive immunity to natural infection, in this case the respiratory tract', 'generate antigen for weeks after immunization, in contrast to subunit vaccination. This increased presence and level of vaccine antigen contributes to and helps sustain a durable memory immune response, even augmenting the selection of higher affinity antibody secreting cells', 'intrinsic augmentation of immunity induced by the vector.', 'HIV-1 replication', 'nucleoplasm and the nucleolus', 'a highly dynamic and structured membrane-less sub-nuclear compartment', 'nucleolus', '49', 'RNA-polymerase-I-directed rDNA transcription, rRNA processing mediated by small nucleolar ribonucleoproteins (soRNPs) and ribosome assembly', 'HIV-1, hCMV, HSV and KSHV', 'B23', 'systematically analysed the nucleolar proteome perturbations occurring in Jurkat T-cells', 'the quantitative changes in the nucleolar proteome of Jurkat T cells constitutively expressing HIV-1 Tat (86aa) versus their Tat-negative counterpart,', 'light (R0K0)', 'heavy (R6K6)', '85 million', '113 kDa', '50 kDa', 'cytoplasmic', 'nuclear', 'The fully annotated list of the quantified nucleolar proteins', 'Jurkat T-cells', '49', 'the first proteomic analysis of dynamic composition of the nucleolus in response to HIV-1 Tat expression', 'mucosal exposure to aerosols or by direct contact of abraded skin with infectious material', 'Old World (OW) and New World (NW)', 'OW Lassa virus (LASV)', 'live attenuated', 'lung epithelial cells are one of the initial cell targets of humans following inhalation of mammarenavirions', '48 h', 'ouabain', 'ATP1A1', 'Combination therapy', 'ATP1A1 and PHB', 'using genetics and pharmacological inhibition of the genes', 'Viruses ', 'Retroviruses ', 'ribozymes or viroids', 'mitochondria, chloroplasts, Rickettsia ', 'ribozymes, catalytic RNAs closely related to viroids', ' catalytically active members, enzymatically active ribozymes. The sequence space for 220-mer RNAs is about 3 × 10 132 (', ' They can polymerize progeny chemically, allow for mutations to occur and can evolve. One molecule serves as catalyst, the other one as substrate. Replication of ribozymes was demonstrated in the test tube (Lincoln and Joyce, 2009) . Ribozymes can form peptide bonds between amino acids (Zhang and Cech, 1997) . Thus, small peptides were available by ribozyme activity. ', 'Replication of RNA molecules can be performed chemically from RNA without polymerase enzymes.', 'deoxyribozymes can form from ribonucleotides (Wilson and Szostak, 1999) . Thus, DNA can arise from RNA chemically, without the key protein enzyme, the reverse transcriptase.', 'circular single-stranded RNAs', 'the genetic triplet code and do not encode proteins', 'structural information by hairpin-loops that form hydrogen bonds between incomplete double strands, and loops free to interact with other molecules.', 'severe joint pain, contorting its victims into unusual postures ', ' fever disease, headache, rash, nausea, vomiting, myalgia, and arthralgia', 'a mosquito-borne emerging pathogen', 'Currently, there is no vaccine or antiviral treatmen', 'With the threat of an emerging global pandemic, the peculiar problems associated with the more immediate and seasonal epidemics warrant the development of an effective vaccine.', 'a mosquito-borne pathogen listed by National Institute of Allergy and Infectious Diseases (NIAID) as a Category C Priority Pathogen that causes Chikungunya fever (CHIKF)', 'an arthropod-borne virus (arbovirus', 'primarily by Aedes aegypti, the infamous yellow fever propagator', 'Kimakonde vernacular language of Tanzania and Mozambique', \"'that which contorts or bends up'\", 'the illness of the bended walker', ' in a sylvatic cycle among forest-dwelling Aedes spp. mosquitoes, wild primates, squirrels, birds, and rodents', ' Ae. aegypti and Ae. albopictus', 'in an urban cycle whereby the mosquito spreads the disease from an infected human to an uninfected human, following an epidemiological pattern similar to dengue fever', 'The 2005-2006 epidemic of CHIKV in La Reunion islands in the Indian Ocean,', '46,000', 'the epidemiology and global expansion of CHIKV', ' its clinical features and pathogenesis and its symptoms and complications, and finally nominates a possible vaccine approach against CHIKV infection.', ' three genotypes based on phylogenetic studies.', 'the gene sequences of an Envelope protein (E1), are Asian, East/Central/ South African, and West African', 'between 50 and 310 y ago,', ' between 100 and 840 y ago', 'has come a long way, with several mutations incorporated, and has continued to wreak epidemics in several regions', ' the Indian epidemic in 2005-2006, which was followed by a sudden explosion of cases in 2007. An estimated 1.3 million people across 13 states were reported to be infected in India [12, 16] , and CHIKV was also widespread in Malaysia, Sri Lanka, and Indonesia [17] . In July-August of 2007, CHIKV was reported in Italy, probably brought in by travelers from CHIKV-prone regions of India, Africa, and Indian Ocean islands such as Mauritius, Madagascar, and Seychelles.', 'from the Kerala isolate, which was associated with a A226V shift in E1 gene that represents a successful evolutionary adaptation in the mosquito vector similar to the ones observed in Reunion Island [', '2-6 d', '4-7 ', 'The first stage is acute, while the second stage, experienced by most but not all, is persistent, causing disabling polyarthritis. Characteristics of the acute phase include an abrupt onset of fever, arthralgia, and in some cases, maculopapular rash [6, 23] . The acute phase causes such intense joint and muscular pain that makes movement very difficult and prostrates its victims [', 'Ninety-five percent of infected adults are symptomatic after infection, and of these, most become disabled for weeks to months as a result of decreased dexterity, loss of mobility, and delayed reaction.', 'The chronic stage of CHIKF is characterized by', ' by polyarthralgia that can last from weeks to years beyond the acute stage', 'fibroblasts', ' The high number of nociceptive nerve endings found within the joints and muscle connective tissues', '50%', '33% ', 'children', 'from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure', 'CHIKV undertakes a complex replication cycle upon host infection (Figure 2 ), which makes its genome susceptible to mutations ', 'CHIKV with an alanine in the 226 position of the E1 gene (E1-A226)', ' in an ecological pressure, favoring replacement of alanine at position 226 with valine (E1-A226V) ', \"CHIKV's secondary vector species, Ae. albopictus, to supplement Ae. aegypti as its primary vector\", ' Ae. albopictus', '34% ', 'All of the CHIKV strains isolated from Mayotte carried the E1-A226V mutation, and the mutation was also found in Madagascar in 2007 [', 'mutation was not present at the beginning of the Indian Ocean Islands outbreak (before September 2005). However, more than 90% of later viral strains found there had incorporated the mutation (December-March 2006), indicating a genotype switch during the winter season', 'an increase in infectivity of Ae. albopictus when compared to its infectivity of Ae. aegypti ', 'Ae. albopictus', ' E1-A226V virus was 100 times more infective to Ae. albopictus than it was to Ae. aegypti', 'Ae. albopictus', 'for over 300 ', 'has been in many areas of the US, since 1985, primarily in Florida [32] and since then has expanded its range in the country.', '50%', 'congenital illness and fetal death', 'During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period (Day 24 to Day +1) [33, 34] , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms.', 'motherto-child transmission most likely happens transplacentally shortly before delivery', 'neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ', ' DNA vaccines could play a major role in combating CHIKV', 'Vaccines are literally a critical component of CHIKV disease control and therefore research in this area is highly encouraged. ', 'as a Category C pathogen alongside the influenza and SARS-CoV viruses ', ' its ability to induce cross-reactive immune responses against the three distinct phylogenetic groups of CHIKV. Also DNA-based vaccines can be produced more rapidly than protein-based vaccines.', 'two', '25.74%', '26', 'less than 50%', 'if HCWs are assured or guaranteed that they and or their families would be taken care of in case of death or while taking care of an EVD case,', 'infectious bronchitis virus (IBV)', 'serum concentration of mannose-binding lectin (MBL)', 'spleen', 'A mechanistic understanding of the impact of bats’ virus hosting capacities, including uniquely constitutive immune pathways, on cellular-scale viral dynamics', ' heightened immune responses limit pathogen-induced cellular morbidity, which can facilitate the establishment of rapidly-propagating persistent infections within-host. Rapidly-transmitting viruses that have evolved with bat immune systems will likely cause enhanced virulence following emergence into secondary hosts with immune systems that diverge from those unique to bats.', 'for their role as reservoir hosts for emerging viral zoonoses, including rabies and related lyssaviruses, Hendra and Nipah henipaviruses, Ebola and Marburg filoviruses, and SARS coronavirus ', 'no obvious disease symptoms upon infection with pathogens that are highly virulent in non-volant mammals (Schountz et al., 2017) but may, instead, support viruses as longterm persistent infections, rather than transient, immunizing pathologies', 'host receptor sequence incompatibilities for some bat-virus combinations (Ng et al., 2015; Takadate et al., 2020) and constitutive expression of the antiviral cytokine', ' the presence of viral RNA or DNA in the cytoplasm of mammalian cells will induce secretion of type I interferon proteins (IFN-a and IFN-b), which promote expression and translation of interferon-stimulated genes (ISGs) in neighboring cells ', 'widespread inflammation and concomitant immunopathology upon viral infection', 'bats support unique adaptations to combat inflammation', 'to mitigate metabolic damage induced during flight', 'to describe the mechanistic underpinnings of long-term patterns of steady-state viral load exhibited by patients in chronic phase infections with HIV, who appeared to produce and clear virus at equivalent rates ', 'bats are natural reservoirs for viruses that have some of the highest fatality rates of any viruses that people acquire from wild animals -including rabies, Ebola and the SARS coronavirus.', 'some bats have an antiviral immune response called the interferon pathway perpetually switched on', ' harmful inflammation', 'Bats, however, have adapted anti-inflammatory traits that protect them from such harm, include the loss of certain genes that normally promote inflammation.', '-the black flying fox -in which the interferon pathway is always on, and another -the Egyptian fruit bat -in which this pathway is only activated during an infection.', ' In both bat species, the strongest antiviral responses were countered by the virus spreading more quickly from cell to cell. This suggests that bat immune defenses may drive the evolution of faster transmitting viruses, and while bats are well protected from the harmful effects of their own prolific viruses, other creatures like humans are not.', 'help scientists develop better ways to predict, prevent or limit the spread of viruses from bats to humans. ', 'demonstrate idiosyncratic induced interferon responses upon viral challenge', 'RoNi/7.1 (Rousettus aegyptiacus) cells', 'PaKiT01 (Pteropus alecto) cell', 'Because plaque assays restrict viral transmission neighbor-to-neighbor in two-dimensional cellular space ', ' For each infection trial, we monitored and re-imaged plates for up to 200 hr of observations or until total monolayer destruction, processed resulting images, and generated a time series of the proportion of infectious-cell occupied plate space across the duration of each trial (see Materials and methods). We used generalized additive models to infer the time course of all cell culture replicates and construct the multi-trial dataset to which we eventually fit our mechanistic transmission model for each cell line-virus-specific combinatio', 'an innovative combination of in vitro experimentation and within-host modeling to explore the impact of unique bat immunity on virus dynamics.', 'that bat cell lines demonstrated a signature of enhanced interferon-mediated immune response, of either constitutive or induced form, which allowed for establishment of rapid within-host, cell-to-cell virus transmission rates ', 'by both data-independent bifurcation analysis of our mean field theoretical model, as well as fitting of this model to viral infection time series established in bat cell culture.', 'the antiviral state induced by the interferon pathway protects live cells from mortality in tissue culture, resulting in in vitro epidemics of extended duration that enhance the probability of establishing a long-term persistent infection.', 'that viruses evolved in bat reservoirs possessing enhanced IFN capabilities could achieve more rapid within-host transmission rates without causing pathology to their hosts. Such rapidly-reproducing viruses would likely generate extreme virulence upon spillover to hosts lacking similar immune capacities to bats.', 'we first developed a novel, within-host, theoretical model elucidating the effects of unique bat immunity, then undertook bifurcation analysis of the model\\'s equilibrium properties under immune absent, induced, and constitutive assumptions. We considered a cell line to be constitutively immune if possessing any number of antiviral cells at disease-free equilibrium but allowed the extent of constitutive immunity to vary across the parameter range for \", the constitutive rate of antiviral acquisition. ', ' invasion threshold is elevated at high values of constitutive antiviral acquisition,', 'Constitutive immune processes can thus prohibit pathogen invasion, while induced responses, by definition, can only control infections post-hoc.', 'Regardless of mechanism (induced or constitutive), interferon-stimulated antiviral cells appear to play a key role in maintaining longer term or persistent infections by safeguarding susceptible cells from rapid infection and concomitant cell death. ', 'that the constitutive IFN-a expression characteristic of P. alecto cells may represent more of a constitutive immune priming process than a perpetual, functional, antiviral defense.', 'enhanced IFN-mediated immune pathways in bat reservoirs may promote elevated within-host virus replication rates prior to cross-species emergence. ', 'general methods to study cross-scale viral dynamics, which suggest that within-host persistence is supported by robust antiviral responses characteristic of bat immune processes. ', ' Viruses which evolve rapid replication rates under these robust antiviral defenses may pose the greatest hazard for cross-species pathogen emergence into spillover hosts with immune systems that differ from those unique to bats. ', 'people 85 years and older', 'person-to-person', '50', 'March 16', 'isolate at home during their illness', 'betacoronavirus', 'MERS-CoV and SARS-CoV.', 'investigation phase, followed by recognition, initiation, and acceleration phases', 'at the end of the acceleration phase', 'People who have serious chronic medical conditions like:\\nHeart disease\\nDiabetes\\nLung disease', 'rRT-PCR test', 'bats', 'Does the patient have recent travel from an affected area?\\nHas the patient been in close contact with someone with COVID-19 or with patients with pneumonia of unknown cause?\\nDoes the patient reside in an area where there has been community spread of COVID-19?', 'severe acute respiratory syndrome coronavirus 2 ', 'December 2019', 'Wuhan, capital of Hubei Province, China', 'daily air travel volume', '≈6 days', ' in 2012 ', 'in Jordan', 'Jeddah, in the Kingdom of Saudi Arabia (KSA)', 'in a bat and in many dromedary camels (DC).', 'across the Arabian Peninsula and in parts of Africa', ' mild upper respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections.', 'remains unknown', 'close and lengthy exposure', 'The KSA ', 'lower respiratory tract (LRT) disease ', 'fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 % to 40 % of those infected. ', ' in mild and influenza-like illnesses and in those with no signs or symptoms.', 'Older males', 'MERS progresses more rapidly to respiratory failure and acute kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in patients with underlying disease and is more often fatal.', 'to lapses in infection prevention and control (IPC) in healthcare settings', ' among healthcare workers (HCWs) and higher exposures in those with occupations that bring them into close contact with camels. ', 'widespread evidence of past infection in adult camels and limited past exposure among humans.', 'An email from Dr Ali Mohamed Zaki, an Egyptian virologist working at the Dr Soliman Fakeeh Hospital in Jeddah in the Kingdom of Saudi Arabia (KSA)', 'on the website of the professional emerging diseases (ProMED) network', '20 th September 2012 ', 'a 60 year old man from Bisha in the KSA', '1,493', 'over a third of the positive people dying (at least 527, 35 %)', 'a virus that had infected over 90 % of adult dromedary camels (DC; Camelus dromedarius) in the KSA [4] , also DCs across the Arabian Peninsula and parts of Africa that are a source of DC imports for the KSA ', ' relatively close and prolonged exposure ', 'The first viral isolate was patented ', ' sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics were quickly described ', 'as exopeptidase dipeptidyl peptidase 4 (DPP4; also called CD26)', 'eliciting a more proinflammatory response than SARS-CoV', 'MERS kills its human host more often than SARS did (20-40 % versus 9 % for SARS ', 'From intermittent animal-to-human spill-over events', 'among older adults, especially males, with pre-existing diseases. ', 'with outbreaks in hospitals, with around 20 % of all cases to date involving healthcare workers (HCWs).', \" the equivalent of a 'common cold' from MERS-CoV infection,\", ' the virus can be a more serious and opportunistic pathogen associated with the death of up to 40 % of reported cases.', ' five to six days, ranging from two to 16 days', '13 to 14 days', '11 to 13 days', 'Fever and gastrointestinal symptoms may form a prodrome, after which symptoms decline, only to be followed by a more severe systemic and respiratory syndrome ', 'a confirmed case included any person whose sample was RT-PCR positive for MERS-CoV, or who produced a seroconversion, irrespective of clinical signs and symptoms.', ' 79 % ', 'its impact among older men with comorbid diseases including diabetes mellitus, cirrhosis and various lung, renal and cardiac conditions ', 'fever, cough and upper respiratory tract (URT) signs and symptoms usually occur first, followed within a week by progressive LRT distress and lymphopaenia', ' pneumonia', 'acute respiratory distress syndrome and multiorgan system failure', ' 35 % ', '42 %', 'ranged from 7 % among younger age groups to 40 % among those aged 60 years and above', ' PCR-based techniques ', 'The first open reading frames ', ' less than 80 % identity between the amino acid sequence of MERS ORF 1ab and betacoronavirus relatives, Tylonycteris bat HKU4 and Pipistrellus bat HKU5', ' Detection of viral proteins rather than viral RNA', '94 %', '100 % ', 'monoclonal antibody-based capture ELISA targeting the MERS-CoV nucleocapsid protein', ' to detect a viral footprint, in the form of antibodies', ' by creating transfected cells expressing recombinant portions of the MERS-CoV nucleocapsid and spike proteins [', 'using a recombinant lentivirus expressing MERS-CoV spike protein and luciferase', 'by confirmatory IFA and/ or a plaque-reduction neutralization (PRNT) [69, 70, 85] or MNT test.', 'the antibodies detected are able to specifically neutralize the intended virus and are not more broadly reactive to other coronaviruses found in DCs (bovine CoV, BCoV) or humans (HCoV-OC43, HCoV-229E, HCoV-NL63, HCoV-HKU1, SARS-CoV).', 'if only mild disease or asymptomatic infection results', ' when sample collection is delayed by a week or more after onset of symptoms', 'are recommended when URT sampling is to be conducted', ' an oropharyngeal and throat swab or a nasopharyngeal aspirate/wash', ' collected two to three weeks apart', 'Human urine and stool have been found to contain MERS-CoV RNA', '12 to 26 days after symptom onset ', ' long periods of viral shedding, sometimes intermittently and not necessarily linked to the presence of disease symptoms.', 'Over three quarters of', 'at least 30 days', '30 %', ' the proportion of deaths among those infected with MERS-CoV is much higher than that known for the HCoVs NL63, HKU1, 229E or', ' nasopharyngeal aspirates', 'URT sample', 'bronchoalveolar lavage', ' is much higher than that known for the HCoVs NL63, HKU1, 229E or OC43', ' above that for SARS-CoV', 'the low transmission rate', 'animal MERS-CoV infections', 'virus or viral RNA', 'seropositive and RNA or virus negative', 't', 'due to new infections among naïve DC populations', 'slaughterhouse workers who kill both younger and older DCs', ' up to 48 h', 'up to 48 h', 'pasteurization', 'for 24 h', ' for 45 min', '4 m', 'Droplet spread between humans', 'sporadic ', 'intra-familial,', 'often healthcare associated', 'inefficient ', 'requiring close and prolonged contact', 'readily transmit to more than one other human', 'readily transmit to more than one other human ', 'the average number of infections caused by one infected individual in a fully susceptible population', 'close to one', 'due to ongoing, sporadic spill-over events from DCs amplified by poorly controlled hospital outbreaks.\\n', 'acute LRT disease', 'in a healthcare setting in Jordan', '21 %', '21 %', '16 %', 'using high throughput or \"deep\" sequencing methods for complete genome deduction', 'only human-derived MERS-CoV genomes', 'the majority of human and camel genomes deduced thus far', 'has had more MERS cases than any other region of the KSA', 'Riyadh', ' Riyadh', 'from infected to uninfected humans in close and prolonged contact ', 'by poor infection control in health care settings', ' nearly 40 %', 'Global alignment of case definitions', 'MERS-CoV has a broader tropism, grows more rapidly in vitro, more rapidly induces cytopathogenic change, triggers distinct transcriptional responses, makes use of a different receptor, induces a more proinflammatory state and has a delayed innate antiviral response compared to SARS-CoV.\\n', 'There is no evidence that MERS-CoV is a virus of pandemic concern', 'based on the presence of febrile illness, cough and requirement for hospitalization with suspicion of lower respiratory tract (LRT) involvement.', \"Public Health Emergency of International Concern'\", 'an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response', 'Global Initiative on Sharing All Influenza Data (GISAID)', 'The equipment in the contaminated area are wiped with\\n2000mg/L chlorine-containing disinfectant. The DR and CT gantry in the contaminated\\narea are wiped with 75% ethanol. The equipment in the buffer area is wiped with\\n500-1000mg/L chlorine-containing disinfectant or alcohol-containing disposable\\ndisinfectant wipes twice a day.', 'The ground is wiped with 1000mg/L chlorine-containing\\ndisinfectant, once /4 hours.', 'diagnosing and categorizing\\nCOVID-19 on the basis of case definitions issued by the WHO', 'N95 mask', '1 mm-thick layers', 'up-to-date case definitions and information about\\nconfirmatory tests to all staff with direct patient contact to allow appropriate barrier precautions\\nto be taken.', 'All typical and atypical imaging features of the disease should be made known to\\nall radiologists', 'to understand the\\nextent and dynamic evolution of lung lesions induced by COVID-19', ' low-dose chest CT has been\\nwidely used in the screening of early lung cancer. It is well known that many early lung cancers\\nare ground-glass opacities (GGO), so we believe that low-dose screening is also applicable for\\nCOVID-19. In addition, considering the rapid development of COVID-19, many CT\\n14\\nexaminations may be conducted in the same individual to monitor disease progress. Low-dose\\nscanning can reduce the radiation damage to patients.', ' (1) coordination between the\\nhospital’s management and planning of infection control and radiology departments; (2)\\ncollection of the most up-to-date protection-related information to educate and train staff in the\\ndepartment; (3) reallocation of staff according to the actual situation; (4) establishment of the\\nCT procedures for patients with COVID-19; and (5) establishment of an emergency\\nmanagement plan for the radiology department to ensure that the department would run\\nnormally.', 'contaminated, semicontaminated,\\nbuffer, and clean areas', 'connected to the fever clinic and\\nincludes the fever accessway, the CT examination room, and the DR examination room for\\n6\\nconfirmed and suspected cases. One CT scanner and one DR system closest to the emergency\\ndepartment are designated the fever-CT and fever-DR to examine patients with suspected and\\nconfirmed COVID-19. There is a separate dedicated access between the contaminated area and\\nthe fever screening tents. ', 'he clean area\\nincludes the administrative office and the diagnostic room.', ' the fever-CT control room,\\nfever-DR control room, and other patient examination access areas. ', 'access areas for medical personnel and a dressing area for technologists. ', 'under the supervision of\\nthe infection control nurse.', ' periodically taking time off ', 'Pregnant staff ', 'data gathering, collaboration, needs assessment, and expert advice ', 'Strategic planning and adequate protections can help protect patients and staff\\nagainst a highly infectious disease while maintaining function at a high volume capacity.\\nKeywords: Coronavirus, COVID-19, novel coronavirus pneumonia, infection control', '80,793 ', '3,169 ', '677,243 people have been identified as having had close contact with\\ninfected patients of whom13,701 ', 'December 2019', 'February 2013', '288', 'The novel coronavirus (2019-nCoV) infection caused pneumonia. ', 'the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). ', 'all of the 6 patients with detectable viral RNA in the blood cohort progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity (p-value = 0.0001). Meanwhile, 8 of the 11 patients with annal swab virus-positive was in severe clinical stage.', 'Patients who were with at least one of the following symptom should be diagnosed to be severe case, 1) distress of respiratory with respiratory rate > = 30/min; 2) Oxygen saturation < = 93% in the rest state, and 3) arterial oxygen tension (PaO₂) over inspiratory oxygen fraction (FIO₂) of less than 300 mm Hg. In the blood detection cohort (Figure 1 (A)), patients who had at less one serum sample measurement with the PCR method were included. ', ' In the 57, 6 cases were detected to be blood positive, all of them (100%) were severe in symptom requiring special care attention, and the blood of the rest 51 cases was without detectable virus in the blood, only 12 of them (23.5%) were severe cases.', 'presence of viral RNA outside of the respiratory tract might herald the severity of the disease and alarm the requirement of special care', 'In the anal swab cohort (Figure 1 (B)), 11 of 28 cases were detected to be anal swab positive, 8 of them (72.7%) were with severe symptoms, which was significantly higher than that 4 (23.5%) of the rest 17 cases without detectable virus in anal were severe cases', 'digestive tract might be one extrapulmonary site for virus replication', 'Intensive structural analysis of the S protein of 2019-nCoV with the SARS-Coronavirus suggested that several critical residues in the viral spike protein might confer favourable interaction with human ACE2 [7] . Of note, ACE2 is also abundantly present in humans in the epithelia of the small intestine besides the respiratory tract and is ubiquitously present in endothelial cells [8] , which might provide possible routes of transmission, and might account for the high transmission capacity of the new virus. ', 'We propose that rampant coronavirus replication in pulmonary alveolus results in the breakdown of the alveolar vessel and the subsequent virus leakage into the blood flow, through which the virus is disseminated across the whole body. Then the virus succeeds in establishing reinfection in the digestive tract by using the highly expressed ACE2 receptor, which exacerbated the disease vice versa', '8 August 2014', 'Personal Protective Equipment', 'neighbouring sub-Saharan countries, North America, and Europe', 'connectedness between health professionals, technological devices, and knowledge', 'large, non-segmented, positive sense and single stranded RNA animal viruses', 'a Bats-Hosts-Reservoir-People transmission network model for simulating the potential transmission from the infection source (probably be bats) to the human infection. ', 'Reservoir-People (RP) transmission network model', 'The value of R 0 was estimated of 2.30 from reservoir to person and 3.58 from person to person which means that the expected number of secondary infections that result from introducing a single infected individual into an otherwise susceptible population was 3.5', 'Our model showed that the transmissibility of SARS-CoV-2 was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than MERS in the Republic of Korea.', 'Huanan Seafood Wholesale Market (reservoir) to people,', 'the virus transmitted among the bats, and then transmitted to unknown hosts (probably some wild animals). The hosts were hunted and sent to the seafood market which was defined as the reservoir of the virus. People exposed to the market got the risks of the infection ', 'susceptible bats (S B ), exposed bats (E B ), infected bats (I B ), and removed bats (R B ).', 'The hosts were also divided into four compartments: susceptible hosts (S H ), exposed hosts (E H ), infected hosts (I H ), and removed hosts (R H )', 'the seafood market', ' into five compartments:\\n\\nsusceptible people (S P ), exposed people (E P ), symptomatic infected people (I P ), asymptomatic infected people (A P ), and removed people (R P ) including recovered and death people.', '5.2 days (95% confidence interval [CI]: 4.1-7.0) ', ' 5-day', ' from 3 to 7 days', 'a mean of 5.8 days (95% CI: 4.3-7.5)', '0.5 times that of symptomatic infection (κ = 0.5), which was the similar value as influenza ', ' 0.3 million people', 'about 2.87 million', '2.7-3.4 or 2-4 in Hong Kong', 'R 0 of SARS was about 2.1 in Hong Kong, China, 2.7 in Singapore, and 3.8 in Beijing, China', '0.8-1.3 ', ' 2.5-7.2', ' to decrease R 0', ' the transmissibility of SARS-CoV-2 might be higher than MERS in the Middle East countries, similar to SARS, but lower than MERS in the Republic of Korea.', 'provide a mathematical model for calculating the transmissibility of SARS-CoV-2', 's are spherical, enveloped, and the largest of positive-strand RNA v', 'uding birds, farm animals, pets, camels, an', '199', '2 to 4 February 2020,', '102 and 47 cases, respectively.', 'case was diagnosed on 1 February, the ship was requested to remain in the ocean near Yokohama from 3 February onwards.', 'he case was diagnosed on 1 February', 'Out of a total of 3711 persons (consisting of 2666 passengers and 1045 crew members), 199 symptomatic cases have been diagnosed on board as of 24 February, and additional asymptomatic infections and symptomatic cases after disembarkation have also been reported', 'about 5.0 days', 'highly successful in greatly reducing the number of secondary transmissions on board.', ' the cumulative incidence with and without close contact would have been as large as 1373 (95% CI: 570, 2176) and 766 (95% CI: 587, 946) cases,', '31 December 2019,', ' 63.1 million per year in 2017 ', '2.1%', 'prevents cleavage of viral proteins required for replication', 'in studies of natural infection, it did not significantly affect viral loads or symptom severity', 'viral', 'respiratory syncytial virus', 'human rhinovirus', 'HRVs, coronaviruses (CoV), influenza, respiratory syncytial virus (RSV) and parainfluenza viruses (PIV)', 'chronic airway inflammation, and a history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough', 'morbid obesity', 'two', 'haemagglutinin (HA) and the neuraminidase (NA) ', 'oseltamivir', 'H275Y', 'difficulty with aerosol delivery, cost and potential harm to healthcare workers', ' lack of awareness or recall bias', ' it has direct implications for public health and hospital infection control', '10 days after illness onset [7] , consistent with the peak in viral load at around that time', ' from person to person,', '2.2', ' 7.5 days', 'slightly lower basic reproductive number.', 'Control measures and changes in population behaviou', ' around 5–6 days, with an upper limit of around 11-14 days [2,5], and delays from illness onset to laboratory confirmation added a further 10 days on average', '75,000', 'on the day of illness onse', 'through large respiratory droplets, ', ' through fine particle aerosols', 'indirect transmission via fomites', ' faecal-oral transmission ', 'through pressure differentials between contaminated effluent pipes, bathroom floor drains and flushing toilets ', 'through a surveillance system for pneumonia of unknown aetiology', 'that there could be many more mild infections than severe infections', 'because it determines the strength of public health response required.', ' to determine high risk groups.', 'older adults, obese individuals or those with underlying medical conditions,', 'when not all exacerbation events occurred during the viral infection but may also occur well after viral clearance (Kim et al., 2008; Stolz et al., 2019) in particular the late onset of a bacterial infection', 'that viral infection increases airway inflammation which aggravates disease symptoms.', 'Recent advances in in vitro air-liquid interface 3D cultures, organoid cultures and the use of novel human and animal challenge models', 'Respiratory virus infection', ' recent novel findings that elucidate how respiratory viral infections alter the epithelial barrier in the airways, the upper airway microbial environment, epigenetic modifications including miRNA modulation, and other changes in immune responses throughout the upper and lower airways.', 'the prevalence of different respiratory viral infections in causing exacerbations in chronic airway inflammatory diseases.', 'how recent models have expanded our appreciation of the mechanisms of viral-induced exacerbations.', 'the importance of the virome within the airway microbiome environment and its impact on subsequent bacterial infection.', 'the understanding of viral induced exacerbation in chronic airway inflammatory diseases and indicates pathways that may be targeted for more effective management of chronic inflammatory diseases.', ' airway inflammation leading to complications such as coughing, wheezing and shortness of breath. ', ' in both the upper airway (such as chronic rhinosinusitis, CRS) and lower airway (such as asthma and chronic obstructive pulmonary disease, COPD)', 'due to the complexity and heterogeneity of the disease.', 'the effect of episodic exacerbations of the disease, defined as worsening of disease symptoms including wheeze, cough, breathlessness and chest tightness ', 'the effect of enhanced acute airway inflammation impacting upon and worsening the symptoms of the existing disease', 'morbidity and sometimes mortality in patients, as well as resulting in major economic burdens worldwide', 'the presence of environmental factors such as allergens, pollutants, smoke, cold or dry air and pathogenic microbes in the airway', ' infiltration of activated immune cells that further release inflammatory mediators that cause acute symptoms such as increased mucus production, cough, wheeze and shortness of breath. ', 'viral infection is one of the major drivers of asthma exacerbations accounting for up to 80-90% and 45-80% of exacerbations in children and adults respectively', '30-80% of acute COPD exacerbations', 'their ease of transmission and infection', ' important to identify the exact mechanisms underpinning viral exacerbations in susceptible subjects', ' to properly manage exacerbations via supplementary treatments that may alleviate the exacerbation symptoms or prevent severe exacerbations.', 'dysregulated inflammation in most chronic airway inflammatory diseases', 'the upper airway', ' recent findings of viral interaction with the upper airway.', 'how viral induced changes to the upper airway may contribute to chronic airway inflammatory disease exacerbations, to provide a unified elucidation of the potential exacerbation mechanisms initiated from predominantly upper airway infections.', 'Despite being a major cause of exacerbation, reports linking respiratory viruses to acute exacerbations only start to emerge in the late 1950s (Pattemore et al., 1992) ; with bacterial infections previously considered as the likely culprit for acute exacerbation ', ' viruses were recovered during acute exacerbations events and reports implicating their role emerged in the late 1980s', 'Rhinovirus (RV) and respiratory syncytial virus (RSV) ', 'parainfluenza virus (PIV), influenza virus (IFV) and adenovirus (AdV)', ' viruses including bocavirus (BoV), human metapneumovirus (HMPV), certain coronavirus (CoV) strains, a specific enterovirus (EV) strain EV-D68, human cytomegalovirus (hCMV) and herpes simplex virus (HSV)', 'they can infect both the upper and/or lower airway, further increasing the inflammatory conditions in the diseased airway', 'within airway epithelial cells ', 'the cells release antiviral factors and cytokines that alter local airway inflammation and airway niche ', 'leads to type 1 inflammatory responses consisting of activation of an antiviral state and infiltration of antiviral effector cells. This eventually results in the resolution of the inflammatory response and clearance of the viral infection ', ' the responses against the virus may be impaired or aberrant, causing sustained inflammation and erroneous infiltration, resulting in the exacerbation of their symptoms (Mallia and Johnston, 2006; Dougherty and Fahy, 2009; Busse et al., 2010; Britto et al., 2017; Linden et al., 2019) . This is usually further compounded by the increased susceptibility of chronic airway inflammatory disease patients toward viral respiratory infections, thereby increasing the frequency of exacerbation as a whole', 'compiling and collating the current known mechanisms of viral-induced exacerbation of chronic airway inflammatory diseases; as well as linking the different viral infection pathogenesis to elucidate other potential ways the infection can exacerbate the disease', 'to provide further understanding of viral induced exacerbation to identify potential pathways and pathogenesis mechanisms that may be targeted as supplementary care for management and prevention of exacerbation.', 'due to the current scarcity of antiviral drugs for the management of viral-induced exacerbations.', 'viruses evoke an inflammatory response as a means of counteracting the infection.', 'Generally, infected airway epithelial cells release type I (IFNα/β) and type III (IFNλ) interferons, cytokines and chemokines such as IL-6, IL-8, IL-12, RANTES, macrophage inflammatory protein 1α (MIP-1α) and monocyte chemotactic protein 1 (MCP-1) (Wark and Gibson, 2006; Matsukura et al., 2013) .', 'enable infiltration of innate immune cells and of professional antigen presenting cells (APCs) that will then in turn release specific mediators to facilitate viral targeting and clearance, including type II interferon (IFNγ), IL-2, IL-4, IL-5, IL-9, and IL-12 (Wark and Gibson, 2006; Singh et al., 2010; Braciale et al., 2012) .', 'These factors heighten local inflammation and the infiltration of granulocytes, T-cells and B-cells (Wark and Gibson, 2006; Braciale et al., 2012) . The increased inflammation, in turn, worsens the symptoms of airway diseases.', 'viral infections such as RV and RSV promote a Type 2-biased immune response (Becker, 2006; Jackson et al., 2014; Jurak et al., 2018) . This amplifies the basal type 2 inflammation resulting in a greater release of IL-4, IL-5, IL-13, RANTES and eotaxin and a further increase in eosinophilia, a key pathological driver of asthma and CRSwNP', 'worsens the classical symptoms of disease and may further lead to life-threatening conditions due to breathing difficulties', 'are more neutrophilic in nature due to the expression of neutrophil chemoattractants such as CXCL9, CXCL10, and CXCL11 (Cukic et al., 2012; Brightling and Greening, 2019) . The pathology of these airway diseases is characterized by airway remodeling due to the presence of remodeling factors such as matrix metalloproteinases (MMPs) released from infiltrating neutrophils (Linden et al., 2019) . Viral infections in such conditions will then cause increase neutrophilic activation; worsening the symptoms and airway remodeling in the airway thereby exacerbating COPD, CRSsNP and even CRSwNP in certain cases ', ' IL-25, IL-33 and TSLP ', ' ILC2s are a group of lymphoid cells', 'induce the expression of IL-25, IL-33 and TSLP, with heighten expression in an inflamed airway', 'These 3 cytokines then work in concert to activate ILC2s to further secrete type 2 cytokines IL-4, IL-5, and IL-13 which further aggravate the type 2 inflammation in the airway causing acute exacerbation (', ' increased ILC2 activation, which retain the capability of differentiating to ILC1, may also further augment the neutrophilic response and further aggravate the exacerbation', ' these factors are not released to any great extent and do not activate an ILC2 response during viral infection in healthy individuals (Yan et al., 2016; Tan et al., 2018a) ; despite augmenting a type 2 exacerbation in chronically inflamed airways (Jurak et al., 2018) . These classical mechanisms of viral induced acute exacerbations are summarized in Figure 1 ', 'antiviral state will be activated to clear the invading pathogen from the airway. Immune response and injury factors released from the infected epithelium normally would induce a rapid type 1 immunity that facilitates viral clearance. ', ' However, in the inflamed airway, the cytokines and chemokines released instead augmented the inflammation present in the chronically inflamed airway, strengthening the neutrophilic infiltration in COPD airway, and eosinophilic infiltration in the asthmatic airway. The effect is also further compounded by the participation of Th1 and ILC1 cells in the COPD airway; and Th2 and ILC2 cells in the asthmatic airway.', 'the synergistic effect of viral infection with other sensitizing agents ', 'he nasal epithelium remains the primary site of most infections.', 'a more complex interplay between the virus and upper airway epithelium which synergize with the local airway environment in line with the \"united airway\" hypothesis ', 'viral infections or their components persist in patients', 'may further alter the local environment and contribute to current and future exacerbations', 'to determine the contribution of the microbiome and mycobiome to viral infections.', ' recent data regarding viral interactions with the airway epithelium that could also contribute to, or further aggravate, acute exacerbations of chronic airway inflammatory diseases.', 'Patients with chronic airway inflammatory diseases ', 'a type 2-skewed inflammatory response which deprives the airway of important type 1 responsive CD8 cells that are responsible for the complete clearance of virusinfected cells ', 'in weak type 1 inflammation-inducing viruses such as RV and RSV', 'there are also evidence of reduced type I (IFNβ) and III (IFNλ) interferon production due to type 2-skewed inflammation, which contributes to imperfect clearance of the virus resulting in persistence of viral components, or the live virus in the airway epithelium ', 'antiviral genes such as type I interferons, inflammasome activating factors and cytokines remained activated resulting in prolong airway inflammation', 'enhance granulocyte infiltration thus prolonging the exacerbation symptoms. Such persistent inflammation may also be found within DNA viruses such as AdV, hCMV and HSV, whose infections generally persist longer (Imperiale and Jiang, 2015) , further contributing to chronic activation of inflammation when they infect the airway', 'human papilloma virus (HPV), a DNA virus highly associated with head and neck cancers and respiratory papillomatosis,', ' the role of HPV infection in causing chronic inflammation in the airway and their association to exacerbations of chronic airway inflammatory diseases, which is scarcely explored', 'viral persistence which lead to continuous expression of antiviral genes may also lead to the development of steroid resistance, which is seen with RV, RSV, and PIV infection', 'may also cause the virus to linger longer in the airway due to the lack of antiviral clearance', 'The concomitant development of steroid resistance together with recurring or prolong viral infection ', 'viruses that induce strong type 1 inflammation and cell death such as IFV (Yan et al., 2016; Guibas et al., 2018) and certain CoV (including the recently emerged COVID-19 virus)', 'massive damage and cell death to the epithelial barrier, so much so that areas of the epithelium may be completely absent post infection (Yan et al., 2016; Tan et al., 2019) . Factors such as RANTES and CXCL10, which recruit immune cells to induce apoptosis, are strongly induced from IFV infected epithelium ', ' further compounds the cell deaths in IFV infected epithelium . The massive cell death induced may result in worsening of the acute exacerbation due to the release of their cellular content into the airway, further evoking an inflammatory response in the airway ', ' further contact with other pathogens and allergens in the airway which may then prolong exacerbations or results in new exacerbations.', 'may also promote further epithelial remodeling during its regeneration as viral infection induces the expression of remodeling genes such as MMPs and growth factors . Infections that cause massive destruction of the epithelium, such as IFV, usually result in severe acute exacerbations with non-classical symptoms of chronic airway inflammatory diseases.', ' receive their annual influenza vaccination as the best means to prevent severe IFV induced exacerbation.', 'the induction of vasodilation or tight junction opening factors which may increase the rate of infiltration. ', 'disruption of tight junctions with the resulting increased rate of viral infiltration. This also increases the chances of allergens coming into contact with airway immune cells.', ' IFV infection was found to induce oncostatin M (OSM) which causes tight junction opening (Pothoven et al., 2015; Tian et al., 2018) . Similarly, RV and RSV infections usually cause tight junction opening which may also increase the infiltration rate of eosinophils and thus worsening of the classical symptoms of chronic airway inflammatory diseases ', ' the expression of vasodilating factors and fluid homeostatic factors such as angiopoietin-like 4 (ANGPTL4) and bactericidal/permeabilityincreasing fold-containing family member A1 (BPIFA1)', 'the relationship between asthma and COPD exacerbations and their association with the airway microbiome.', 'specific bacterial species in the microbiome which may thrive in the inflamed airway environment ', ' the effect induced by the virus may destabilize the equilibrium of the microbiome present (Molyneaux et al., 2013; Kloepfer et al., 2014; Kloepfer et al., 2017; Jubinville et al., 2018; van Rijn et al., 2019) . In addition, viral infection may disrupt biofilm colonies in the upper airway (e.g., Streptococcus pneumoniae) microbiome to be release into the lower airway and worsening the inflammation', 'the nutrient profile in the airway through release of previously inaccessible nutrients that will alter bacterial growth', ' impaired bacterial immune response, either from direct viral influences, or use of corticosteroids to suppress the exacerbation symptoms', 'more far reaching effect when normal flora is replaced with opportunistic pathogens, altering the inflammatory profiles ', 'due to the interplay between virus and pathogenic bacteria in exacerbating chronic airway inflammatory diseases ', ' have shown efficacy in the treatments of irritable bowel syndrome by restoring the intestinal microbiome (', 'the disruption of mucociliary function, an important component of the epithelial barrier. ', 'The upper airway epithelium', 'serves to increase contact between environmental triggers with the lower airway and resident immune cells.', 'oxidative stress which will further increase the local inflammation in the airway. ', 'modulation of miRNAs and epigenetic modification such as DNA methylation and histone modifications that promote dysregulation in inflammation', 'growth of pathogenic bacteria that may replace the airway microbiome. ', 'inflammation and alteration of the lower airway environment, resulting in prolong exacerbation episodes following viral infection. ', 'RV, RSV, and IFV', ' to directly destroy the cilia of the ciliated cells and almost all respiratory viruses infect the ciliated cells', ' disrupt the equilibrium of the mucociliary function following viral infection, resulting in symptoms of acute exacerbation', 'MicroRNAs (miRNAs)', 'short non-coding RNAs involved in post-transcriptional modulation of biological processes, and implicated in a number of diseases ', ' viral infections and may play a role in the modulation of antiviral responses and inflammation ', 'circulating miRNA changes', 'from the infected epithelium and responding immune cells, which may serve to further dysregulate airway inflammation leading to exacerbations.', ' to increase miR-21 and augmented inflammation in experimental murine asthma models, which is reversed with a combination treatment of anti-miR-21 and corticosteroids', ' increase miR-125a and b, and miR-132 in COPD epithelium which inhibits A20 and MAVS; and p300 and IRF3, respectively, resulting in increased susceptibility to viral infections ', 'miR-22 was shown to be suppressed in asthmatic epithelium in IFV infection which lead to aberrant epithelial response, contributing to exacerbations ', 'as targets to modulate viral induced airway changes as a means of managing exacerbation of chronic airway inflammatory diseases.', 'epigenetic modification such as DNA methylation ', 'the association of epigenetic modification and chronic airway inflammatory diseases, and that the nasal methylome was shown to be a sensitive marker for airway inflammatory changes (Cardenas et al., 2019; Gomez, 2019) .', ' viral infections such as RV and RSV alters DNA methylation and histone modifications in the airway epithelium which may alter inflammatory responses, driving chronic airway inflammatory diseases and exacerbations', 'that antiviral factors such as IFNγ epigenetically modifies the viral resistance of epithelial cells.', ' an altered inflammatory state contributing to further viral persistence and exacerbation of chronic airway inflammatory diseases ', ' enhanced production of reactive oxygen species (ROS), oxidative stress and mitochondrial dysfunction in the airway epithelium ', 'state of constant oxidative stress ', 'may trigger the further production of ROS as an antiviral mechanism', ' infiltrating cells in response to the infection such as neutrophils will also trigger respiratory burst as a means of increasing the ROS in the infected region. The increased ROS and oxidative stress in the local environment may serve as a trigger to promote inflammation thereby aggravating the inflammation in the airway ', ' also may alter the management of the disease or confer resistance toward treatments that worked before. ', 'important information regarding viral pathogenesis and changes induced within the airway of chronic airway inflammatory disease patients to identify novel targets and pathway for improved management of the disease.', ' epithelial cell models such as the air-liquid interface, in vitro airway epithelial model that has been adapted to studying viral infection and the changes it induced in the airway ', 'to identify systemic mechanisms of acute exacerbation', ' the humanized mouse model that possess human immune cells ', 'the best mode of verification of the associations of the virus with the proposed mechanism of viral induced acute exacerbations ', ' due to the complex interactions between the host and the exacerbation agents', 'hemorrhagic fever with renal syndrome', 'enveloped, negative-sense RNA virus', 'rodents', 'plasma viral load', 'an antiviral medicine', 'rs12252 C allele and CC genotype', 'IFITM1, 2, and 3', 'restrict viral infection at the stage of cellular entry', 'rs12252 C allele', 'significant impact\\nof interventions implemented several weeks earlier.', '11th March', '59,000 deaths', 'case isolation, the closure of schools and\\nuniversities, banning of mass gatherings and/or public events, and most recently, widescale social\\ndistancing including local and national Iockdowns', 'semi-mechanistic Bayesian hierarchical model', 'calculating backwards from the deaths observed over time to estimate transmission that\\noccurred several weeks prior, allowing for the time lag between infection and death.', 'each intervention has the same effect on the\\nreproduction number across countries and over time', '2-3 weeks', 'reduce the effective reproduction number', 'infections will increase (dependent on how much greater than 1 the reproduction number is)', '23rd January', 'downward trend in the number of\\nconfirmed new cases during February', 'banning large gatherings and advising individuals not to socialize outside\\ntheir households', 'from\\naround 2-4 during the uncontrolled epidemic down to below 1', 'high proportion of\\ninfections not detected by health systems”7 and regular changes in testing policies,', 'back-calculate infections from\\nobserved deaths', '9.8% [3.2%-25%] of the population', '15.0% (7.0 [18-19] million people)', 'Germany', '1.1% [0.36%-3.1%]', '3.7% [1.3%-9.7%]', '1.1% [0.40%-3.1%]', '3.0% [1.1%-7.4%]', '0.72% [0.28%-1.8%]', '9.8% [3.2%-26%]', '0.41% [0.09%-1.2%]', '15% [3.7%-41%]', '3.1% [0.85%-8.4%]', '3.2% [1.3%-7.6%]', '2.7% [1.2%-5.4%]', '3.87 [3.01-4.66]', 'too early to detect substantial\\nintervention impact in many countries at earlier stages of their epidemic', 'close spacing of interventions in time', ' number of daily infections', 'fit a counterfactual model without the interventions\\nand compare this to the actual model', 'banned gatherings of more than 2 people', 'underreporting as well as systematic and country-specific changes in testing', 'strong recommendations or laws to the general\\npublic and primary care about self—isolation when showing COVID-19-like symptoms', 'isolation if travelling back from an epidemic country', 'banning all public events of more than 100 participants', 'work from home wherever possible', 'reducing use ofpublictransport', 'regulations/legislations regarding strict face-to-face social interaction', 'time from infection to the onset\\nof symptoms', 'time from the onset of symptoms to death', 'adjusted for the age structure and contact patterns of\\neach country', ' initial reproduction number before interventions and the effect sizes from\\ninterventions', 'infection to onset of symptoms', 'infection-\\nto-onset', 'Gamma distributed with a mean of 18.8 days and a\\ncoefficient of va riation 0.45', 'distribution is Gamma distributed with mean 5.1 days and coefficient of variation\\n0.86', '23.9 days', 'discrete renewal process', 'reproductive number', 'herd immunity', 'cumulatively, 5.9 [1.9-15.2] million people have been\\ninfected as of March 28th', '10.8%', 'phase 6', 'spread in more than two continents', 'estimated at $30-$100 billion', '2019-nCoV was transmitted through respiratory tract and then induced pneumonia,', 'We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral–fecal route.', 'the current strategy for the detection of viral RNA in oral swabs used for 2019-nCoV diagnosis is not perfect. The virus may be present in anal swabs or blood of patients when oral swabs detection negative.', ' patients infected with 2019-nCoV may harbour the virus in the intestine at the early or late stage of disease. It is also worth to note none of the patients with viremia blood had positive swabs. These patients would likely be considered as 2019-nCoV negative through routine surveillance, and thus pose a threat to other people.', 'serology should be considered for 2019-nCoV epidemiology.', 'we cannot discharge a patient purely based on oral swabs negative, who may still shed the virus by oral-fecal route. Above all, we strongly suggest using viral IgM and IgG serological test to confirm an infection, considering the unreliable results from oral swabs detection', 'zoonotic diseases', 'long noncoding RNAs (lncRNAs)', 'colocalized after HTNV infection', 'the first study to describe the role of NEAT1 in HTNV infection', 'Of the remaining 29, 20 reported fever, 14 reported cough and eight reported weakness. Additional symptoms reported included headaches (6 cases), sore throat (2), rhinorrhoea (2), shortness of breath (2), myalgia (1), diarrhoea (1) and nausea (1)', 'demographics, history of recent travel to affected areas, close contact with a probable or confirmed COVID-19 case, underlying conditions, signs and symptoms of disease at onset, type of specimens from which the virus was detected, and clinical outcome. ', '27 January 2020', '47', '21 were linked to two clusters in Germany and France, 14 were infected in China', '42 years', ' 25 ', '4,250 ', '12 January 2020', 'coronavirus disease 2019 (COVID -19)', 'United Kingdom (UK)', 'a comparison between cases detected among travellers from China and cases whose infection was acquired due to subsequent local transmission.', ' to complete a WHO standard COVID-19 case report form for all confirmed and probable cases according to WHO criteria', ' to support the global strategy of containment of COVID-19 with rapid identification and follow-up of cases linked to affected countries in order to minimise onward transmission.', 'to: describe the key epidemiological and clinical characteristics of COVID-19 cases detected in Europe; inform country preparedness; and improve further case detection and management. ', 'a confirmed case was a person with laboratory confirmation of SARS-CoV-2 infection (ECDC recommended two separate SARS-CoV-2 RT-PCR tests), irrespective of clinical signs and symptoms, whereas a probable case was a suspect case for whom testing for SARS-CoV-2 was inconclusive or positive using a pan-coronavirus assay', '15 February', ' up to 14 days [', ' 35 cases (missing for three cases), of whom 14 were infected in China (Hubei province: 10 cases; Shandong province: one case; province not reported for three cases). The remaining 21 cases were infected in Europe. ', '14 were linked to a cluster in Bavaria, Germany, and seven to a cluster in Haute-Savoie, France ', 'All but two cases were hospitalised (35 of 37 where information on hospitalisation was reported)', ' it is likely that most were hospitalised to isolate the person rather than because of severe disease. ', 'ranged between 0 and 10 days with a mean of 3.7 days ', 'The mean number of days to hospitalisation was 2.5 days for cases imported from China, but 4.6 days for those infected in Europe.', 'This was mostly a result of delays in identifying the index cases of the two clusters in France and Germany. In the German cluster, for example, the first three cases detected locally were hospitalised in a mean of 5.7 days, whereas the following six took only a mean of 2 days to be hospitalised.', ' 31 cases', 'Two cases ', 'as part of screening following repatriation and during contact tracing respectively. ', ' nine cases', 'In 16 of 29 symptomatic cases', 'seven cases', 'five', 'one was reported to be obese and one had pre-existing cardiac disease. No data on clinical signs e.g. dyspnea etc. were reported for any of the 38 cases.', 'two reported in Italy and two reported in France', 'All hospitalised cases had a benign clinical evolution except four,', 'were admitted to intensive care and required respiratory support and one French case died.', 'was hospitalised for 21 days and required intensive care and mechanical ventilation for 19 days', 'a median of 13 days (range: 8-23 days)', 'according to specific assays targeting at least two separate genes (envelope (E) gene as a screening test and RNA-dependent RNA polymerase (RdRp) gene or nucleoprotein (N) gene for confirmation) ', '15 had positive nasopharyngeal swabs, nine had positive throat swabs, three cases had positive sputum, two had a positive nasal swab, one case had a positive nasopharyngeal aspirate and one a positive endotracheal aspirate.', 'there are 4,250 cases including 113 deaths reported among 38 countries', 'sporadic cases among travellers from China (14 cases) and cases who acquired infection due to subsequent local transmission in Europe (21 cases).', 'that the time from symptom onset to hospitalisation/case isolation was about 3 days longer for locally acquired cases than for imported cases.', \"significant resources for contact tracing and quarantine, and countries should be prepared to allocate considerable public health resources during the containment phase, should local clusters emerge in their population. In addition, prompt sharing of information on cases and contacts through international notification systems such as the International Health Regulations (IHR) mechanism and the European Commission's European Early Warning and Response System is essential to contain international spread of infection.\\n\", 'had a history of travel to China', 'Testing of suspected cases based on geographical risk of importation needs to be complemented with additional approaches to ensure early detection of local circulation of COVID-19, including through testing of severe acute respiratory infections in hospitals irrespectively of travel history as recommended in the WHO case definition updated on 27 February 2020 ', 'include fever among several clinical signs or symptoms indicative for the suspected case definition.', 'to help plan for the impact on the healthcare system and the wider population.', 'to understand the proportion of cases who are asymptomatic.', 'help estimate the incidence of severe cases and identify risk factors for severity and death', 'Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose. In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2', 'will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread.', ' to complement surveillance data to build knowledge on the infectious period, modes of transmission, basic and effective reproduction numbers, and effectiveness of prevention and case management options also in settings outside of China.', \"a 'Valley of Death' 1,2 no less, between broadening strides in fundamental biomedical research and their incommensurate reach into the clinic. \", ' recent changes in the structure of government funding, 2 new public and private joint ventures and specialist undergraduate and postgraduate courses', 'exponentially, up 1800%', \"by creatively leveraging the so-called 'strengths' of viruses. Viral RNA polymerisation and reverse transcription enable resistance to treatment by conferring extraordinary genetic diversity. \", ' by strongly limiting virus genome sizes and their incorporation of new information. ', \"'information economy paradox'.\", 'by manipulating multifunctional or multitasking host cell proteins (MMHPs), thereby maximising host subversion and viral infectivity at minimal informational cost.', ' via host-oriented therapies to impose devastating informational and fitness barriers on escape mutant selection.', 'since MMHPs are often conserved targets within and between virus families,', ' break the vicious cycle of escalating therapeutic development costs and trivial escape mutant selection, both quickly and in multiple places. ', ' alternative posttranslational and RNA-based antiviral approaches, designer vaccines, immunotherapy and the emerging field of neo-virology.', ' will enable the tapping of useful new biological functions and processes, methods for controlling infection, and the deployment of symbiotic or subclinical viruses in new therapies and biotechnologies that are so crucially needed.', 'stimulate expression of numerous host inflammatory factors that support recruitment and activation of immune cells. ', 'this same process also causes immunopathology when prolonged or deregulated.', 'post-transcriptionally control expression of crucial inflammatory factors in various tissues and their potential therapeutic applications', 'tristetraprolin and AUF1', 'promote degradation of AU-rich element (ARE)-containing mRNA', 'members of the Roquin and Regnase families', 'promote or effect degradation of mRNAs harbouring stem-loop structures', 'RNA methylation machinery', 'in controlling inflammatory mRNA stability.', ' in various subcellular compartments ', 'are differentially regulated', \"a 'brake' on the immune system\", 'may ultimately be toggled therapeutically', 'Another mRNA under post-transcriptional regulation by Regnase-1 and Roquin', ' Furin', 'a conserved proprotein convertase crucial in human health and disease.', ' in immune regulation, cancer and the entry, maturation or release of a broad array of evolutionarily diverse viruses including human papillomavirus (HPV), influenza (IAV), Ebola (EboV), dengue (DenV) and human immunodeficiency virus (HIV)', ' the roles of furin in these processes, as well as the history and future of furin-targeting therapeutics.', 'how two IFN-cinducible factors exhibit broad-spectrum inhibition of IAV, measles (MV), zika (ZikV) and HIV by suppressing furin activity.', ' a recent boom in metagenomics and the cataloguing of the microbiome of our world.', ' to directly sequence an RNA virus genome (IAV)', 'a near-complete picture of the main armaments in the human antiviral arsenal. ', 'examination of the types and roles of viruses and antiviral defences that exist throughout our biosphere.', 'as a revolutionary gene-editing biotechnology in plants and animals.', 'the ancient lineage of nucleocytosolic large DNA viruses (NCLDVs)', 'emerging human pathogens that possess enormous genomes of up to several megabases in size encoding hundreds of proteins with unique and unknown functions.', ' the true number may be in the millions and many harbour zoonotic potential. ', ' an emerging field engaged in cataloguing and characterising this biodiversity through a global consortium.', 'a vast wealth of currently unexplored biodiversity, leading to biotechnologies and treatments that leverage the host-virus interactions developed throughout evolution.', 'Supporting industry-academia collaboration and nurturing talent and skills in the Indo-Pacific region', 'antimicrobial resistance, global health and health security, drug repurposing and translational research infrastructure,', 'Establishing durable international relationships that integrate diverse expertise', 'translating the biomedical research output of that country.', 'as to whether or not our seasonal or pandemic flu might have another reservoir host.', 'Bat is believed to harbor many more viruses than we ever thought as a reservoir host or even a susceptible host ', 'potential human infecting HKU-1, 4, 5 and 9 [17, 18] . Recent MERS-CoV infection is another example for severe disease caused by used-to-be-less pathogenic coronaviruses. Shi and colleagues [19] by using NGS have discovered many unknown animal viruses from bat, especially some important paramyxoviruses and reoviruses. Filovirus has also been identified in bat with potential severe outcomes. Lyssaviruses (with many genotypes, including rabies virus) in the Rhabdoviridae family have been linked with severe fatal human cases, even in the developed countries, including Australia, with the bites of bats in the city [20, 21] .', 'reverse transcription polymerase chain reaction (RT-PCR)', '50 million deaths worldwide', 'An estimated one third of the world’s population (or\\nz500 million persons) were infected and had clinical-\\nly apparent illnesses', 'Case-\\nfatality rates were >2.5%, compared to <0.1% in other\\ninﬂuenza pandemics', 'Total deaths were estimated at\\nz50 million (577) and were arguably as high as 100 mil-\\nlion ', ' All inﬂuenza A pandemics since that time, and\\nindeed almost all cases of inﬂuenza A worldwide (except-\\ning human infections from avian Viruses such as H5N1 and\\nH7N7), have been caused by descendants of the 1918\\nVirus, including “drifted” H1N1 Viruses and reassorted\\nH2N2 and H3N2 Viruses.', 'The latter are composed of key\\ngenes from the 1918 Virus, updated by subsequently-incor—\\nporated avian inﬂuenza genes that code for novel surface\\n\\n \\n\\n*Armed Forces Institute of Pathology, Rockville, Maryland, USA;\\nand TNational Institutes of Health, Bethesda, Maryland, USA\\n\\nproteins, making the 1918 Virus indeed the “mother” of all\\npandemics.', 'That question did not begin to be resolved until the 1930s,\\nwhen closely related inﬂuenza Viruses (now known to be\\nH1N1 Viruses) were isolated, ﬁrst from pigs and shortly\\nthereafter from humans. Seroepidemiologic studies soon\\nlinked both of these viruses to the 1918 pandemic', ' descendants of the 1918\\nVirus still persists enzootically in pigs. They probably also\\ncirculated continuously in humans, undergoing gradual\\nantigenic drift and causing annual epidemics, until the\\n1950s. With the appearance of a new H2N2 pandemic\\nstrain in 1957 (“Asian ﬂu”), the direct H1N1 Viral descen-\\ndants 0f the 1918 pandemic strain disappeared from human\\ncirculation entirely, although the related lineage persisted\\nenzootically in pigs.', ' But in 1977, human H1N1 Viruses\\nsuddenly “reemerged” from a laboratory freezer (9). They\\ncontinue to circulate endemically and epidemically.', ' 2 major descendant lineages of the 1918\\nH1N1 Virus, as well as 2 additional reassortant lineages,\\npersist naturally: a human epidemic/endemic H1N1 line-\\nage, a porcine enzootic H1N1 lineage (so-called classic\\nswine ﬂu), and the reassorted human H3N2 Virus lineage,\\nwhich like the human H1N1 Virus, has led to a porcine\\nH3N2 lineage.', 'None of these Viral descendants, however,\\napproaches the pathogenicity of the 1918 parent Virus.', 'the human H1N1 and H3N2 lin-\\neages have both been associated with substantially lower\\nrates ofillness and death than the virus of 1918. In fact, cur-\\nrent H1N1 death rates are even lower than those for H3N2\\nlineage strains (prevalent from 1968 until the present).', 'H1N1 Viruses descended from the 1918 strain, as well as \\nH3N2 Viruses, have now been cocirculating worldwide for\\n29 years and show little evidence of imminent extinction.', 'ongoing studies to map Virulence\\nfactors are yielding interesting results. The 1918 sequence\\ndata, however, leave unanswered questions about the ori-\\ngin of the Virus (19) and about the epidemiology of the\\npandemic.', 'Historical and epidemiologic data are inade-\\nquate to identify the geographic origin of the Virus (21),\\nand recent phylogenetic analysis of the 1918 Viral genome\\ndoes not place the Virus in any geographic context', 'Confounding deﬁnite assignment of a geographic\\npoint of origin, the 1918 pandemic spread more or less\\nsimultaneously in 3 distinct waves during an z12-month\\nperiod in 191871919, in Europe, Asia, and North America\\n(the ﬁrst wave was best described in the United States in\\nMarch 1918)', 'the simultaneous (or nearly simultaneous) infection\\nof humans and swin', 'Historical records since the 16th century suggest that\\nnew inﬂuenza pandemics may appear at any time of year,\\nnot necessarily in the familiar annual winter patterns of\\ninterpandemic years,', 'confronted by the selection pressures of population immu-\\nnity, these pandemic Viruses begin to drift genetically and\\neventually settle into a pattern of annual epidemic recur-\\nrences caused by the drifted Virus variants.', ' a ﬁrst or spring wave\\nbegan in March 1918 and spread unevenly through the\\nUnited States, Europe, and possibly Asia over the next 6\\nmonths', ' Illness rates were high, but death rates\\nin most locales were not appreciably above normal.', ' A sec-\\nond or fall wave spread globally from September to\\nNovember 1918 and was highly fatal. In many nations, a\\nthird wave occurred in early 1919 ', 'the much higher fre-\\nquency of complicated, severe, and fatal cases in the last 2\\nwaves.', 'The occurrence, and to some extent the severity, of recur-\\nrent annual outbreaks, are driven by Viral antigenic drift,\\nwith an antigenic variant Virus emerging to become domi-\\nnant', ' lower environ-\\nmental temperatures and human nasal temperatures (bene-\\nﬁcial to thermolabile Viruses such as inﬂuenza), optimal\\nhumidity, increased crowding indoors, and imperfect ven-\\ntilation due to closed windows and suboptimal airﬂow', 'such factors cannot explain the 3 pandemic\\nwaves of 1918-1919, which occurred in the spring-sum-\\nmer, summer—fall, and winter (of the Northern\\nHemisphere), respectively. The ﬁrst 2 waves occurred at a\\ntime of year normally unfavorable to inﬂuenza Virus\\nspread. The second wave caused simultaneous outbreaks\\nin the Northern and Southern Hemispheres from\\nSeptember to November. ', 'pandemic Virus samples we have\\nyet identiﬁed are from second-wave patients', 'nothing\\ncan yet be said about whether the ﬁrst (spring) wave, or for\\nthat matter, the third wave, represented circulation of the\\nsame Virus or variants of it', 'Viral sequence data now suggest that the entire 1918\\nVirus was novel to humans in, or shortly before, 1918, and\\nthat it thus was not a reassortant Virus produced from old\\nexisting strains that acquired 1 or more new genes', 'Inﬂuenza Virus gene\\nsequences from a number ofﬁxed specimens ofwild birds\\ncollected circa 1918 show little difference from avian\\nViruses isolated today, indicating that avian Viruses likely\\nundergo little antigenic change in their natural hosts even\\nover long periods', 'The curve of inﬂuenza deaths by age at death has histor-\\nically, for at least 150 years, been U-shaped (Figure 2),\\nexhibiting mortality peaks in the very young and the very\\nold, with a comparatively low frequency of deaths at all\\nages in between', 'age-speciﬁc death rates in the\\n1918 pandemic exhibited a distinct pattern that has not been\\ndocumented before or since: a “W—shaped” curve, similar to\\nthe familiar U-shaped curve but with the addition of a third\\n(middle) distinct peak of deaths in young adults z20410\\nyears of age', 'Persons 65 years of age in 1918 had a dispro-\\nportionately high inﬂuenza incidence', 'those 5 to 14\\nyears of age accounted for a disproportionate number of\\ninﬂuenza cases, but had a much lower death rate from\\ninﬂuenza and pneumonia than other age groups. ', ' the 1918 Virus had an intrinsically high Virulence, tem-\\npered only in those patients who had been born before\\n1889, e.g., because of exposure to a then-circulating Virus\\ncapable of providing partial immunoprotection against the\\n1918 Virus strain only in persons old enough (>35 years) to\\nhave been infected during that prior era ', ' the 1918\\npandemic was different in degree, but not in kind, from\\nprevious and subsequent pandemics. Despite the extraordi-\\nnary number of global deaths, most inﬂuenza cases in\\n1918 (>95% in most locales in industrialized nations) were\\nmild and essentially indistinguishable from inﬂuenza cases\\ntoday. ', 'the 1918 and 1918-like Viruses would be\\nas sensitive as other typical Virus strains to the Food and\\nDrug Administrationiapproved antiinﬂuenza drugs riman-\\ntadine and oseltamivir.', 'Clinically and pathologically, these\\nhigh death rates appear to be the result of several factors,\\nincluding a higher proportion of severe and complicated\\ninfections of the respiratory tract, rather than involvement\\nof organ systems outside the normal range of the inﬂuenza\\nVirus. Also, the deaths were concentrated in an unusually\\nyoung age group', 'While data bearing\\non inﬂuenza Virus human cell adaptation (e.g., receptor\\nbinding) are beginning to be understood at the molecular\\nlevel, the basis for Viral adaptation to efﬁcient human-to-\\nhuman spread, the chief prerequisite for pandemic emer-\\ngence, is unknown for any inﬂuenza Virus.', 'exponential growth pattern', '469 (95% CI: 403&minus;540) unreported cases from 1 to 15 Januar', 'basic reproduction number,', 'reased 21-fold (95% CI: 18', '019-nCoV at 2.56 (95% CI', ' to have occurred during the first ha', 's first identified in Wuhan, China', 'ymptoms including fever, cough, and sh', 'sed', 'k had resulted in 2066 (618 of them are in Wuhan) confirmed cases and 56 (45 of them were in Wuhan) deaths in ', ' were reported in Thailand, Japan, Republic of Korea, Hong Kong, Taiwan, Australia, and', 'at there had been 4000 (95%CI: 1000-9700) cases in Wuhan with symptoms onset by 18 January 2020, and the basic reproduction number (R 0 ) was estimated at 2.6 (95', 'y released by the Wuhan Municipal ', ', and later by the National Health C', ', the C i series, as an exponential growi', ', the C i series, as an exponential growin', 'bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes.', 'Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses.', 'the external subdomain of Spike’s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. ', ' its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands.', 'Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus', 'Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA viruses that belong to the subfamily Coronavirinae, family Coronavirdiae, order Nidovirales.', 'Alphacoronavirus (αCoV), Betacoronavirus (βCoV), Deltacoronavirus (δCoV), and Gammacoronavirus (γCoV) ', ' that bats and rodents are the gene sources of most αCoVs and βCoVs, while avian species are the gene sources of most δCoVs and γCoVs.', 'severe acute respiratory syndrome CoV (SARS-CoV) which emerged in China in 2002-2003 to cause a large-scale epidemic with about 8000 infections and 800 deaths, and Middle East respiratory syndrome CoV (MERS-CoV) which has caused a persistent epidemic in the Arabian Peninsula since 2012', 'these viruses have likely originated from bats and then jumped into another amplification mammalian host [the Himalayan palm civet (Paguma larvata) for SARS-CoV and the dromedary camel (Camelus dromedarius) for MERS-CoV] ', '6 CoVs were known to infect human, including 2 αCoV (HCoV-229E and HKU-NL63) and 4 βCoV (HCoV-OC43 [ ', 'self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and elderly ', ' SARS-CoV (lineage B βCoV) and MERS-CoV (lineage C βCoV) may cause severe lower respiratory tract infection with acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea, lymphopenia, deranged liver and renal function tests, and multiorgan dysfunction syndrome, among both immunocompetent and immunocompromised hosts with mortality rates of ∼10% and ∼35%, respectively ', 'a familial cluster of 2019-nCoV infection in a Shenzhen family with travel history to Wuhan ', 'a 2019-nCoV complete genome from a patient in this familial cluster and compared it with the genomes of related βCoVs to provide insights into the potential source and control strategies.', '2019-nCoV HKU-SZ-005b was available at GenBank (accession no. MN975262)', 'strains collected from human, bats, and Himalayan palm civet between 2003 and 2018, with one 229E coronavirus strain as the outgroup.', ' by the neighbour joining method was performed using MEGA X software, with bootstrap values being calculated from 1000 trees', 'using the Poisson correction method and were in the units of the number of amino acid substitutions per site [', 'using PSI-blast-based secondary structure PREDiction (PSIPRED) ', ' initial amino acid sequences were input and analysed using neural networking and its own algorithm. ', '29891 nucleotides in size, encoding 9860 amino acids', '38%', 'There are no remarkable differences between the orfs and nsps', ' in orf3b, Spike and orf8 but especially variable in Spike S1 and orf8 which were previously shown to be recombination hot spots.', 'The S1 subunit contains a signal peptide, followed by an N-terminal domain (NTD) and receptor-binding domain (RBD), while the S2 subunit contains conserved fusion peptide (FP), heptad repeat (HR) 1 and 2, transmembrane domain (TM), and cytoplasmic domain (CP).', 'S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs (SL-CoV ZXC21 and ZC45) and human SARS-CoV ', ' the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials ', 'Though the S1 subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV (Figure 3(A) ), the core domain of RBD (excluding the external subdomain) are highly conserved (', 'Most of the amino acid differences of RBD are located in the external subdomain,', ' the external subdomain,', 'its receptor usage, interspecies transmission and pathogenesis.', 'bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain (RBD) when compared with that of human SARS-CoV', 'Yunnan strains such as the WIV1', 'can use human ACE2 as a cellular entry receptor. ', 'can infect suckling rats and cause inflammation in the brain tissue, and pathological changes in lung & intestine. ', 'The two retained deletion sites in the Spike genes of ZXC21 and ZC45', \" that different orf3b proteins display different IFN antagonist activities and this function is independent of the protein's nuclear localization, suggesting a potential link between bat SARS-related-CoV orf3b function and pathogenesis.\", 'an accessory protein found in the Betacoronavirus lineage B coronaviruses', 'fulllength orf8', 'two bat SARS-related-CoV (Bat-CoV YNLF_31C and YNLF_34C) ', 'the group that includes the closest genome sequences of bat SARS-related-CoV ZXC21 and ZC45. ', 'the new 2019-nCoV orf8 is distant from the conserved orf8 ', 'to trigger intracellular stress pathways and activates NLRP3 inflammasomes', 'to form a protein with an alpha-helix, following with a betasheet(s) containing six strands ', '2019-nCoV is a novel lineage B Betacoronavirus closely related to bat SARS-related coronaviruses. It also has unique genomic features which deserves further investigation to ascertain their roles in viral replication cycle and pathogenesis. More animal sampling to determine its natural animal reservoir and intermediate animal host in the market is important. This will shed light on the evolutionary history of this emerging coronavirus which has jumped into human after the other two zoonotic Betacoroanviruses, SARS-CoV and MERS-CoV.', 'Wuhan, Hubei Province, China', 'Global Initiative on Sharing All Influenza Data (GISAID) (https://www.gisaid.org/)', 'E and RdRp genes', 'smokers were 1.4 times more likely (RR=1.4, 95% CI: 0.98–2.00) to have severe symptoms of COVID-19 and approximately 2.4 times more likely to be admitted to an ICU, need mechanical ventilation or die compared to non-smokers (RR=2.4, 95% CI: 1.43–4.04)', 'Previous studies have shown that smokers are twice more likely than non-smokers to contract influenza and have more severe symptoms, while smokers were also noted to have higher mortality in the previous MERS-CoV outbreak', 'limited information available regarding incubation time, transmissibility, and virus origin', 'Washington', 'January 15, 2020', 'January 24, 2020', 'Chicago', 'January 30, 2020', 'January 30, 2020', 'January 31, 2020,', 'Fever and cough ', 'patients with underlying medical conditions and the elderly', 'patients with underlying medical conditions and the elderly', 'between 2 and 14 days', 'close contact with an infected person', 'Although the likelihood of coinfection of 2019-nCoV and another respiratory virus is thought to be low, a positive finding of another respiratory pathogen does not exclude the diagnosis of 2019-nCoV', '168 million people across 50 countries', 'those in complex humanitarian crises, which lack the infrastructure, support, and health systems to mount a comprehensive response. ', 'Poor governance, public distrust, and political violence ', 'Populations affected by humanitarian crises ', 'due to displacement, crowded housing, malnutrition, inadequate water, sanitation, and hygiene (WASH) tools, and stigmatization', 'Disease outbreaks further reduce access to limited healthcare, which is increasingly disrupted by attacks on health facilities and the persistent overburdening of health systems. ', ' limited public health, laboratory, and primary care services ', 'Providing the limited healthcare worker cadre with appropriate training and personal protective equipment, and ensuring a continuous supply chain ', ' Frequent displacement and limited contact information ', 'overcrowding limit the implementation of both quarantine of those exposed and isolation of those who are ill. ', 'increased vulnerabilities, humanitarian crises', 'to protect healthcare workers, develop and deploy rapid testing, improve surveillance, and enact quarantine and isolation of contacts and cases.', ' Respiratory hygiene i', 'hand hygiene, safe cough practice, and social distancing [', ' the distribution of soap to households in humanitarian settings has been shown to increase handwashing by over 30%', 'the rights to dignity and to fully participate in decisions related to assistance in humanitarian crises. ', 'Widespread introduction of alcohol-based hand rubs ', 'The Sphere Handbook, a collection of rights-based guidelines for humanitarian response', ' reducing both bacterial and viral pathogen transmission,', 'evidence pertaining to the prevention of illnesses transmitted by the faecal-oral route, with the focus on hand hygiene proximate to latrines', 'latrines in crisis settings are often shared and distant from residential shelters,', ' for accessing latrine-adjacent handwashing stations, particularly for hand hygiene to prevent respiratory pathogen transmission.', 'Crisis-affected community engagement is integral in pandemic planning,', ' mitigation plans will fall short of health and human rights obligations in outbreak response', 'Transparent and credible information-sharing mechanisms ', 'Diplomacy bridging long-standing mistrust of public health and biomedical interventions and facilitating engagement with contentious actors ', 'During the 1918-1919 influenza pandemic, between 21 and 25 million people died of influenza worldwide.', 'Malnutrition weakened the human immune system and made a person more vulnerable to infectious diseases like tuberculosis and influenza, therefore, hunger and malnutrition were indirectly responsible for millions of deaths in the world in that period of time.', ' in 1918 and 1919, physicians and nurses almost had nothing in their hands to help individuals who were infected by influenza viruses. T', ' Today, although we still do not have very effective, powerful, and practical anti-influenza drugs available, we at least have some improved, useful, and helpful anti-viral drugs like zanamivir, and effective, convenient anti-cold medicines like Tylenol or Advil.', ' in the United States of America, the influenza classed mortality rate declined from 10.2/100,000 in the 1940s to 0.56/100,000 in the 1990s; and the classed mortality rates of 1957-1958 and 1968-1969 influenza pandemics were not remarkably different from the non-pandemic seasons', 'We do not have a universal vaccine to prevent all influenza virus infections, but we can make effective vaccines to a specific influenza virus strain in a short time.', 'that most cases of H1N1 influenza A virus infections were mild, the symptomatic case fatality rate was only 0.005% in New Zealand (16) ; and in New York City, the case fatality rate was 0.0094-0.0147% for persons ≥65 years old, and for those of 0-17 years old, the case fatality rate was 0.0008-0.0012% (17) .', 'Nowadays, we travel faster, and we travel more frequently and globally, and we have more complicated social activities and lifestyles, thereby increasing the chances of viral mutation; and we realize that influenza viruses are even easier to reassort, recombine, and mutate in nature than many other RNA viruses.', ' influenza virus infections are controllable and preventable, with the increased population health and immunity, with the WHO Global Influenza Surveillance and Response System, and with standard/routine epidemiological practices, and with new effective anti-viral agents and vaccines in production in the future. ', ' the detected 32.14% (45/140, one case from Taiwan, and one case from Hong Kong) (22, 23).\\n', \"most people usually think a common cold is a very common and normal occurrence, and they don't take flu-like illnesses seriously. In most situations, they would just stay home and take some medicines. Only those who have very severe flu-like symptoms would see doctors, and thereby be detected and diagnosed, accordingly the real case fatality rate should be much lower\", 'single-strand RNA filoviruses', '2013-2016', 'African bats', 'a maintenance function play by the host(s)', 'infectious transmission pathways between hosts']\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"id":"bhnP06yLS6yf","executionInfo":{"status":"ok","timestamp":1601558235809,"user_tz":-330,"elapsed":1161,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# use pandas to create dataframe\n","import pandas as pd"],"execution_count":12,"outputs":[]},{"cell_type":"code","metadata":{"id":"uYB6irqSS7Qk","executionInfo":{"status":"ok","timestamp":1601558289550,"user_tz":-330,"elapsed":1246,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# get the list of tuples from two lists and merge them by using zip().  \n","list_of_tuples = list(zip(question_list, answer_list))"],"execution_count":13,"outputs":[]},{"cell_type":"code","metadata":{"id":"QbdbEDIPS7E_","executionInfo":{"status":"ok","timestamp":1601558346782,"user_tz":-330,"elapsed":1163,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# Converting lists of tuples into pandas Dataframe.  \n","df = pd.DataFrame(list_of_tuples, columns = ['Questions', 'Answers'])"],"execution_count":15,"outputs":[]},{"cell_type":"code","metadata":{"id":"v5wjJegDS6e1","executionInfo":{"status":"ok","timestamp":1601558351563,"user_tz":-330,"elapsed":1177,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}},"outputId":"5c86a29b-ea4e-467b-b994-7f0ac55e076a","colab":{"base_uri":"https://localhost:8080/","height":204}},"source":["# check the questions and answers\n","df.head()"],"execution_count":16,"outputs":[{"output_type":"execute_result","data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Questions</th>\n","      <th>Answers</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>What is the main cause of HIV-1 infection in c...</td>\n","      <td>Mother-to-child transmission (MTCT) is the mai...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>What plays the crucial role in the Mother to C...</td>\n","      <td>DC-SIGNR plays a crucial role in MTCT of HIV-1...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>How many children were infected by HIV-1 in 20...</td>\n","      <td>more than 400,000 children were infected world...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>What is the role of C-C Motif Chemokine Ligand...</td>\n","      <td>High copy numbers of CCL3L1, a potent HIV-1 su...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>What is DC-GENR and where is  it expressed?</td>\n","      <td>Dendritic cell-specific ICAM-grabbing non-inte...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["                                           Questions                                            Answers\n","0  What is the main cause of HIV-1 infection in c...  Mother-to-child transmission (MTCT) is the mai...\n","1  What plays the crucial role in the Mother to C...  DC-SIGNR plays a crucial role in MTCT of HIV-1...\n","2  How many children were infected by HIV-1 in 20...  more than 400,000 children were infected world...\n","3  What is the role of C-C Motif Chemokine Ligand...  High copy numbers of CCL3L1, a potent HIV-1 su...\n","4        What is DC-GENR and where is  it expressed?  Dendritic cell-specific ICAM-grabbing non-inte..."]},"metadata":{"tags":[]},"execution_count":16}]},{"cell_type":"code","metadata":{"id":"sEcA5XyjUm-W","executionInfo":{"status":"ok","timestamp":1601558580909,"user_tz":-330,"elapsed":1212,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# convert this file to csv file\n","df.to_csv('/content/drive/My Drive/2020_Intern_03_VIIT_03_Chatbot/Coding Part (Implementation)/Database and JSON/All Data/QA List Data/COVID_QA.csv')"],"execution_count":17,"outputs":[]},{"cell_type":"code","metadata":{"id":"ot5K9FrwVeWW","executionInfo":{"status":"ok","timestamp":1601558721337,"user_tz":-330,"elapsed":1014,"user":{"displayName":"Sanket Sonje","photoUrl":"","userId":"05822068833245189120"}}},"source":["# file successfully exported to the mentioned path\n","# path = /content/drive/My Drive/2020_Intern_03_VIIT_03_Chatbot/Coding Part (Implementation)/Database and JSON/All Data/QA List Data/COVID_QA.csv\n","# DATA - PRE-PROCESSING IS REMAINING"],"execution_count":18,"outputs":[]},{"cell_type":"code","metadata":{"id":"QoWAbzgDVq6E"},"source":[""],"execution_count":null,"outputs":[]}]}